id,trn_extracted,dual_coded,timestamp_finished,incidental_screening,incidental_screening_changes,incidental_screening_comment,comments
tri00635,ChiCTR2000031494,TRUE,2021-10-14T08:08:11Z,NA,NA,NA,"Unclear whether date in both pubs is completion date: This study was a single-center open-label, individually randomized, standard treatment-controlled trial conducted at Huangshi Hospital of Traditional Chinese Medicine in Hubei Province from Feb 12 to March 25, 2020"
tri03049,NCT04351152,TRUE,2021-10-14T08:11:48Z,NA,NA,NA,Recent press release on results so maybe publication soon
tri03365,NCT04371822,TRUE,2021-10-07T06:10:26Z,NA,NA,NA,NA
tri02287,NCT04400799,TRUE,2021-10-07T05:10:41Z,NA,NA,NA,NA
tri02371,NCT04403243,TRUE,2021-10-07T05:13:30Z,NA,NA,NA,NA
tri02490,NCT04405544,TRUE,2021-10-07T05:27:47Z,NA,NA,NA,NA
tri05983,NCT04508439,TRUE,2021-10-07T05:23:01Z,NA,NA,NA,NA
tri06493,NCT04577378,TRUE,2021-10-07T05:12:07Z,NA,NA,NA,NA
tri00803,ACTRN12620000468921,TRUE,2021-10-07T07:29:39Z,NA,NA,NA,NA
tri00893,NCT04252664,TRUE,2021-10-07T07:28:17Z,NA,NA,NA,NA
tri00006,NCT04261426,TRUE,2021-10-14T08:35:17Z,TRUE,FALSE,"Unclear whether the trial was withdrawn. Preprint at doi.org/10.2139/ssrn.3696870 indicates trial not preformed: 'Early this year, we initiated a randomized controlled trials in China, to evaluate the benefit of high-dose IVIg in severe COVID-19 patients comparing with standard care (NCT04261426). Unfortunately, the randomization was not carried out due to force majeure at that time in China. However, high-dose IVIg was used as planned in severe COVID-19 patients in participating centers.' However, another study (published in Nov 2020) indicates it is ongoing: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665876/ 'There are two ongoing clinical trials (NCT04411667 and NCT04261426) that are evaluating the effectiveness of administering high dose of IVIg in confirmed SARS-CoV-2 patients.'","Incidental screening. Preprint at doi.org/10.2139/ssrn.3696870 indicates trial not preformed: Early this year, we initiated a randomized controlled trials in China, to evaluate the benefit of high-dose IVIg in severe COVID-19 patients comparing with standard care (NCT04261426). Unfortunately, the randomization was not carried out due to force majeure at that time in China. However, high-dose IVIg was used as planned in severe COVID-19 patients in participating centers.\n\nPeter (2021-04-04) However, this study still refers to it as ongoing (published in Nov 2020): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665876/  There are two ongoing clinical trials (NCT04411667 and NCT04261426) that are evaluating the effectiveness of administering high dose of IVIg in confirmed SARS-CoV-2 patients."
tri06492,NCT04577235,TRUE,2021-10-14T08:25:20Z,NA,NA,NA,Diagnostic and not really intervention trial. They compared ultrasound and CT scores
tri06786,NCT04622826,TRUE,2021-10-06T02:39:29Z,NA,NA,NA,NA
tri02130,NCT04384445,TRUE,2021-10-14T08:37:54Z,NA,NA,NA,NA
tri00303,ChiCTR2000030475,TRUE,2021-10-07T07:27:46Z,NA,NA,NA,NA
tri00445,ChiCTR2000030476,TRUE,2021-10-07T07:31:05Z,NA,NA,NA,rehab trial which we exclude. No acute outcomes.
tri01648,IRCT20180129038542N1,TRUE,2021-10-07T04:40:31Z,NA,NA,NA,NA
tri02245,NCT04331600,TRUE,2021-10-07T05:08:16Z,NA,NA,NA,https://www.umed.wroc.pl/content/wroclaw-corona-study-2020 website of the study
tri01324,NCT04366180,TRUE,2021-10-07T04:35:10Z,NA,NA,NA,NA
tri01974,NCT04390139,TRUE,2021-10-07T04:47:14Z,TRUE,FALSE,In a publication from Jan 2021 the trial is described to as ready to go but likely did not kick off yet: 'We have designed and completed all administrative and regulatory procedures needed to initiate a phase I/II clinical trial (COVIDMES; clinicaltrials.gov identifier: NCT04390139) to assess the efficacy and safety of Wharton's jelly MSC in patients with COVID-19 ARDS with the participation of five Catalan hospitals. We will begin to prepare production of new batches of such cells should this trial prove effective.' see: https://europepmc.org/article/MED/33539280,"Tjada searched after Peter, They now updated registry entry, no full search needed - completion date now in 2021."
tri00181,ChiCTR2000029956,TRUE,2021-10-14T08:28:02Z,NA,NA,NA,"The objectives here are: Increased resistance during recovery of cured patients of COVID-19, reducing and reducing the risk of repeated infection with COVID-19. \n\nThis has a prevention component for reinfection but it's mainly a study about rehab."
tri00416,ChiCTR2000030720,TRUE,2021-10-07T07:29:52Z,NA,NA,NA,"Once again, it's for patients in &quot;recovery&quot; so no really treatment or prevention"
tri00513,ChiCTR2000030922,TRUE,2021-10-07T07:31:36Z,NA,NA,NA,NA
tri02209,ChiCTR2000033286,TRUE,2021-10-07T05:05:43Z,NA,NA,NA,NA
tri04006,JPRN-UMIN000040837,TRUE,2021-10-07T08:47:57Z,NA,NA,NA,NA
tri04701,CTRI/2020/06/026220,TRUE,2021-10-07T06:29:15Z,NA,NA,NA,NA
tri00894,NCT04257656,TRUE,2021-10-14T08:32:21Z,NA,NA,NA,NA
tri00895,NCT04273646,TRUE,2021-10-07T07:27:51Z,NA,NA,NA,NA
tri02082,NCT04393961,TRUE,2021-10-07T04:55:05Z,NA,NA,NA,Diagnostic
tri06469,NCT04573270,TRUE,2021-10-07T05:13:30Z,NA,NA,NA,NA
tri00424,ChiCTR2000030703,TRUE,2021-10-07T07:30:24Z,TRUE,FALSE,"The protocol makes it clear this research is ongoing:\n\nTrial registration number is ChiCTR2000030703 (version 1.7 as of March 19, 2020). The recruitment is ongoing, and the date recruitment was initiated in June 2020. The anticipated date of the end of data collection is June 2021.",NA
tri01243,ISRCTN83971151,TRUE,2022-03-03T02:23:03Z,NA,NA,NA,"There is some weirdness about DISCOVERY and its role in SOLIDARITY and whether we should consider it it's own trial or just the French wing of SOLIDARITY. See the DISCOVERY protocol:\nhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507250/\n\nAlso in the NEJM SOLIDARITY publication they give the ClinicalTrials.gov ID for DISCOVERY alongside SOLIDARITY. It looks like DISCOVERY feeds data to SOLIDARITY through a common protocol but may also be recording its own data. For our purposes I'm inclined to think it might be better to combine. If so, we would add the DISCOVERY IDs to the cross-registrations above. (NCT04315948 and whatever the EUCTR entry is)"
tri02683,DRKS00021447,TRUE,2021-10-07T05:38:11Z,NA,NA,NA,NA
tri02699,DRKS00021573,TRUE,2021-10-07T05:39:08Z,NA,NA,NA,NA
tri04704,CTRI/2020/06/026221,TRUE,2021-10-07T06:29:57Z,NA,NA,NA,NA
tri02445,NCT04292730,TRUE,2021-10-07T05:16:41Z,NA,NA,NA,NA
tri02446,NCT04292899,TRUE,2021-11-10T01:21:01Z,NA,NA,NA,NA
tri02091,NCT04306393,TRUE,2021-10-07T05:02:01Z,NA,NA,NA,NA
tri02447,NCT04320615,TRUE,2021-11-10T01:35:58Z,NA,NA,NA,NA
tri00744,NCT04322773,TRUE,2021-09-14T11:47:36Z,NA,NA,NA,"EUCTR has study completion as the day after CT.gov, so I've switched it to that. PCD remains the same."
tri03748,NCT04327388,TRUE,2021-10-07T06:28:14Z,NA,NA,NA,NA
tri03295,NCT04335136,TRUE,2021-10-26T05:09:18Z,NA,NA,NA,NA
tri02334,NCT04351516,TRUE,2021-10-07T05:12:20Z,NA,NA,NA,Cross-reg: 2020-001482-37\n\nProtocol: https://clinicaltrials.gov/ct2/bye/rQoPWwoRrXS9-i-wudNgpQDxudhWudNzlXNiZip9Ei7ym67VZRFncgCtORCJA6h9Ei4L3BUgWwNG0it\n\nNote of withdrawal on EUCTR: https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001482-37/results
tri02956,NCT04368728,TRUE,2021-10-07T05:47:15Z,NA,NA,NA,NA
tri03130,NCT04425460,TRUE,2022-09-09T13:06:23Z,NA,NA,NA,Prematurely ended according to cross-registration: EUCTR2020-001608-40 (tri04111). Possible press release: https://www.prnewswire.com/in/news-releases/zhejiang-hisun-pharmaceutical-covid-19-pandemic-brought-under-control-in-china-with-favipiravir-showing-excellent-clinical-results-829741127.html
tri03499,NCT04433910,TRUE,2021-10-21T08:40:12Z,NA,NA,NA,Looks like there are some kinda related pubs about diagnostics but not worth listing I don't think.
tri05951,NCT04501978,TRUE,2021-10-14T08:28:16Z,NA,NA,NA,Interim because this is just 1 arm of an adaptive trial (Like RECOVERY). Not adding completion date here as they are difficult to define for this trial and it's adaptive anyway so the actual completion date for the whole trial is far in the future.
tri03340,NCT04362137,TRUE,2021-10-21T08:43:05Z,NA,NA,NA,the other publication of an abstract about the trial design is what the embase link leads to
tri03212,NCT04382053,TRUE,2021-10-07T06:00:22Z,NA,NA,NA,NA
tri06926,NCT04645407,TRUE,2021-10-14T08:50:06Z,NA,NA,NA,NA
tri01483,NCT04280705,TRUE,2021-10-07T04:36:57Z,NA,NA,NA,"Same doi (10.1056/NEJMoa2007764) for both interim and full result. Recorded as both publication types.; results comment: Statistical Analysis Plan (SAP) v3; Protocol v3; Registry results updated 2020-12-09.\n\nND: 2020-04-22 was provided as the original completion date from the first round, but I've removed as I don't think that is correct. That's just the cut of the data the DSMB used to decide whether to stop the trial or not."
tri00919,NCT04333420,TRUE,2021-10-21T08:17:16Z,NA,NA,NA,These results are interim because they are the Phase 2 part of a Phase 2/3 study.\n\nAccidentally clicked the TRN searches so that's how I found the preprint (the pub was in the registry) so just added so we have documented.
tri03057,NCT04362813,TRUE,2021-10-21T08:23:55Z,NA,NA,NA,Press release showing the trial happened and completed and saying it didn't meet its endpoints and will submit a paper: https://www.novartis.com/news/media-releases/novartis-provides-update-can-covid-trial-hospitalized-patients-covid-19-pneumonia-and-cytokine-release-syndrome-crs
tri00172,ChiCTR2000029989,TRUE,2021-09-29T03:18:43Z,NA,NA,NA,NA
tri01597,ChiCTR2000029638,TRUE,2021-10-07T04:39:15Z,NA,NA,NA,Using information from the preprint and the final paper to get to completion date together (preprint makes clearer that the April date is the end of enrollment).\n\nSSRN link leads nowhere which is weird: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3622363
tri01614,IRCT20200204046369N1,TRUE,2021-10-07T04:40:03Z,NA,NA,NA,Enrolment date defaulted to 1st of month
tri02778,IRCT20200318046812N1,TRUE,2022-04-26T07:43:07Z,NA,NA,NA,Looks like follow-up was open-ended based on the time to event.
tri02322,NCT04307693,TRUE,2021-10-07T05:11:30Z,NA,NA,NA,Terminated (Terminated early because no patients were further enrolled since mid-Apr 2020.)
tri02933,NCT04315298,TRUE,2021-11-10T01:44:27Z,NA,NA,NA,NA
tri02557,NCT04315948,TRUE,2022-03-02T06:09:48Z,NA,NA,NA,We decided to make DISCOVERY it's own record separate from SOLIDARITY. SOLIDARITY results should be an &quot;Other&quot; result for DISCOVERY because the data from DISCOVERY aren't meaningfully disaggregated. Trial is still ongoing so every other result is interim.
tri00904,NCT04321174,TRUE,2021-10-21T08:55:53Z,NA,NA,NA,NA
tri02244,NCT04321278,TRUE,2021-10-07T05:07:30Z,NA,NA,NA,NA
tri02448,NCT04322123,TRUE,2021-10-07T05:25:03Z,NA,NA,NA,The SCD for this study being way in the future doesn't really make much sense based on what is registered and the finality of the publication.\n\nThe primary outcome appears to be the longest followed-up outcome (though when they assessed it was highly variable for outpatients) therefore we've selected it as Primary.
tri02016,NCT04322565,TRUE,2021-10-07T04:48:40Z,NA,NA,NA,NA
tri03026,NCT04322682,TRUE,2021-10-11T08:31:19Z,NA,NA,NA,"In the manuscript, they say LPLV was in January 2021 but don't give a specific date nor do they give a specific date for the end of enrollment."
tri03287,NCT04324463,TRUE,2021-10-07T06:01:53Z,NA,NA,NA,NA
tri02559,NCT04327401,TRUE,2021-10-07T05:30:12Z,NA,NA,NA,"Terminated (The Data Monitoring Committee recommended to stop the trial based on the Recovery Trial results, which was accepted by the CoDEX Steering Committee.)\n\nPrimary and Study completion are the same so called it Primary"
tri01279,NCT04328480,TRUE,2021-10-07T04:53:02Z,NA,NA,NA,NA
tri02451,NCT04329832,TRUE,2021-10-07T05:26:04Z,NA,NA,NA,NA
tri01097,NCT04331808,TRUE,2022-07-01T09:56:48Z,NA,NA,"This article reports on CORIMUNO-TOCI 1, a CORIMUNO, multicenter, open-label, randomized clinical trial in patients with moderate or severe pneumonia. The trial registration, NCT04331808, describes this study and a second study, CORIMUNO-TOCI 2, a trial conducted in patients with critical pneumonia. Although the 2 trials were placed under the same registration number, they are distinct studies with different participants, and were never intended to be reported together.","We decided that since the registration contained two different trial, the publication of each trial will be a full result. The first full publication of either of these 2 trials would be the one used for analysis. Sub-trial of NCT04324047/EUCTR2020-001246-18 (tri00659) observational supra-'trial' (excluded)"
tri02937,NCT04335305,TRUE,2021-10-07T05:43:12Z,NA,NA,NA,NA
tri00781,NCT04338698,TRUE,2021-10-07T07:30:12Z,NA,NA,NA,No conflicts but this review: https://www.nature.com/articles/s41467-021-22446-z confirms the trial has collected some data as they got some.
tri03303,NCT04343729,TRUE,2021-10-07T06:06:23Z,NA,NA,NA,NA
tri01424,NCT04343768,TRUE,2021-10-07T04:36:05Z,NA,NA,NA,NA
tri00953,NCT04344756,TRUE,2021-10-07T07:27:31Z,NA,NA,NA,Sub-trial of NCT04324047/EUCTR2020-001246-18 (tri00659) observational supra-'trial' (excluded)
tri00960,NCT04345445,TRUE,2021-10-07T07:27:07Z,NA,NA,NA,NA
tri03309,NCT04346355,TRUE,2022-04-26T07:43:38Z,NA,NA,NA,"results comment: On June 11, 2020, the trial Scientific Committee decided to interrupt the study for futility with an enrollment of 126 patients.\n\nSo I don't think 11 June 2020 was actually the LPLV based on what is described. It's actually unclear exactly what day was both the end of ranomdization or LPLV."
tri05356,NCT04347031,TRUE,2021-10-07T06:32:40Z,NA,NA,NA,NA
tri01007,NCT04351490,TRUE,2021-10-01T18:40:27Z,NA,NA,NA,NA
tri01123,NCT04351724,TRUE,2021-10-14T09:24:04Z,NA,NA,NA,NA
tri01899,NCT04354259,TRUE,2021-10-07T04:43:40Z,NA,NA,NA,NA
tri02335,NCT04354428,TRUE,2021-09-30T09:21:17Z,NA,NA,NA,"because the lopinavir-ritonavir arm was not reported at all, we decided to code the results as interim"
tri03327,NCT04356937,TRUE,2021-10-11T08:45:57Z,NA,NA,NA,NA
tri01168,NCT04359095,TRUE,2021-10-14T09:28:28Z,NA,NA,NA,NA
tri02580,NCT04359511,TRUE,2021-11-10T01:02:43Z,NA,NA,NA,NA
tri01906,NCT04362085,TRUE,2021-10-07T04:44:53Z,NA,NA,NA,NA
tri01514,NCT04363437,TRUE,2021-10-07T04:37:38Z,NA,NA,NA,NA
tri02467,NCT04363736,TRUE,2021-11-10T01:08:49Z,NA,NA,NA,Not really an &quot;other&quot; but this preprint used some data from this trial: https://www.medrxiv.org/content/10.1101/2020.12.23.20247379v1.full.pdf
tri03351,NCT04365582,TRUE,2021-10-07T06:10:03Z,NA,NA,NA,NA
tri03366,NCT04372186,TRUE,2021-10-07T06:11:45Z,NA,NA,NA,Full results b/c full primary endpoint results. F/u for longest secondary reported here was 60 days but doesn't really matter b/c there are more registered outcomes for a year of f/u.
tri02586,NCT04372589,TRUE,2022-04-04T05:55:03Z,NA,NA,NA,"These two NEJM papers are both full results published on the same day. They are reported as a pooled analysis, not disaggregated, of this trial plus the heparin arms of two other ongoing adaptive trials. If those were completed, this would be a lot more complicated in our data but since they are not, and are therefore not going to be data points in our final analysis anyway, we can follow the precedent from the prone positioning trial and treat this as a pooled meta-result of the three trials with this one being fully reported in a journal article. So even though we couldn't disaggregate the data from this specific registration, we feel comfortable assigning the full results to the registration based on our data."
tri01560,NCT04377750,TRUE,2021-10-07T04:38:15Z,NA,NA,NA,NA
tri01845,NCT04381858,TRUE,2021-10-07T04:43:05Z,NA,NA,NA,A little unsure about the follow-up for the secondary outcome. Seems open ended.
tri02964,NCT04381962,TRUE,2021-11-10T01:12:40Z,NA,NA,NA,Their website (https://atomic2.octru.ox.ac.uk/) has updates including latest: Monday 1st February 2021 'Trial recruitment paused'
tri03075,NCT04386850,TRUE,2021-10-07T05:58:43Z,NA,NA,NA,NA
tri03397,NCT04389840,TRUE,2021-12-09T05:53:47Z,NA,NA,NA,NA
tri02073,NCT04392141,TRUE,2021-10-07T04:49:23Z,NA,NA,NA,NA
tri03406,NCT04394377,TRUE,2021-10-21T08:34:16Z,NA,NA,NA,NA
tri02269,NCT04395105,TRUE,2021-10-07T05:09:01Z,NA,NA,NA,Terminated (Low rate of recruitment)
tri02284,NCT04400058,TRUE,2021-10-07T05:09:56Z,NA,NA,NA,"The DSMB voted to continue the study until phase 3 randomized placebo-controlled multicenter study of IVIG in COVID-19 (Octagam 10% therapy in COVID-19 patients with severe disease; clinicaltrials.gov, NCT04400058, May 22, 2020) became available. (https://journals.lww.com/ccejournal/Fulltext/2020/11000/Intravenous_Immunoglobulin_Plus_Methylprednisolone.14.aspx)"
tri02973,NCT04403100,TRUE,2021-10-07T05:50:36Z,NA,NA,NA,"There is a discrepancy between the abstract and article in nothing the end of recruitment (30 Sept vs. 9 Oct) This might be due to a difference between enrollment and randomization dates if there was a lag.\n\nThe secondary outcomes were all 28 days, but the primary was outcome. Assume AEs (another secondary outcome) were also followed-up through 90 days but that wasn't explicit. Doesn't matter though as the longest outcome was the 90 day outcome."
tri02393,NCT04406389,TRUE,2021-10-07T05:14:32Z,NA,NA,NA,NA
tri02405,NCT04407507,TRUE,2021-11-10T01:06:08Z,NA,NA,NA,NA
tri03434,NCT04409262,TRUE,2021-10-07T06:16:21Z,NA,NA,NA,"Trial happened, results were negative, and results expected to be published: https://www.roche.com/media/releases/med-cor-2021-03-11.htm"
tri03092,NCT04409886,TRUE,2021-10-25T08:04:29Z,NA,NA,NA,NA
tri03458,NCT04422561,TRUE,2021-10-07T06:18:51Z,NA,NA,NA,NA
tri03542,NCT04438850,TRUE,2021-10-07T06:22:25Z,NA,NA,NA,NA
tri03634,NCT04446104,TRUE,2021-10-07T08:40:10Z,NA,NA,NA,"When they say &quot;follow-up was nearly complete&quot; they mean the 12 people who dropped out. Everyone else finished follow-up.\nFor enrollment, they say it began on 18 May 2020, then they recruited for 14 days. If you include the 18th, that is until 31 May 2020.\n"
tri03747,NCT04348305,TRUE,2021-10-07T06:25:56Z,NA,NA,NA,"EUCTR and CT.gov completion dates differ slightly:\n\nPCD on CT.gov: September 10, 2020\nSCD on CT.gov: June 8, 2021\n\nEUCTR: \t2020-09-03\n\n&quot;Due to the results of the RECOVERY trial, the Management Committee of the COVID STEROID trial decided to pause enrolment as of 16 June 2020. The trial is officially paused until the full peer?reviewed RECOVERY paper and the results of an ongoing prospective meta?analysis of corticosteroids for COVID?19 are published.&quot;"
tri01222,NCT04363840,TRUE,2021-10-07T04:33:18Z,NA,NA,NA,NA
tri01842,NCT04381364,TRUE,2021-10-07T04:42:21Z,NA,NA,NA,NA
tri02080,NCT04392713,TRUE,2021-10-14T09:31:13Z,NA,NA,NA,NA
tri03644,NCT04447235,TRUE,2021-10-07T06:23:39Z,NA,NA,NA,NA
tri05450,NCT04451174,TRUE,2021-10-07T06:33:56Z,NA,NA,NA,NA
tri05535,NCT04459247,TRUE,2021-10-07T08:51:29Z,NA,NA,NA,The new completion dates in the registration are clearly wrong since we have a full publication. The old ones at least make sense for the publication timeline. No dates in the pub.
tri05811,NCT04486508,TRUE,2021-10-14T07:48:16Z,NA,NA,NA,NA
tri05932,NCT04499313,TRUE,2021-10-07T06:36:22Z,NA,NA,NA,NA
tri05935,NCT04499677,TRUE,2021-10-07T05:27:49Z,NA,NA,NA,"From Protocol - Trial status: Protocol version 4.0 dated 7th January 2021. Date of first enrolment: October 2020. Recruitment is ongoing, with anticipated finish date of 31st March 2021."
tri05950,NCT04501965,TRUE,2021-10-07T05:25:49Z,NA,NA,NA,NA
tri06054,NCT04516941,TRUE,2021-10-07T05:22:26Z,NA,NA,NA,NA
tri06103,NCT04523831,TRUE,2021-10-14T08:37:29Z,NA,NA,NA,NA
tri06132,NCT04527211,TRUE,2021-10-07T05:20:56Z,NA,NA,NA,NA
tri06139,NCT04527562,TRUE,2021-10-07T05:20:31Z,NA,NA,NA,NA
tri06143,NCT04528329,TRUE,2021-10-07T05:15:58Z,NA,NA,NA,Decision to exclude based on outcomes
tri06156,NCT04529525,TRUE,2022-02-04T08:27:50Z,NA,NA,NA,"Abstract and main text contradicted about whether 2021-02-22 was end of 'randomization' or 'conducting.' Comparing to the registry (completion date of 2021-02-22), we used 2021-02-22 as completion date."
tri06160,NCT04530409,TRUE,2021-10-07T05:15:00Z,NA,NA,NA,NA
tri06161,NCT04530422,TRUE,2021-10-26T05:12:24Z,NA,NA,NA,NA
tri06331,NCT04551781,TRUE,2022-02-04T08:29:47Z,NA,NA,NA,"Post covid19 Pulmonary Fibrosis, so not treatment/prevention"
tri06729,NCT04613271,TRUE,2021-10-06T02:40:06Z,NA,NA,NA,"Suspended (Study halted prematurely but potentially will resume, the protocol will be amended)"
tri06788,NCT04622891,TRUE,2021-10-14T08:48:16Z,NA,NA,NA,NA
tri06932,NCT04646109,TRUE,2022-02-04T08:35:53Z,NA,NA,NA,I think this team had a little trouble with registration and what 'Primary outcomes' meant but I think it's clear they are looking at if Ivermectin helps people with severe covid.
tri01096,NCT04330638,TRUE,2021-10-07T04:30:31Z,NA,NA,NA,Searched b/c PCD now before cutoff
tri02969,NCT04397510,TRUE,2021-11-10T01:04:05Z,NA,NA,NA,NA
tri02384,NCT04405843,TRUE,2021-10-07T05:14:11Z,NA,NA,NA,Primary and secondary f/u were same length so noted as &quot;Primary&quot;
tri03437,NCT04410354,TRUE,2021-10-07T06:16:54Z,NA,NA,NA,Terminated (Failure to meet primary endpoint)
tri03462,NCT04425629,TRUE,2021-10-07T06:19:41Z,NA,NA,NA,NA
tri03639,NCT04446429,TRUE,2022-04-04T05:53:42Z,NA,NA,NA,This trial has a load of publications reflecting a trial registration that has completely changed numerous times. Extracted it to align to the registry as it currently stands with results for other treatments treated as 'Other' publications. Article subsequently retracted.
tri06962,NCT04476745,TRUE,2021-10-06T02:33:56Z,NA,NA,NA,It's examining cytokine levels in uninfected people. I don't think the connection is there to treatment or prevention really.
tri03746,NCT04381936,TRUE,2021-10-07T06:24:40Z,NA,NA,NA,"I think we should make a call that all adaptive trials like this have &quot;interim&quot; results.\n\nI went and added all the RECOVERY results even if they weren't the registry, just for completeness."
tri03418,NCT04401579,TRUE,2021-10-07T06:15:11Z,NA,NA,NA,"2020-001052-18 is the blanket ACTT registration on the EUCTR so it also links to to ACTT-1\nhttps://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001052-18/results\nThis has results but for ACTT-2 it is only in a link to the paper, so not counting as registry results."
tri00585,ChiCTR2000031196,TRUE,2021-10-07T07:30:39Z,NA,NA,NA,NA
tri02666,ChiCTR2000033774,TRUE,2021-10-07T05:35:50Z,NA,NA,NA,This is a commentary from that group that references the trial: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459257/#CR25
tri01982,ACTRN12620000571976,TRUE,2021-10-07T04:47:47Z,NA,NA,NA,NA
tri04565,CTRI/2020/05/025425,TRUE,2021-09-30T08:33:24Z,NA,NA,NA,The registry had a small abstract of results...determine not detailed enough to count\nhttp://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=44043
tri03274,NCT04269525,TRUE,2022-04-26T07:44:11Z,NA,NA,NA,"The article states: In our protocol, the follow?up time would be 28 days in total. Due to the quarantine, the actual follow?up time was 39 days (7?67 days). Inclusion criteria and exclusion criteria were provided in supplementary file (Table 1), however follow-up for the primary outcome was 14 days. We also don't know when those longer follow-ups took place during enrollment so I'm just going with the stated enrollment (they only report at days 14 and 28 anyway).\nCompletion dates on the registry are very clearly wrong."
tri03401,NCT04392219,TRUE,2021-10-07T06:13:30Z,NA,NA,NA,Healthy volunteers - Phase 1
tri05584,NCT04463472,TRUE,2021-10-21T08:49:37Z,NA,NA,NA,Phase 1 immunogenicity so included
tri06441,NCT04568811,TRUE,2021-10-07T08:14:32Z,NA,NA,NA,Just looking at AEs for primary outcome
tri02516,NCT04409327,TRUE,2021-10-14T08:56:56Z,NA,NA,NA,Results Submitted (2021-06-07) but not publicly available on registry yet:\nhttps://clinicaltrials.gov/ct2/show/results/NCT04409327\n
tri07034,NCT04584567,TRUE,2021-10-06T02:19:03Z,NA,NA,NA,NA
tri00169,ChiCTR2000029994,TRUE,2021-10-04T08:26:33Z,NA,NA,NA,NA
tri00126,ChiCTR2000030102,TRUE,2021-09-29T02:55:56Z,NA,NA,NA,NA
tri01061,ChiCTR2000032205,TRUE,2021-10-07T08:13:03Z,NA,NA,NA,The primary outcome is a VAS scale of pulmonary/cardiology symptoms during recovery (convalescence) so I don't think this meets our inclusion definiton.
tri00811,ACTRN12620000480987,TRUE,2021-10-07T07:29:22Z,NA,NA,NA,NA
tri01919,NCT04378712,TRUE,2021-10-07T04:45:56Z,NA,NA,NA,"erratum: 10.21037/jtd-2020-062\nnot finding publication date, only &quot;accepted for publication date&quot; used the date 2020-06-15 because it was same month as publication\n"
tri01658,IRCT20200409047007N1,TRUE,2021-10-07T04:41:42Z,NA,NA,NA,NA
tri00884,JPRN-JapicCTI-205238,TRUE,2021-10-07T07:28:57Z,NA,NA,NA,"results comment: press release published in September, as of today (2020-12-27) I could not identify a full publication; https://rctportal.niph.go.jp/en/detail?trial_id=JapicCTI-205238\nResults referenced in other publication but no link to results, e.g., https://dx.doi.org/10.1002%2Fcpt.2251\nProbably a good example of publication bias\nother press releases: \nhttps://www.fdanews.com/articles/199222-fujifilms-avigan-shows-promise-in-phase-3-covid-19-trial \nhttps://trialsitenews.com/avigan-favipiravir-meets-endpoints-in-phase-3-japanese-clinical-trial-sponsor-will-register-as-a-therapy-for-covid-19/"
tri00288,ChiCTR2000030518,TRUE,2021-10-07T07:24:30Z,NA,NA,NA,NA
tri03293,NCT04331899,TRUE,2021-10-07T06:04:37Z,NA,NA,NA,NA
tri05408,NCT04400019,TRUE,2021-10-07T06:33:10Z,NA,NA,NA,NA
tri02632,NCT04414124,TRUE,2021-10-07T05:34:55Z,NA,NA,NA,NA
tri02568,NCT04343092,TRUE,2021-10-07T05:31:29Z,NA,NA,NA,Non-specific completion date of May 2020
tri04758,CTRI/2020/07/026535,TRUE,2022-04-26T07:44:42Z,NA,NA,NA,NA
tri02153,NCT04394013,TRUE,2021-10-07T05:04:09Z,NA,NA,NA,NA
tri03480,NCT04432103,TRUE,2021-10-07T06:20:48Z,NA,NA,NA,NA
tri03547,NCT04438980,TRUE,2021-10-07T06:23:10Z,NA,NA,NA,NA
tri06269,NCT04542447,TRUE,2021-10-07T05:14:12Z,NA,NA,NA,NA
tri00339,ChiCTR2000030892,TRUE,2021-10-07T08:11:26Z,NA,NA,NA,'post-COVID-19 fibrosis' so not included
tri02875,JPRN-UMIN000040602,TRUE,2021-10-07T05:42:05Z,NA,NA,NA,NA
tri02912,RPCEC00000311,TRUE,2021-09-30T09:03:36Z,NA,NA,NA,NA
tri04958,CTRI/2020/08/027477,TRUE,2021-10-07T06:32:07Z,NA,NA,NA,I found four different case report studies from the clinical trial via keyword search on google scholar and google. I only put in one result extraction with the earliest publication date. \n\nhttps://www.researchgate.net/profile/Atul-Desai/publication/353400306_A_Case_Report_on_the_Effects_of_Onion_Steam_VapourNebulisation_and_T-AYU-_HM_Premium_Tablets_in_Covid-19_Patient_Citation_A_Case_Report_on_the_Effects_of_Onion_Steam_VapourNebulisation_and_T-AYU-HM/links/60fa4ddc1e95fe241a811200/A-Case-Report-on-the-Effects-of-Onion-Steam-Vapour-Nebulisation-and-T-AYU-HM-Premium-Tablets-in-Covid-19-Patient-Citation-A-Case-Report-on-the-Effects-of-Onion-Steam-Vapour-Nebulisation-and-T-AYU-HM.pdf\n\nhttps://www.researchgate.net/profile/Atul-Desai/publication/353400388_A_case_report_study_on_effectiveness_of_T-AYU-HM_Premium_tablet_and_Onion_steam_vaporisation_in_Covid-19_patient/links/60fa4ecc1e95fe241a8112f3/A-case-report-study-on-effectiveness-of-T-AYU-HM-Premium-tablet-and-Onion-steam-vaporisation-in-Covid-19-patient.pdf\n\nhttp://www.ijpsdr.com/index.php/ijpsdr/article/view/2108/784\n\nhttp://ijpsdr.com/index.php/ijpsdr/article/view/2318/785
tri00538,NCT04264858,TRUE,2021-10-07T07:31:03Z,NA,NA,NA,NA
tri02944,NCT04348656,TRUE,2022-09-09T13:02:11Z,NA,NA,NA,Full results of terminated study. Unclear secondary outcome follow-up time since some outcomes didn't have number of days and some patients discharged and not explicitly follow-up past day 30. This trial apparently had 2 NCT IDs collapsed into one. The other NCT04418518 (tri02990) is obsolete.
tri05538,NCT04459325,TRUE,2021-10-07T06:35:03Z,NA,NA,NA,"Protocol, in Russian"
tri00862,IRCT20190727044343N1,TRUE,2021-10-14T08:58:18Z,NA,NA,NA,follow-up time for primary outcome (rate of hospitalisation) is not specified in the paper.
tri03183,EUCTR2020-001243-15,TRUE,2022-05-17T06:49:39Z,NA,NA,NA,No last enrollment date given
tri00816,ChiCTR2000032011,TRUE,2021-10-04T08:36:46Z,NA,NA,NA,NA
tri00892,NCT04252118,TRUE,2021-10-14T09:06:41Z,NA,NA,NA,"- The Protocol includes primary efficacy outcomes (e.g. size of lesion area by chest radiograph). However, the publication describes it as a phase 1 trial reporting mostly safety/toxicity outcomes. \n- No clear Follow-up time for primary outcome!\n- report the trial number as a prior study AND as the current ID-number! However, there is much evidence indicating that the registry entry and the publication match (start date, authors, sample-size etc.) \n\nAlthough slight difference and a line in the paper refering to the Trial ID as another study, this is pretty clearly the same study as the SSRN preprint and as the registry by determination of the team.\n"
tri00600,ChiCTR2000030198,TRUE,2021-09-02T05:57:37Z,NA,NA,NA,Rehab
tri00112,ChiCTR2000030173,TRUE,2021-09-02T05:47:59Z,NA,NA,NA,NA
tri03173,ISRCTN21363594,TRUE,2021-09-09T08:16:38Z,NA,NA,NA,Two different case reports from this study have been published:\nhttps://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-020-01665-0\nhttps://onlinelibrary.wiley.com/doi/10.1002/ccr3.3397\n\nUnclear secondary outcome follow-up.
tri04057,ISRCTN34160010,TRUE,2021-09-09T08:25:46Z,NA,NA,NA,NA
tri02921,RPCEC00000320,TRUE,2021-09-02T09:22:15Z,NA,NA,NA,Article found was an observational study on how well the treatment was administered in this and another trial. Confirms trial's existence.
tri04551,CTRI/2020/05/025335,TRUE,2021-09-09T08:31:47Z,NA,NA,NA,Link to trial didn't show up above. Is here: https://ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=43949\nThere is a small paragraph with basic results at the end of the trial entry but it does not contain sufficient detail for us to count as results.
tri04662,CTRI/2020/06/025998,TRUE,2021-09-09T08:39:18Z,NA,NA,NA,This study looks like it predated the registered study: https://ijsrm.humanjournals.com/role-of-raj-nirvan-bati-in-treatment-of-covid19-rt-pcr-positive-cases/\n\nCan't access the full-text of this: http://www.indianjournals.com/ijor.aspx?target=ijor:ah&volume=13&issue=1&article=012 so not sure if it's the same study. We cannot confirm.
tri00002,NCT04252885,TRUE,2021-09-02T08:39:26Z,NA,NA,NA,NA
tri00675,NCT04330586,TRUE,2021-09-02T08:54:28Z,NA,NA,NA,Registry completion date from Korean Registry (2021-04-16)
tri00201,ChiCTR2000030433,TRUE,2021-09-02T05:52:07Z,NA,NA,NA,NA
tri00679,NCT04332666,TRUE,2021-09-02T08:59:07Z,NA,NA,NA,NA
tri01040,ACTRN12620000417987,TRUE,2021-08-26T06:17:24Z,NA,NA,NA,The C4 Trial was stopped early due to lack of community transmission of SARS-CoV-2
tri05439,NCT04447833,TRUE,2021-09-09T09:02:33Z,NA,NA,NA,Phase 1 safety study. Some efficacy secondary outcomes but not primary.
tri05469,NCT04452669,TRUE,2021-09-09T08:43:56Z,NA,NA,NA,NA
tri05658,NCT04470999,TRUE,2021-09-09T08:49:11Z,NA,NA,NA,NA
tri06625,NCT04596085,TRUE,2021-09-09T08:56:20Z,NA,NA,NA,NA
tri01515,NCT04363593,TRUE,2021-09-02T09:05:45Z,NA,NA,NA,"'the main objective of this study is to evaluate the diagnostic performance of the COVID-19 immunoglobulin (IgG) Dia-Pro serological test, in view of its deployment at the Cornish Hospital Union Laboratory'"
tri01922,NCT04379076,TRUE,2021-09-09T09:31:16Z,NA,NA,NA,NA
tri00106,ChiCTR2000029400,TRUE,2021-09-02T05:47:38Z,NA,NA,NA,NA
tri00556,NCT04316728,TRUE,2021-09-27T08:33:26Z,NA,NA,NA,NA
tri00028,ChiCTR2000029819,TRUE,2021-08-26T05:50:39Z,NA,NA,NA,NA
tri00046,ChiCTR2000029768,TRUE,2021-08-26T05:59:35Z,NA,NA,NA,NA
tri00118,ChiCTR2000030138,TRUE,2021-08-26T05:58:48Z,NA,NA,NA,NA
tri00302,ChiCTR2000030477,TRUE,2021-08-26T05:59:35Z,NA,NA,NA,NA
tri02910,RPCEC00000309,TRUE,2022-03-02T06:14:04Z,NA,NA,NA,"We decided, in the absence of clearer information about the hospitalized arm and whether those are to be expected, we will count the available journal publication as full results as it is not clear additional results should be expected."
tri00535,NCT04255017,TRUE,2021-08-26T06:03:26Z,NA,NA,NA,NA
tri00757,NCT04332094,TRUE,2021-10-11T08:35:22Z,NA,NA,NA,NA
tri00952,NCT04344730,TRUE,2021-08-26T06:05:39Z,NA,NA,NA,NA
tri02251,NCT04346693,TRUE,2021-08-26T06:06:29Z,NA,NA,NA,NA
tri01301,NCT04359810,TRUE,2021-10-11T08:51:33Z,NA,NA,NA,I think all outcomes were 28 days though they aren't specific about all secondary outcomes (like time to supplemental oxygen) that said the follow-up is identical for the completion dates in the registry as well.
tri01941,NCT04385264,TRUE,2021-08-26T06:08:59Z,NA,NA,NA,Suspended (Sufficient number of subjects would probably not reach)
tri03227,NCT04402944,TRUE,2021-08-26T06:10:22Z,NA,NA,NA,NA
tri02391,NCT04406246,TRUE,2021-11-02T06:21:19Z,NA,NA,NA,NA
tri03110,NCT04422678,TRUE,2021-08-26T06:13:57Z,NA,NA,NA,NA
tri03615,NCT04445324,TRUE,2021-08-26T06:17:31Z,NA,NA,NA,NA
tri05464,NCT04452565,TRUE,2021-08-26T06:18:00Z,NA,NA,NA,NA
tri07087,NCT04649424,TRUE,2021-08-26T09:13:32Z,NA,NA,NA,'purpose of this trial is to compare 2 types of nasonasopharyngeal swabs (a new design to a conventional nylon-flocked nasopharyngeal swab) for effectiveness'
tri05804,NCT04485429,TRUE,2021-11-02T06:55:12Z,NA,NA,NA,NA
tri06002,NCT04510233,TRUE,2021-08-26T06:19:54Z,NA,NA,NA,NA
tri06262,NCT04542213,TRUE,2021-11-02T07:14:22Z,NA,NA,NA,"This is for diabetes control in people with Covid, not treatment of Covid"
tri06407,NCT04563702,TRUE,2021-08-26T06:21:14Z,NA,NA,NA,Press release on results: https://investors.vaxart.com/news-releases/news-release-details/vaxart-announces-positive-preliminary-data-phase-1-clinical
tri06671,NCT04603729,TRUE,2021-11-05T03:07:35Z,NA,NA,NA,NA
tri06971,NCT04492475,TRUE,2021-08-26T06:22:11Z,NA,NA,NA,NA
tri07079,NCT04647695,TRUE,2021-10-06T02:16:04Z,NA,NA,NA,NA
tri07012,NCT04560257,TRUE,2021-09-14T11:46:37Z,NA,NA,NA,NA
tri07004,NCT04552366,TRUE,2021-11-05T03:14:04Z,NA,NA,NA,Full secondary follow-up isn't completed yet so left that blank
tri01987,ISRCTN85216856,TRUE,2021-08-26T06:23:51Z,NA,NA,NA,NA
tri06977,NCT04504032,TRUE,2021-08-26T06:24:03Z,NA,NA,NA,"Terminated (Based on Data Monitoring Committee's recommendation on February 3, 2021, the study was stopped due to futility.)"
tri06976,NCT04501952,TRUE,2021-11-03T13:39:09Z,NA,NA,NA,NA
tri04973,CTRI/2020/09/027548,TRUE,2021-08-26T06:24:24Z,NA,NA,NA,Seems this study did happen but no official results anywhere outside of random news and press releases:\nhttps://www.emedinexus.com/post/26485/mulmina-mango-as-adjunctive-therapy-in-treating-hospitalized-covid-19-patients\nhttps://www.business-standard.com/content/press-releases-ani/jagdale-healthcare-announces-recent-clinical-study-results-on-mulmina-for-its-immune-boosting-benefits-120121200420_1.html
tri01275,NCT04273763,TRUE,2021-09-16T08:13:48Z,NA,NA,NA,NA
tri03481,NCT04432298,TRUE,2021-10-25T08:51:49Z,NA,NA,NA,Terminated (The study was terminated by Sponsor due to low enrollment.)
tri03142,NCT04426201,TRUE,2021-09-09T08:11:47Z,NA,NA,NA,NA
tri03450,NCT04419610,TRUE,2022-03-02T06:33:28Z,NA,NA,NA,D-dimer primary outcome included (higher d-dimer indicates thrombosis)
tri02543,NCT04411680,TRUE,2021-09-02T09:17:36Z,NA,NA,NA,NA
tri02401,NCT04407286,TRUE,2021-08-26T06:27:36Z,NA,NA,NA,NA
tri05342,NCT04318431,TRUE,2021-08-26T06:26:45Z,NA,NA,NA,observational: Data collection and rhinopharyngeal swab
tri00753,NCT04331470,TRUE,2021-08-26T06:27:45Z,NA,NA,NA,NA
tri02462,NCT04351243,TRUE,2021-10-25T08:20:02Z,NA,NA,NA,NA
tri01492,NCT04341441,TRUE,2021-10-25T08:09:46Z,NA,NA,NA,"Terminated (Interim analysis did not reveal any safety concerns by the DSMB, but unblinded data did not provide support to continue. Event rate did not meet projected magnitude; given low recruitment potential, it is unlikely that a positive result will occur.) https://eu.freep.com/story/news/health/2021/01/11/henry-ford-study-hydroxychloroquine-covid-19/6625541002/\n"
tri03046,NCT04347239,TRUE,2021-09-16T08:37:49Z,NA,NA,NA,Press release:\nhttps://www.cytodyn.com/newsroom/press-releases/detail/512/cytodyns-leronlimab-decreased-mortality-at-14-days-by\n\nThis apparently got them in trouble with the FDA:\nhttps://www.fda.gov/drugs/drug-safety-and-availability/statement-leronlimab\n\nA similar pilot study also is available but not the same study:\nhttps://www.sciencedirect.com/science/article/pii/S1201971220323055?via%3Dihub\nhttps://www.medrxiv.org/content/10.1101/2020.05.02.20084673v1
tri00993,NCT04348695,TRUE,2021-08-26T06:29:43Z,NA,NA,NA,NA
tri03334,NCT04358549,TRUE,2021-08-26T06:30:51Z,NA,NA,NA,NA
tri01280,NCT04329923,TRUE,2022-04-26T07:46:32Z,NA,NA,NA,"We will call the preprint and the journal full results since they each fully report a single primary outcome. While the preprint does not match the paper, they are still the same trial. This will lead to a preprint occurring after the final journal article but we will just have to deal with that and describe it."
tri06920,NCT04644276,TRUE,2021-11-05T03:08:00Z,NA,NA,NA,Tangentially related to prevention but not directly.
tri06913,NCT04643964,TRUE,2021-08-26T06:36:21Z,NA,NA,NA,NA
tri06816,NCT04627519,TRUE,2021-09-09T08:57:01Z,NA,NA,NA,NA
tri06783,NCT04621903,TRUE,2021-08-26T06:37:25Z,NA,NA,NA,NA
tri06744,NCT04615416,TRUE,2021-09-02T09:54:57Z,NA,NA,NA,NA
tri06731,NCT04613310,TRUE,2021-09-02T09:56:11Z,NA,NA,NA,NA
tri06727,NCT04612972,TRUE,2021-10-06T03:08:30Z,NA,NA,NA,NA
tri06718,NCT04610567,TRUE,2021-08-26T07:10:39Z,NA,NA,NA,NA
tri06714,NCT04610502,TRUE,2021-11-03T13:38:15Z,NA,NA,NA,press release refers to trial &quot;in the previous study NCT04610502 no significant variations were observed regarding efficacy and safety between two different pharmaceutical preparations of equine hyperimmune sera and adequate tolerability was reported with both investigational products&quot;
tri06708,NCT04609722,TRUE,2021-08-26T07:11:38Z,NA,NA,NA,NA
tri06623,NCT04595695,TRUE,2021-09-02T09:57:45Z,NA,NA,NA,NA
tri06617,NCT04595097,TRUE,2021-11-05T06:34:26Z,NA,NA,NA,rehabilitation
tri06585,NCT04590430,TRUE,2021-11-05T03:06:33Z,NA,NA,NA,Phase 1 treatment in healthy adults
tri06573,NCT04589117,TRUE,2021-11-05T03:05:11Z,NA,NA,NA,NA
tri06498,NCT04578236,TRUE,2021-09-30T08:40:38Z,NA,NA,NA,NA
tri06456,NCT04570254,TRUE,2021-11-03T13:31:21Z,NA,NA,NA,NA
tri06452,NCT04569825,TRUE,2021-09-30T08:45:46Z,NA,NA,NA,Anosmia (loss of smell) so not acute covid
tri06378,NCT04559035,TRUE,2021-09-22T02:09:57Z,NA,NA,NA,NA
tri06358,NCT04557046,TRUE,2021-11-05T03:04:16Z,NA,NA,NA,NA
tri06329,NCT04551755,TRUE,2021-10-07T09:30:36Z,NA,NA,NA,"- May be preceded by https://doi.org/10.3329/jbcps.v38i0.47512 Many Bangladeshi journals and it's hard to navigate what trials are associated with what\n- scoping review to provide a rationale for study: https://link.springer.com/article/10.1007/s40264-021-01066-y\n- very similar study (same inclusion criteria, same intervention, simliar outcome) but phase 3 and different authors: https://clinicaltrials.gov/ct2/show/NCT04523831\n"
tri06320,NCT04550325,TRUE,2021-11-05T03:02:47Z,NA,NA,NA,Safety primary outcome but in COVID-19 pts.\n\nPress release of top-line results: https://www.kamada.com/news/kamada-announces-top-line-results-from-its-phase-1-2-clinical-trial-of-its-plasma-derived-hyperimmune-globulin-igg-treatment-for-coronavirus-disease-covid-19/
tri06256,NCT04541979,TRUE,2021-10-14T08:43:39Z,NA,NA,NA,"https://europepmc.org/article/PMC/PMC8205261 this is not results. It was pilot data that informed the study, not preliminary results of the study based on this line:\n\nBased on the data presented here, we are currently carrying out a phase 2 single-blinded, placebo-controlled, and randomized clinical trial (number: 2020-001849-39 in the EudraCT registry, ClinicalTrials.gov identifier: NCT04541979) to determine whether rhDNase reduces oxygen requirements in severe COVID-19."
tri06255,NCT04541485,TRUE,2021-09-09T08:54:46Z,NA,NA,NA,"Phase 1 drug safety as primary outcome, so excluded even though not in healthy volunteers"
tri06236,NCT04537962,TRUE,2021-10-21T08:54:10Z,NA,NA,NA,Entire study 60 minutes so enrollment is presumably completion as well
tri06144,NCT04528368,TRUE,2021-08-26T07:17:09Z,NA,NA,NA,NA
tri06130,NCT04527133,TRUE,2021-08-26T07:17:53Z,NA,NA,NA,NA
tri06119,NCT04525742,TRUE,2021-11-03T13:23:42Z,NA,NA,NA,NA
tri06116,NCT04525417,TRUE,2021-09-30T08:49:42Z,NA,NA,NA,Evaluation of a covid diagnostic device
tri06104,NCT04524052,TRUE,2021-09-09T08:53:31Z,NA,NA,NA,NA
tri06088,NCT04521400,TRUE,2021-10-14T08:33:10Z,NA,NA,NA,"- The study was commenced at August 20th and terminated at September 4th, 2020 at Loghman Hakim hospital. I took september 4th as final enrollment Date \n- Primary outcome was Time To Clinical Improvement with no follow-up time reported and K-M curve clearly shows f/u beyond 21 days,"
tri06067,NCT04518969,TRUE,2021-08-26T07:18:40Z,NA,NA,NA,NA
tri06065,NCT04518514,TRUE,2021-10-07T09:28:19Z,NA,NA,NA,Single arm technology intervention
tri06014,NCT04511819,TRUE,2021-09-22T02:04:09Z,NA,NA,NA,NA
tri05953,NCT04502056,TRUE,2021-09-22T02:02:49Z,NA,NA,NA,NA
tri05946,NCT04501458,TRUE,2021-11-03T13:49:54Z,NA,NA,NA,NA
tri05893,NCT04495933,TRUE,2021-09-30T09:13:16Z,NA,NA,NA,NA
tri05865,NCT04492501,TRUE,2021-09-16T09:06:21Z,NA,NA,NA,"It will be an interventional retrospective case control, single centre based cohort study in Pak Emirates Military Hospital Rawalpindi (PEMH), Pakistan from 1st April to 31st July 2020"
tri05872,NCT04493242,TRUE,2021-10-07T06:35:38Z,NA,NA,NA,NA
tri05840,NCT04490239,TRUE,2021-08-26T07:22:36Z,NA,NA,NA,Phase 1 trial in healthy volunteers. No direct COVID treatment.
tri05834,NCT04488575,TRUE,2021-09-14T11:44:12Z,NA,NA,NA,NA
tri05827,NCT04487990,TRUE,2021-10-14T08:17:25Z,NA,NA,NA,Primary outcome of clogged dialyzers is not treatment or prevention of covid therefore exclude. Probably shouldn't blanket exclude anti-coagulation studies though.
tri05765,NCT04480606,TRUE,2021-09-02T10:02:06Z,NA,NA,NA,NA
tri05757,NCT04480138,TRUE,2022-03-02T06:16:58Z,NA,NA,NA,We decided that this publication does not represent a matched result for this registry entry: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944859/
tri05695,NCT04474340,TRUE,2021-09-09T08:52:18Z,NA,NA,NA,Primary outcome was longest outcome so selected &quot;primary&quot; for type of completion date for our purposes.
tri05703,NCT04475120,TRUE,2021-11-11T03:59:09Z,NA,NA,NA,NA
tri05646,NCT04470297,TRUE,2021-08-26T07:26:03Z,NA,NA,NA,NA
tri05635,NCT04468893,TRUE,2021-09-02T10:02:53Z,NA,NA,NA,NA
tri05547,NCT04459676,TRUE,2021-09-02T10:03:23Z,NA,NA,NA,Confirmation Enrollment Completed: globenewswire.com/news-release/2021/03/25/2198986/0/en/Angion-Completes-Enrollment-in-Phase-2-Study-of-ANG-3777-for-Acute-Lung-Injury-in-Patients-with-COVID-19-Associated-Pneumonia.html
tri05543,NCT04459455,TRUE,2021-09-02T10:03:43Z,NA,NA,NA,NA
tri05533,NCT04458519,TRUE,2021-09-09T08:47:46Z,NA,NA,NA,Completion dates are all over the place for this trial. The February one seems the most sensible
tri05480,NCT04453488,TRUE,2021-10-07T06:34:20Z,NA,NA,NA,NA
tri03664,NCT04449380,TRUE,2022-02-04T08:17:55Z,NA,NA,NA,Protocol in preprint form: https://doi.org/10.21203/rs.3.rs-42306/v1\n\nSeems trial terminated but with enrollment. Results should be expected.
tri03612,NCT04445272,TRUE,2021-08-26T07:30:13Z,NA,NA,NA,NA
tri03558,NCT04441424,TRUE,2021-10-14T08:23:37Z,NA,NA,NA,"results comment: no doi from journal; protocol\n\nPreprint/journal article states: The current study started on April 3rd, 2020 and lasted till June 1st 2020 and was conducted in Baghdad, Iraq"
tri03523,NCT04436276,TRUE,2021-10-25T08:56:58Z,NA,NA,NA,"and the follow-up for this day 71 interim analysis was completed on October 3, 2020"
tri05429,NCT04433988,TRUE,2021-08-26T07:31:40Z,NA,NA,NA,NA
tri03250,NCT04429724,TRUE,2021-10-25T08:30:38Z,NA,NA,NA,NA
tri03161,NCT04429529,TRUE,2021-08-26T07:54:40Z,NA,NA,NA,Phase 1 drug trial in healthy volunteers.
tri03009,NCT04421534,TRUE,2021-08-26T07:32:22Z,NA,NA,NA,NA
tri03008,NCT04421391,TRUE,2021-09-02T09:23:36Z,NA,NA,NA,NA
tri03453,NCT04420338,TRUE,2021-11-02T06:53:39Z,NA,NA,NA,NA
tri02997,NCT04420260,TRUE,2021-10-07T05:53:44Z,NA,NA,NA,NA
tri02986,NCT04418206,TRUE,2021-09-14T11:43:28Z,NA,NA,NA,NA
tri02637,NCT04415073,TRUE,2021-08-26T07:34:31Z,NA,NA,NA,Suspended
tri02633,NCT04414371,TRUE,2021-09-02T09:21:05Z,NA,NA,NA,NA
tri02545,NCT04412239,TRUE,2021-09-16T08:55:17Z,NA,NA,NA,NA
tri03230,NCT04412057,TRUE,2021-11-02T06:36:29Z,NA,NA,NA,https://journals.asm.org/doi/10.1128/mSphere.00699-20 <- Talks about start of trial\n\nNo specific completion or final enrollment date given (just December 2020)
tri02612,NCT04411446,TRUE,2021-09-30T09:30:31Z,NA,NA,NA,NA
tri02493,NCT04406181,TRUE,2021-10-25T08:21:34Z,NA,NA,NA,NA
tri03426,NCT04405921,TRUE,2021-08-26T07:36:35Z,NA,NA,NA,NA
tri02307,NCT04402203,TRUE,2021-09-16T08:54:58Z,NA,NA,NA,NA
tri02290,NCT04400890,TRUE,2021-08-26T07:38:48Z,NA,NA,NA,Terminated (Feasibility)
tri02482,NCT04396067,TRUE,2021-08-27T04:28:38Z,NA,NA,NA,NA
tri02148,NCT04393727,TRUE,2021-09-22T01:49:09Z,NA,NA,NA,: Terminated (Study was stopped because the Promoter was changed and a new study on convalescent plasma promoted by AIFA was started in Italy.)
tri02268,NCT04393415,TRUE,2021-09-22T01:48:44Z,NA,NA,NA,NA
tri02143,NCT04393051,TRUE,2021-09-22T01:48:21Z,NA,NA,NA,NA
tri02078,NCT04392427,TRUE,2021-09-22T01:47:18Z,NA,NA,NA,NA
tri02141,NCT04392232,TRUE,2021-09-22T01:47:05Z,NA,NA,NA,NA
tri02060,NCT04390412,TRUE,2021-08-26T08:55:47Z,NA,NA,NA,NA
tri01856,NCT04382755,TRUE,2021-08-26T07:41:59Z,NA,NA,NA,NA
tri01855,NCT04382729,TRUE,2021-08-26T07:42:30Z,NA,NA,NA,NA
tri02589,NCT04382040,TRUE,2021-09-02T09:20:01Z,NA,NA,NA,"THe full text says: &quot;In line with the interim results released on the 20th August 2020&quot; However, I did not find these interim results anywhere"
tri01846,NCT04381871,TRUE,2021-08-26T08:58:30Z,NA,NA,NA,NA
tri02350,NCT04378803,TRUE,2021-08-26T07:45:09Z,NA,NA,NA,NA
tri01545,NCT04376788,TRUE,2021-09-14T11:40:25Z,NA,NA,NA,NA
tri02123,NCT04373096,TRUE,2021-09-16T08:52:31Z,NA,NA,NA,NA
tri01350,NCT04368156,TRUE,2021-09-22T01:40:03Z,NA,NA,NA,protocol stated that recruitment was expected to be completed by 2020-07-31
tri02033,NCT04366960,TRUE,2021-09-02T09:37:03Z,NA,NA,NA,Letter about trial in Other
tri01227,NCT04365127,TRUE,2021-10-04T08:55:13Z,NA,NA,NA,NA
tri01224,NCT04364022,TRUE,2021-12-01T05:46:28Z,NA,NA,NA,NA
tri02029,NCT04359537,TRUE,2021-09-22T01:37:32Z,NA,NA,NA,NA
tri01171,NCT04359316,TRUE,2021-09-14T11:39:01Z,NA,NA,NA,NA
tri01468,NCT04373824,TRUE,2021-08-26T07:45:59Z,NA,NA,NA,NA
tri01816,NCT04375046,TRUE,2021-08-26T07:51:16Z,NA,NA,NA,NA
tri05389,NCT04378738,TRUE,2021-08-26T07:51:36Z,NA,NA,NA,Behavioral: survey
tri01860,NCT04383002,TRUE,2021-08-26T07:52:14Z,NA,NA,NA,NA
tri02079,NCT04392453,TRUE,2021-08-26T07:52:37Z,NA,NA,NA,NA
tri02519,NCT04409522,TRUE,2021-09-16T08:32:37Z,NA,NA,NA,"Some weird outcome stuff going on b/w registry and paper but I think that's just poor registration. The point of this trial is clearly to see if melatonin helps to treat COVID. We could not determine how long the primary outcome was followed up, but overall study period was clearly 4 weeks."
tri02651,NCT04417270,TRUE,2021-09-16T08:33:40Z,NA,NA,NA,NA
tri03126,NCT04425005,TRUE,2021-08-26T07:54:06Z,NA,NA,NA,NA
tri00063,ChiCTR2000029639,TRUE,2021-08-26T09:12:13Z,NA,NA,NA,NA
tri00074,ChiCTR2000029602,TRUE,2021-08-26T09:22:49Z,NA,NA,NA,Quote from registry: The home/designated isolation population under the supervision of the Community Health Service Center of Wuchang District was divided into observation group and randomized control group according to their wishes. \n\nThe actual difference between the two groups for this study was a Chinese traditional medicine. That is the variable being tested.
tri01999,ChiCTR2000033057,TRUE,2021-08-26T09:26:59Z,NA,NA,NA,Rehab
tri00621,ISRCTN14966673,TRUE,2021-09-01T08:18:37Z,NA,NA,NA,comparison of covid tests and time to diagnosis
tri01501,NCT04351906,TRUE,2021-09-01T08:34:04Z,NA,NA,NA,"In discussion, we determined that there are no more results coming/this is final results (4 patients)"
tri07225,ISRCTN27106947,TRUE,2021-09-01T09:41:22Z,NA,NA,NA,NA
tri06980,NCT04506268,TRUE,2021-09-01T09:06:22Z,NA,NA,NA,Primary Outcome Measures : Proportion Enrolled [ Time Frame: 4 weeks ] The proportion of those invited that enroll in the stud
tri01592,ChiCTR2000032915,TRUE,2021-09-01T08:44:28Z,NA,NA,NA,"Found https://doi.org/10.1016/j.ijantimicag.2020.106216 which looks to be a result but in methods says it is results for ChiCTR2000033049, but the registrations look very similar, so may be duplicates; reviewed both registries as a team and don't think they are the same trial"
tri01827,NCT04380688,TRUE,2021-09-01T08:49:12Z,NA,NA,NA,NA
tri03255,NCT04430608,TRUE,2021-09-01T08:51:30Z,NA,NA,NA,NA
tri03302,NCT04343261,TRUE,2021-09-01T09:03:00Z,NA,NA,NA,follow-up time unclear
tri03561,NCT04441632,TRUE,2021-09-01T09:03:49Z,NA,NA,NA,NA
tri03679,ISRCTN37530113,TRUE,2021-09-01T09:04:57Z,NA,NA,NA,NA
tri03920,ISRCTN17896927,TRUE,2021-09-01T09:10:44Z,NA,NA,NA,Behavioural
tri06645,NCT04599959,TRUE,2021-09-01T09:07:25Z,NA,NA,NA,Diagnostic study
tri04045,ISRCTN74727214,TRUE,2021-09-01T09:19:03Z,NA,NA,NA,"No follow-up time specified for primary outcome ('main outcomes were the need for invasive mechanical ventilation (IMV) and in-hospital death'). Secondary outcome had variable follow-up time ('day 0 and day 4, day 14, or discharge'); we agreed on not including the follow-up time since it was ambiguous"
tri05964,NCT04504240,TRUE,2021-09-01T09:08:30Z,NA,NA,NA,NA
tri05645,NCT04470258,TRUE,2021-09-01T09:44:41Z,NA,NA,NA,registration applies to two sub-projects: first is device development (does not meet our covid treatment inclusion criteria) whereas the 2nd evaluates device in covid patients with outcome measures for reduction of covid symptoms (and thus meets our inclusion criteria)\nfound a dissertation in Portuguese (http://repositorio.ufc.br/handle/riufc/59049) but cannot read beyond the English abstract and not sure it is the full results for the trial portion of the study. This doesn't really matter though as it is an 'other' result anyway. Results for the usability part of the trial also included in an 'Other' result.
tri05551,NCT04459962,TRUE,2021-09-01T09:09:43Z,NA,NA,NA,Diagnostics
tri04674,CTRI/2020/06/026087,TRUE,2021-09-01T09:28:53Z,NA,NA,NA,NA
tri04233,ISRCTN68675756,TRUE,2021-09-01T09:10:43Z,NA,NA,NA,NA
tri04220,ISRCTN16842454,TRUE,2021-09-01T09:11:17Z,NA,NA,NA,NA
tri04207,ISRCTN79623250,TRUE,2021-09-01T09:11:43Z,NA,NA,NA,NA
tri04205,ISRCTN25647404,TRUE,2021-09-01T09:33:54Z,NA,NA,NA,previous work: https://pubmed.ncbi.nlm.nih.gov/33215159/
tri04151,ISRCTN13455972,TRUE,2021-09-01T09:20:52Z,NA,NA,NA,Behavioral intervention for self-isolation - technically for covid prevention but outcome measures are &quot;Number of times a person reports leaving the house while self-isolating&quot; and &quot;Number of risky contacts a person reports having while self-isolating&quot; and not medical outcomes
tri00011,ChiCTR2000029941,TRUE,2021-09-02T05:43:39Z,NA,NA,NA,NA
tri00030,ChiCTR2000029814,TRUE,2021-09-02T05:44:02Z,NA,NA,NA,NA
tri00037,ChiCTR2000029790,TRUE,2021-09-02T05:44:24Z,NA,NA,NA,NA
tri00077,ChiCTR2000029578,TRUE,2021-09-02T05:44:55Z,NA,NA,NA,Registry has results download link but fails to download (&quot;&quot;The file does not exist or the file is illegally obtained!&quot;&quot;) (Still the case for Phase 2)
tri00080,ChiCTR2000029559,TRUE,2021-09-02T05:46:07Z,NA,NA,NA,NA
tri00082,ChiCTR2000029548,TRUE,2021-09-02T05:46:49Z,NA,NA,NA,NA
tri00084,ChiCTR2000029542,TRUE,2021-09-02T08:42:51Z,NA,NA,NA,"On a re-reading, I think these are the final results of the study. Switched from interim to final. Preliminary just means they are an &quot;early&quot; study in this instance."
tri00137,ChiCTR2000030058,TRUE,2021-10-04T08:25:16Z,NA,NA,NA,"Confusing situation between the two journal articles, refer to: \nhttps://academic.oup.com/cid/article-abstract/72/12/e1165/6020003?redirectedFrom=fulltext\nhttps://academic.oup.com/cid/article-abstract/72/12/e1164/6018211"
tri00139,ChiCTR2000030054,TRUE,2021-09-02T05:48:45Z,NA,NA,NA,NA
tri00140,ChiCTR2000030046,TRUE,2021-09-02T05:49:16Z,NA,NA,NA,investigators updated trial completion date to account for earlier end and results publication
tri00142,ChiCTR2000030041,TRUE,2021-09-02T05:49:34Z,NA,NA,NA,NA
tri00143,ChiCTR2000030039,TRUE,2021-09-02T05:49:50Z,NA,NA,NA,NA
tri00148,ChiCTR2000030029,TRUE,2021-09-02T05:50:07Z,NA,NA,NA,NA
tri00157,ChiCTR2000030010,TRUE,2021-09-02T05:50:24Z,NA,NA,NA,NA
tri00167,ChiCTR2000029996,TRUE,2021-09-29T03:11:44Z,NA,NA,NA,NA
tri00170,ChiCTR2000029992,TRUE,2021-09-29T03:18:09Z,NA,NA,NA,NA
tri00179,ChiCTR2000029960,TRUE,2021-09-02T08:45:05Z,NA,NA,NA,- Outcome not reported in registry. \n- Intervention is not clearly reported either: &quot;integrated Chinese medicine&quot;\n- Included based on study title: Comparative study for integrate Chinese and conventional medicine the the treatment of novel coronavirus pneumonia (COVID-19) in Hu'nan province
tri00241,ChiCTR2000030219,TRUE,2021-10-04T08:28:31Z,NA,NA,NA,NA
tri00242,ChiCTR2000030218,TRUE,2021-09-02T08:33:34Z,NA,NA,NA,"'It should be noted that ChiCTR2000030218 and NCT04275388 are probably the same study due to the same applicant, study period, design, sample size, and interventions.' DOI: 10.21203/rs.3.rs-32800/v1"
tri00249,ChiCTR2000030013,TRUE,2021-09-29T03:20:13Z,NA,NA,NA,NA
tri00250,ChiCTR2000029991,TRUE,2021-10-04T08:30:20Z,NA,NA,NA,NA
tri00285,ChiCTR2000030540,TRUE,2021-09-29T03:20:55Z,NA,NA,NA,NA
tri00304,ChiCTR2000030472,TRUE,2021-10-07T07:28:10Z,NA,NA,NA,NA
tri00306,ChiCTR2000030469,TRUE,2021-09-02T05:53:45Z,NA,NA,NA,NA
tri00354,ChiCTR2000030853,TRUE,2021-09-02T05:53:59Z,NA,NA,NA,NA
tri00358,ChiCTR2000030841,TRUE,2021-10-07T07:28:31Z,NA,NA,NA,NA
tri00390,ChiCTR2000030779,TRUE,2021-09-02T05:54:49Z,NA,NA,NA,NA
tri00361,ChiCTR2000030836,TRUE,2021-09-02T08:45:52Z,NA,NA,NA,Incidental screening. Protocol notes follow-up ongoing. http://doi.org/10.1097%2FMD.0000000000023874
tri00397,ChiCTR2000030761,TRUE,2021-10-07T07:28:55Z,NA,NA,NA,NA
tri00407,ChiCTR2000030751,TRUE,2021-10-07T07:29:15Z,NA,NA,NA,NA
tri00440,ChiCTR2000030545,TRUE,2021-09-02T05:55:50Z,NA,NA,NA,"results comment: Abstract, no link to full pub. Available only in WHO database with link to an &quot;&quot;internal database&quot;&quot; so unclear whether it is public."
tri00483,ChiCTR2000031138,TRUE,2021-10-07T07:31:31Z,NA,NA,NA,NA
tri00494,ChiCTR2000030989,TRUE,2021-09-16T06:04:56Z,NA,NA,NA,NA
tri00503,ChiCTR2000030944,TRUE,2021-09-16T08:59:24Z,NA,NA,NA,NA
tri00512,ChiCTR2000030929,TRUE,2021-09-02T05:56:42Z,NA,NA,NA,NA
tri00588,ChiCTR2000030988,TRUE,2021-09-02T05:57:13Z,NA,NA,NA,NA
tri00592,ChiCTR2000030937,TRUE,2021-09-02T08:47:27Z,NA,NA,NA,"Trail for recovery, outcomes don't have to do with treatment or prevention."
tri00623,ChiCTR2000031630,TRUE,2021-10-04T08:34:43Z,NA,NA,NA,"registry results as uploaded spreadsheet, does not meet minimum criteria to count as full results."
tri00638,ChiCTR2000031453,TRUE,2021-09-02T08:49:55Z,NA,NA,NA,. treatment of  pulmonary fibrosis in healed Covid patients!
tri00695,ChiCTR2000031834,TRUE,2021-09-02T05:58:17Z,NA,NA,NA,primary outcome was to observe effects of remote monitoring exercise rehabilitation on discharged COVID-19 patients.
tri00701,ChiCTR2000031772,TRUE,2021-09-02T05:58:31Z,NA,NA,NA,NA
tri03093,NCT04410016,TRUE,2021-09-02T08:25:53Z,NA,NA,NA,NA
tri03451,NCT04420247,TRUE,2021-09-02T08:27:02Z,NA,NA,NA,NA
tri04396,IRCT20150825023753N17,TRUE,2021-09-02T08:27:39Z,NA,NA,NA,NA
tri04632,CTRI/2020/06/025801,TRUE,2021-09-02T08:31:42Z,NA,NA,NA,- some fesults are available in news reports and company-reports
tri04937,CTRI/2020/08/027359,TRUE,2021-09-02T08:32:29Z,NA,NA,NA,While it is trying to technically teach &quot;prevention&quot; I think this is not inclusive of our definition of &quot;prevention.&quot; We haven't included educational interventions.
tri05060,CTRI/2020/10/028231,TRUE,2021-09-02T08:32:57Z,NA,NA,NA,NA
tri05388,NCT04377165,TRUE,2021-09-02T08:34:04Z,NA,NA,NA,"This is a behavior change app. Though it's aimed on reducing the spread, it's not a direct intervention."
tri00327,NCT04293887,TRUE,2021-09-02T08:35:47Z,NA,NA,NA,Covid is secondary outcome measure
tri00722,EUCTR2020-001333-13,TRUE,2021-09-02T08:36:44Z,NA,NA,NA,NA
tri00789,NCT04341038,TRUE,2021-09-02T08:41:02Z,NA,NA,NA,NA
tri07143,NCT04657809,TRUE,2021-09-02T08:38:03Z,NA,NA,NA,Rehabilitiation study for improvement of smell sensation
tri00801,NCT04344080,TRUE,2021-09-09T08:19:21Z,NA,NA,NA,NA
tri06775,NCT04620798,TRUE,2021-09-02T08:42:04Z,NA,NA,NA,NA
tri06767,NCT04619290,TRUE,2021-09-02T08:42:55Z,NA,NA,NA,NA
tri00897,NCT04280224,TRUE,2021-09-02T08:44:14Z,NA,NA,NA,NA
tri06711,NCT04609865,TRUE,2022-01-31T10:21:09Z,NA,NA,NA,NA
tri00912,NCT04325061,TRUE,2021-09-02T08:45:40Z,NA,NA,NA,Terminated (Lack of enrollment)
tri06633,NCT04597216,TRUE,2021-11-11T01:30:22Z,NA,NA,NA,NA
tri06473,NCT04573361,TRUE,2021-09-02T08:45:59Z,NA,NA,NA,rehabilitiation
tri00997,NCT04349410,TRUE,2021-09-30T09:13:26Z,NA,NA,NA,Secondary follow-up is unclear in paper.
tri06431,NCT04568096,TRUE,2021-09-02T08:46:29Z,NA,NA,NA,NA
tri01119,NCT04348474,TRUE,2021-09-02T08:51:02Z,NA,NA,NA,"More context: https://covexit.com/new-brazilian-study-shows-telemedicine-hydroxychloroquine-treatment-reduce-need-for-hospitalization/\n\nSuspended (Azidus, the CRO hired for this study by Prevent Senior has lost the interest to conduct this study.)"
tri06406,NCT04563689,TRUE,2021-11-11T03:59:39Z,NA,NA,NA,NA
tri00610,NCT04322344,TRUE,2021-09-02T08:47:52Z,NA,NA,NA,NA
tri00632,ChiCTR2000031501,TRUE,2021-09-02T08:48:20Z,NA,NA,NA,NA
tri01127,NCT04352946,TRUE,2021-09-02T08:51:38Z,NA,NA,NA,"From late august: &quot;&quot;As with other HCQ prevention trials, HERO-HCQ enrollment has been hindered by commentary from politicians, the media, as well as retracted publications. With all the information out there, it is easy for people to become confused about HCQ. Our message in HERO-HCQ remains the same: HCQ is safe, generally well tolerated, and the question we are asking, is HCQ effective in preventing COVID-19, remains important.&quot;&quot; https://heroesresearch.org/hero-hcq-continues-to-generate-evidence-on-prophylactic-use-of-hcq/"
tri01155,NCT04357808,TRUE,2021-09-02T08:52:42Z,NA,NA,NA,protocol: https://doi.org/10.1186/s13063-020-04588-5
tri06372,NCT04558463,TRUE,2021-09-02T08:52:52Z,NA,NA,NA,NA
tri06275,NCT04542941,TRUE,2021-11-11T01:16:49Z,NA,NA,NA,NA
tri01172,NCT04359329,TRUE,2021-09-02T08:53:27Z,NA,NA,NA,NA
tri01249,ChiCTR2000032487,TRUE,2021-09-02T08:53:48Z,NA,NA,NA,NA
tri01273,EUCTR2020-001408-41,TRUE,2021-09-02T08:54:51Z,NA,NA,NA,NA
tri06170,NCT04530656,TRUE,2021-11-05T06:32:10Z,NA,NA,NA,Primary Outcome: Occurrence of adverse reactions (AR) within 7 days after each dose of the recombinant SARS-CoV-2 vaccine
tri01286,NCT04345848,TRUE,2021-09-02T08:55:13Z,NA,NA,NA,NA
tri06155,NCT04529499,TRUE,2021-11-11T01:11:45Z,NA,NA,NA,NA
tri01288,NCT04348435,TRUE,2021-09-02T08:56:26Z,NA,NA,NA,NA
tri05936,NCT04500067,TRUE,2021-11-11T01:09:52Z,NA,NA,NA,non-english result(?) via google scholar keyword search: http://jpaic.aaukr.org/index.php/2519-2078/article/view/220624
tri01331,NCT04366882,TRUE,2021-09-02T08:57:03Z,NA,NA,NA,"observational: Determination of cause of death and contributing factors based on clinical, radiological, microbiological and histopathological data of the deceased patient"
tri00966,NCT04345887,TRUE,2021-09-02T09:00:43Z,NA,NA,NA,This letter talks about starting the trial see &quot;Other&quot; above
tri05805,NCT04486001,TRUE,2021-09-02T09:00:31Z,NA,NA,NA,pre-work: https://pubmed.ncbi.nlm.nih.gov/32423449/
tri05764,NCT04480593,TRUE,2021-11-11T01:25:11Z,NA,NA,NA,NA
tri00992,NCT04348461,TRUE,2021-09-02T09:02:55Z,NA,NA,NA,"suspended on ct.gov, prematurely ended on EUCTR\n\nThis pilot study confirms this trial is in process: https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20)30198-X/fulltext"
tri01353,NCT04368260,TRUE,2021-09-02T09:06:01Z,NA,NA,NA,Primary outcome: diagnostic: Number of subjects for which the prototype swab and the control swab provide the same COVID-19 PCR result
tri05654,NCT04470609,TRUE,2021-09-02T09:01:58Z,NA,NA,NA,NA
tri05622,NCT04467918,TRUE,2021-09-02T09:02:28Z,NA,NA,NA,NA
tri05519,NCT04456452,TRUE,2021-11-05T06:27:26Z,NA,NA,NA,Primary Outcome Measures :\n\n    Incidence and severity of adverse events [ Time Frame: Primary endpoint at day 5 ]\n    Incidence and severity of adverse events
tri05514,NCT04456153,TRUE,2021-09-02T09:04:53Z,NA,NA,NA,NA
tri01154,NCT04357782,TRUE,2021-09-02T09:03:47Z,NA,NA,NA,NA
tri01285,NCT04344457,TRUE,2021-09-02T09:04:15Z,NA,NA,NA,NA
tri01426,NCT04346667,TRUE,2021-09-02T09:05:18Z,NA,NA,NA,study was terminated
tri05473,NCT04452773,TRUE,2021-09-02T09:05:55Z,NA,NA,NA,NA
tri05451,NCT04451239,TRUE,2021-11-05T06:26:56Z,NA,NA,NA,NA
tri05432,NCT04435522,TRUE,2021-09-02T09:07:22Z,NA,NA,NA,previous work? https://www.biorxiv.org/content/10.1101/2020.08.12.246389v1
tri01419,NCT04324489,TRUE,2021-09-02T09:10:16Z,NA,NA,NA,NA
tri05402,NCT04393077,TRUE,2021-09-02T09:07:50Z,NA,NA,NA,NA
tri05396,NCT04383717,TRUE,2021-11-05T06:26:20Z,NA,NA,NA,NA
tri04964,CTRI/2020/08/027491,TRUE,2021-09-02T09:09:23Z,NA,NA,NA,NA
tri04778,CTRI/2020/07/026631,TRUE,2021-09-02T09:09:48Z,NA,NA,NA,NA
tri04578,CTRI/2020/05/025483,TRUE,2021-09-23T09:09:14Z,NA,NA,NA,NA
tri01434,NCT04360122,TRUE,2021-09-02T09:11:56Z,NA,NA,NA,NA
tri04544,CTRI/2020/05/025326,TRUE,2021-09-02T09:11:35Z,NA,NA,NA,NA
tri04526,CTRI/2020/05/025275,TRUE,2021-09-23T09:08:36Z,NA,NA,NA,NA
tri02330,NCT04334850,TRUE,2021-09-30T08:36:09Z,NA,NA,NA,"This is really testing a strategy for when to give antibiotics, not really testing a covid treatment itself."
tri04148,ACTRN12620001104943,TRUE,2021-09-23T08:59:47Z,NA,NA,NA,"primary outcome: To determine the Safety and Tolerability of a single and multiple intranasal doses of REVTx-99 when administered to healthy adults as assessed by the collection of safety data, such as adverse events, clinical laboratory tests, vital signs, 12-lead ECGs and Physical Exams."
tri02427,ISRCTN99248812,TRUE,2021-09-02T09:14:27Z,NA,NA,NA,NA
tri02432,ISRCTN43900695,TRUE,2021-09-02T09:14:48Z,NA,NA,NA,NA
tri04042,ACTRN12620000817943,TRUE,2021-09-23T08:54:05Z,NA,NA,NA,NA
tri02567,NCT04341142,TRUE,2021-09-02T09:18:06Z,NA,NA,NA,Diagnostics
tri03749,NCT04451083,TRUE,2021-09-02T09:18:30Z,NA,NA,NA,NA
tri03666,ACTRN12620000698976,TRUE,2021-09-02T09:19:05Z,NA,NA,NA,NA
tri03624,NCT04445467,TRUE,2021-09-02T09:19:46Z,NA,NA,NA,NA
tri03587,NCT04443725,TRUE,2021-09-02T09:20:13Z,NA,NA,NA,NA
tri01439,NCT04369820,TRUE,2021-09-02T09:29:23Z,NA,NA,NA,observational: receptor expression
tri03566,NCT04442048,TRUE,2021-11-05T06:26:06Z,NA,NA,NA,"Primary Outcome Measures :\n\n    The rate of &quot;flu-like illness&quot; which includes: [ Time Frame: 1 year ]\n        WHO definition of &quot;influenza-like illness&quot; (ILI) [Fitzner 2018] or confirmed viral/bacterial respiratory infection AND\n        Results in a change or delay in cancer treatment or requirement for and unscheduled medical assesment, hospitalization or death.\n"
tri03536,NCT04438057,TRUE,2021-09-02T09:21:03Z,NA,NA,NA,NA
tri03522,NCT04435808,TRUE,2021-11-05T06:25:29Z,NA,NA,NA,Registry: Terminated (Stopped for futility by DSMB)
tri03511,NCT04435184,TRUE,2021-11-05T06:23:50Z,NA,NA,NA,"I would say the trial is about the treatment of Covid-19 but the primary outcome is not:\n\nPrimary Outcome Measures :\n\n    Soluble P-selectin level [ Time Frame: Day 3 after randomization or day of hospital discharge, whichever is earlier ]\n    Level of soluble P-selectin in ng/ml."
tri03407,NCT04394793,TRUE,2021-11-05T06:22:35Z,NA,NA,NA,NA
tri03324,NCT04355728,TRUE,2021-11-05T06:19:56Z,NA,NA,NA,\nPrimary Outcome Measures :\n\n    Incidence of pre-specified infusion associated adverse events [ Time Frame: Day 5 ]\n    Safety will be defined by the incidence of pre-specified infusion associated adverse events as assessed by treating physician\n\n    Incidence of Severe Adverse Events [ Time Frame: 90 days ]\n    Safety will be defined by the incidence of severe adverse events as assessed by treating physician
tri03304,NCT04343976,TRUE,2021-09-02T09:23:51Z,NA,NA,NA,NA
tri03028,NCT04331795,TRUE,2021-09-02T09:31:06Z,NA,NA,NA,"Results submitted to registry but not fully posted yet: https://clinicaltrials.gov/ct2/show/results/NCT04331795 The original biochecmical primary outcome was a time-to-event outcome but in the paper they say: Originally, the primary biochemical outcomes were rate of and time to CRP normalization, guided by earlier tocilizumab-related work.7, 17 During the conduct of the study, it became apparent that CRP normalization would lag behind a patient's clinical improvement and the patient could be safely discharged before CRP had normalized, making CRP normalization an impractical outcome measure. We therefore report the percentage of patients who achieved biochemical response, defined as a CRP reduction ? 25% from baseline in the 24-48 hours after tocilizumab administration, consistent with a decline determined by CRP half-life. I take this to mean it's a 2 day max f/u and the other primary outcome is just at 24 hours."
tri03209,NCT04371029,TRUE,2021-11-05T06:18:52Z,NA,NA,NA,NA
tri03196,NCT04311177,TRUE,2021-09-23T09:20:47Z,NA,NA,NA,NA
tri03163,NCT04429854,TRUE,2021-09-02T09:27:28Z,NA,NA,NA,NA
tri03145,NCT04426292,TRUE,2021-11-05T06:17:46Z,NA,NA,NA,NA
tri03045,NCT04347174,TRUE,2021-11-05T06:16:46Z,NA,NA,NA,NA
tri02968,NCT04395807,TRUE,2021-09-09T09:29:25Z,NA,NA,NA,Terminated (\nFew eligible patients at study start\nPatients received HFNC prior to intermediate care ward admission\nNIV was locally considered a step-up therapy to HFNC\nFull-face masks replaced the Helmet interface as local NIV standard\n)
tri01500,NCT04349098,TRUE,2021-09-02T09:32:15Z,NA,NA,NA,NA
tri02954,NCT04367545,TRUE,2021-09-09T09:26:57Z,NA,NA,NA,NA
tri02863,JPRN-UMIN000040341,TRUE,2021-09-02T09:32:54Z,NA,NA,NA,NA
tri01580,NCT04379479,TRUE,2021-09-02T09:32:56Z,NA,NA,NA,NA
tri01582,NCT04379661,TRUE,2021-09-02T09:33:54Z,NA,NA,NA,Behavioral: Online support Group
tri02795,IRCT20080901001165N59,TRUE,2021-09-02T09:34:03Z,NA,NA,NA,NA
tri01822,NCT04379271,TRUE,2021-09-02T09:34:59Z,NA,NA,NA,NA
tri02647,NCT04416360,TRUE,2021-09-02T09:36:10Z,NA,NA,NA,NA
tri01921,NCT04378920,TRUE,2021-09-09T08:22:38Z,NA,NA,NA,NA
tri02575,NCT04348500,TRUE,2021-09-02T09:41:19Z,NA,NA,NA,case report: https://pubmed.ncbi.nlm.nih.gov/32563584/
tri01994,ChiCTR2000033133,TRUE,2021-09-02T09:37:44Z,NA,NA,NA,NA
tri02056,NCT04390061,TRUE,2021-09-02T09:38:37Z,NA,NA,NA,NA
tri02081,NCT04392778,TRUE,2021-09-09T08:24:39Z,NA,NA,NA,NA
tri02086,NCT04394182,TRUE,2021-09-09T09:04:48Z,NA,NA,NA,NA
tri02100,NCT04347681,TRUE,2021-09-02T09:43:24Z,NA,NA,NA,NA
tri02225,EUCTR2020-001536-98,TRUE,2021-09-02T09:44:13Z,NA,NA,NA,prematurely ended
tri02297,NCT04401202,TRUE,2021-09-09T08:38:15Z,NA,NA,NA,NA
tri02344,NCT04368988,TRUE,2021-10-29T02:06:37Z,NA,NA,NA,the full results journal article includes around 14000 patients instead of 1400 mentioned in the registry - maybe a typo?
tri02571,NCT04345692,TRUE,2021-09-02T09:46:55Z,NA,NA,NA,Terminated (RECOVERY Trial results - no efficacy)
tri02346,NCT04374526,TRUE,2021-09-02T09:47:33Z,NA,NA,NA,NA
tri02416,ACTRN12620000635965,TRUE,2021-09-09T08:52:52Z,NA,NA,NA,NA
tri02570,NCT04345276,TRUE,2021-09-09T09:25:31Z,NA,NA,NA,NA
tri02421,ChiCTR2000033627,TRUE,2021-09-02T09:50:45Z,NA,NA,NA,NA
tri02450,NCT04323228,TRUE,2021-09-09T08:57:53Z,NA,NA,NA,NA
tri02477,NCT04385186,TRUE,2021-09-02T09:51:56Z,NA,NA,NA,NA
tri02532,NCT04410510,TRUE,2021-09-09T09:16:48Z,NA,NA,NA,NA
tri04638,CTRI/2020/06/025800,TRUE,2021-09-09T08:32:45Z,NA,NA,NA,No dates in piece
tri04605,CTRI/2020/06/025590,TRUE,2021-09-02T10:10:57Z,NA,NA,NA,NA
tri04441,RPCEC00000334,TRUE,2021-09-02T10:11:54Z,NA,NA,NA,NA
tri04160,ChiCTR2000039000,TRUE,2021-09-02T10:12:20Z,NA,NA,NA,NA
tri04052,ISRCTN95933274,TRUE,2021-09-09T08:21:58Z,NA,NA,NA,No dates in the article
tri03275,NCT04288102,TRUE,2021-09-09T08:20:41Z,NA,NA,NA,NA
tri03172,ISRCTN40302986,TRUE,2022-04-26T07:46:07Z,NA,NA,NA,Study ended in November 2020 according to article but no additional information.\n\nThe registry says follow-up was only to 14 days but follow-up actually reported in the article is much longer.
tri01021,NCT04352959,TRUE,2021-09-14T11:49:30Z,TRUE,FALSE,"The current protocol version is 6, August 4th, 2020. Recruitment began on April 6, 2020 and is anticipated to be complete by April 5, 2021.",NA
tri05485,NCT04453553,TRUE,2021-09-22T01:57:37Z,NA,NA,NA,diagnosis
tri00202,ChiCTR2000030432,TRUE,2021-09-27T08:13:51Z,NA,NA,NA,NA
tri01766,CTRI/2020/05/024981,TRUE,2021-09-27T08:30:54Z,NA,NA,NA,NA
tri03032,NCT04337996,TRUE,2021-09-27T08:53:10Z,NA,NA,NA,NA
tri06437,NCT04568525,TRUE,2021-11-03T13:29:45Z,NA,NA,NA,diagnosis
tri03525,NCT04436471,TRUE,2021-09-16T08:50:43Z,NA,NA,NA,result article report pooled results from this study and NCT04436471
tri05576,NCT04462627,TRUE,2021-11-03T13:08:37Z,NA,NA,NA,NA
tri04895,CTRI/2020/08/027120,TRUE,2021-09-22T01:40:50Z,NA,NA,NA,NA
tri01197,NCT04361435,TRUE,2021-09-09T08:39:17Z,NA,NA,NA,NA
tri01360,NCT04368676,TRUE,2021-09-09T08:39:59Z,NA,NA,NA,NA
tri01479,NCT04374903,TRUE,2021-09-09T08:40:54Z,NA,NA,NA,NA
tri01625,IRCT20200328046886N1,TRUE,2021-09-09T08:44:40Z,NA,NA,NA,related? https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3792895
tri01940,NCT04385199,TRUE,2021-09-16T08:12:01Z,NA,NA,NA,NA
tri02110,NCT04355897,TRUE,2021-09-09T08:46:43Z,NA,NA,NA,NA
tri02355,NCT04384497,TRUE,2021-09-09T08:47:19Z,NA,NA,NA,NA
tri02381,NCT04405310,TRUE,2021-09-09T08:54:07Z,NA,NA,NA,NA
tri03853,IRCT20150107020592N29,TRUE,2021-09-16T08:13:55Z,NA,NA,NA,"- no DOI available\n- Outcome switching.. in protocol was primary outcome oxagenation and secondary mortality and in the publication it was the other way around\n- poor reporting, no enrollment date, no study completion date...\n- time for primary outcome: The survival time was calculated from the time of ICU admission to hospital discharge."
tri04047,ChiCTR2000034825,TRUE,2021-09-29T03:12:00Z,NA,NA,NA,Exclude because no efficacy outcome as primary endpoint for phase 1 vaccine trial
tri04169,ChiCTR2000037524,TRUE,2021-09-16T08:27:06Z,NA,NA,NA,"Rehab Trial\n- To evaluate the psychological and sleep status of patients with COVID-19 after recovery, and to test the effect of psychological intervention based on online mindfulness-based training in the form of a randomized controlled study.\n- Inclusion criteria: Patients with novel coronavirus pneumonia history"
tri04176,ChiCTR2000036333,TRUE,2021-09-09T09:19:38Z,NA,NA,NA,NA
tri04511,CTRI/2020/05/025215,TRUE,2021-09-09T09:20:08Z,NA,NA,NA,NA
tri04598,CTRI/2020/06/025530,TRUE,2022-03-02T08:14:58Z,NA,NA,NA,Primary outcome is 'Viral Fevers including COVID19' which we include. 'Brief summary' posted in registry but does not meet minimum requirements for summary results; also indicates that outcome measured via self-report via whatsapp
tri05338,NCT04252820,TRUE,2021-09-09T09:20:54Z,NA,NA,NA,NA
tri01157,NCT04357860,TRUE,2021-09-09T09:23:49Z,NA,NA,NA,NA
tri01367,NCT04369469,TRUE,2021-09-09T09:26:51Z,NA,NA,NA,article related to trial: https://pubmed.ncbi.nlm.nih.gov/32554923/\ninterim results because the authors refer to phase 3 as ongoing and states the analysis is on preliminary data to confirm modified dosing regimen
tri01081,EUCTR2020-001417-21,TRUE,2021-09-22T00:26:52Z,NA,NA,NA,NA
tri00022,ChiCTR2000029853,TRUE,2021-09-27T08:05:01Z,NA,NA,NA,NA
tri05825,NCT04487964,TRUE,2021-09-13T09:04:56Z,NA,NA,NA,"Odd date in registration: 'The study will be conducted after January 18, 2017'\nProtocol linked in registration without publication date, links to google drive, but need to request access\nRelated background by trial team: https://doi.org/10.1016/j.phyplu.2021.100043"
tri05806,NCT04486144,TRUE,2021-09-13T09:06:29Z,NA,NA,NA,NA
tri00954,NCT04344782,TRUE,2021-09-30T08:30:33Z,NA,NA,NA,Sub-trial of NCT04324047/EUCTR2020-001246-18 (tri00659) observational supra-'trial' (excluded)
tri01100,NCT04333589,TRUE,2021-09-16T08:34:26Z,NA,NA,NA,"- follow-up time was not clearly reported. I stated 30 days for primary outcome because of this sentence: At the end of this clinical trial (30 days), the proportion of SARS-CoV-2 RNA PCR turning negative in the favipiravir group was much higher than control. And 14 days for secondary outcome because it was assessed &quot;after treatment&quot; which was max. 14 days."
tri01485,NCT04326790,TRUE,2021-09-16T08:42:17Z,NA,NA,NA,Terminated (Slow enrollment as a result of the rapid flattening of the curve of COVID-19 cases in Greece)
tri01795,NCT04273321,TRUE,2021-09-16T08:48:29Z,NA,NA,NA,- Trial was terminated early but results are available for all included participants\n- The Responsible party as stated in the registry (Shi Huanzhong) was not listed as author on the publication.
tri01882,NCT04334148,TRUE,2021-10-26T05:15:55Z,NA,NA,NA,NA
tri02565,NCT04339816,TRUE,2021-09-14T11:42:50Z,NA,NA,NA,Terminated (Steering Committee decision in accordance with stopping rule 1: Emergence of new data)
tri06967,NCT04483271,TRUE,2021-09-14T11:46:08Z,NA,NA,NA,Inclusion criteria: patients without a medical diagnosis of COVID-19 infection.\nThe very confusing title is: The Effect of Omega-3 Supplements on the Serum Levels of Selected Cytokines Involved in Cytokine Storm of Covid-19; A Randomized Clinical Trial in the Covid-19 Uninfected Jordanian People
tri00901,NCT04318015,TRUE,2021-10-11T08:25:21Z,NA,NA,NA,NA
tri03035,NCT04341922,TRUE,2021-09-14T11:49:50Z,NA,NA,NA,NA
tri03039,NCT04344288,TRUE,2021-09-14T11:50:14Z,NA,NA,NA,Terminated (Competent Authority's decision)
tri02577,NCT04355936,TRUE,2021-09-30T09:29:40Z,NA,NA,NA,"primary outcome: biomarker level (CRP), that is why we excluded the trial"
tri02948,NCT04351581,TRUE,2021-09-30T09:31:25Z,NA,NA,NA,NA
tri03158,NCT04428099,TRUE,2021-09-14T11:56:10Z,NA,NA,NA,NA
tri03593,NCT04444271,TRUE,2021-09-14T11:56:38Z,NA,NA,NA,NA
tri03162,NCT04429763,TRUE,2021-09-14T11:57:13Z,NA,NA,NA,NA
tri03468,NCT04427098,TRUE,2021-10-25T08:05:51Z,NA,NA,NA,NA
tri01930,NCT04384731,TRUE,2021-09-14T11:58:57Z,NA,NA,NA,NA
tri01950,NCT04386239,TRUE,2021-09-30T08:42:40Z,NA,NA,NA,"the investigator is part of an international Sarilumab COVID-19 Global Study Group that published results ( https://pubmed.ncbi.nlm.nih.gov/33676590/ ) ; publication is linked to another study TRN though, so not a result"
tri02181,NCT04397705,TRUE,2021-09-30T08:47:54Z,NA,NA,NA,monitoring/device tolerability rather than prevention/patient outcomes
tri02463,NCT04355364,TRUE,2021-09-30T08:51:27Z,NA,NA,NA,NA
tri02617,NCT04412018,TRUE,2021-09-30T08:56:06Z,NA,NA,NA,Primary Outcome Measures :\n\n    Change in hs-CRP levels from the randomization visit (Day 1) to the Day 14 visit [ Time Frame: 14 days ]
tri00114,ChiCTR2000030167,TRUE,2021-09-14T12:01:03Z,NA,NA,NA,NA
tri00668,NCT04328272,TRUE,2021-09-14T12:01:19Z,NA,NA,NA,NA
tri00937,NCT04343144,TRUE,2021-09-14T12:01:36Z,NA,NA,NA,Sub-trial of NCT04324047/EUCTR2020-001246-18 (tri00659) observational supra-'trial' (excluded)
tri01107,NCT04338009,TRUE,2021-10-29T01:37:02Z,NA,NA,NA,NA
tri01282,NCT04335071,TRUE,2021-11-11T01:02:17Z,NA,NA,NA,Terminated (1.) Not possible to recruit the planned number of patients during the planned study period; 2.) &quot;Dexamethason&quot; was included in the standard of care for the study population during the course of the study and inclusion criteria could no longer be met.)
tri01805,NCT04346199,TRUE,2021-09-14T12:03:21Z,NA,NA,NA,https://www.astrazeneca.com/media-centre/press-releases/2020/update-on-calavi-phase-ii-trials-for-calquence-in-patients-hospitalised-with-respiratory-symptoms-of-covid-19.html
tri02049,NCT04389385,TRUE,2021-09-14T12:03:47Z,NA,NA,NA,NA
tri02054,NCT04389801,TRUE,2021-09-14T12:04:05Z,NA,NA,NA,NA
tri02934,NCT04316377,TRUE,2022-09-09T12:35:28Z,NA,NA,NA,"Because of rapidly decreasing incidence of COVID-19 in Norway, the trial was prematurely stopped by the trial sponsor on May 25, 2020"
tri03323,NCT04354805,TRUE,2021-09-14T12:05:17Z,NA,NA,NA,NA
tri04114,ISRCTN10197987,TRUE,2021-09-23T08:58:52Z,NA,NA,NA,NA
tri05529,NCT04458246,TRUE,2021-09-14T12:05:56Z,NA,NA,NA,NA
tri05721,NCT04476888,TRUE,2021-11-11T01:17:51Z,NA,NA,NA,NA
tri05781,NCT04482634,TRUE,2021-09-14T12:06:53Z,NA,NA,NA,NA
tri06399,NCT04563065,TRUE,2021-09-14T12:07:08Z,NA,NA,NA,NA
tri06586,NCT04590469,TRUE,2021-09-14T12:07:24Z,NA,NA,NA,NA
tri05350,NCT04340557,TRUE,2021-09-30T08:26:08Z,NA,NA,NA,NA
tri04453,TCTR20201015003,TRUE,2021-09-16T06:06:55Z,NA,NA,NA,NA
tri00204,ChiCTR2000030420,TRUE,2021-09-16T06:09:39Z,NA,NA,NA,NA
tri00661,NCT04325867,TRUE,2021-09-16T08:43:08Z,NA,NA,NA,NA
tri00755,NCT04331665,TRUE,2021-09-16T06:10:33Z,NA,NA,NA,NA
tri01002,NCT04350281,TRUE,2021-09-16T06:11:01Z,NA,NA,NA,NA
tri01006,NCT04351295,TRUE,2021-09-16T08:45:28Z,NA,NA,NA,NA
tri02142,NCT04393038,TRUE,2022-09-19T07:29:03Z,NA,NA,NA,Trial status on REPEC as &quot;Without starting enrollment&quot; however terminated/prematurely ended on ClinicalTrials.gov/EUCTR and results submitted/posted indicates patients were included and trial was not withdrawn prior to patient enrollment
tri05581,NCT04463264,TRUE,2021-09-16T08:53:57Z,NA,NA,NA,NA
tri06277,NCT04542967,TRUE,2021-09-16T08:55:07Z,NA,NA,NA,NA
tri02067,NCT04391712,TRUE,2021-09-16T08:20:46Z,NA,NA,NA,NA
tri02112,NCT04360837,TRUE,2021-09-16T08:24:28Z,NA,NA,NA,"This has some results here: https://link.springer.com/chapter/10.1007/978-3-030-64610-3_52\n\nLooks like we may have included in first round (though it wouldn't have been fully searched) but I think this is pretty clearly a diagnostics, not treatment study. It's about imaging and measuring various lung things but not treating them. Primary Purpose on CT.gov is also diagnostics."
tri02458,NCT04344951,TRUE,2021-09-16T06:16:30Z,NA,NA,NA,NA
tri03020,NCT04424134,TRUE,2021-09-16T06:20:56Z,NA,NA,NA,NA
tri06059,NCT04517162,TRUE,2021-09-16T08:40:13Z,NA,NA,NA,NA
tri06885,NCT04638842,TRUE,2021-09-16T06:27:53Z,NA,NA,NA,Psychological outcomes
tri00735,NCT04291729,TRUE,2022-04-26T07:45:06Z,NA,NA,NA,NA
tri00877,IRCT20200325046860N2,TRUE,2021-09-16T06:30:24Z,NA,NA,NA,NA
tri01206,NCT04361916,TRUE,2021-09-16T09:03:23Z,NA,NA,NA,Monitoring isn't treatment or prevention
tri02055,NCT04389944,TRUE,2021-09-16T06:31:25Z,NA,NA,NA,NA
tri02198,ChiCTR2000033372,TRUE,2021-09-16T09:09:14Z,NA,NA,NA,NA
tri03404,NCT04393948,TRUE,2021-09-16T06:35:10Z,NA,NA,NA,NA
tri03745,NCT04324606,TRUE,2022-04-04T05:48:30Z,NA,NA,NA,NA
tri00044,ChiCTR2000029776,TRUE,2021-09-20T02:31:15Z,NA,NA,NA,NA
tri05744,NCT04479202,TRUE,2021-10-21T08:51:13Z,NA,NA,NA,NA
tri00056,ChiCTR2000029741,TRUE,2021-10-14T08:39:51Z,NA,NA,NA,NA
tri00065,ChiCTR2000029636,TRUE,2021-09-23T08:31:01Z,NA,NA,NA,NA
tri00087,ChiCTR2000029518,TRUE,2021-09-22T00:02:37Z,NA,NA,NA,NA
tri00088,ChiCTR2000029517,TRUE,2021-09-22T00:03:03Z,NA,NA,NA,NA
tri00105,ChiCTR2000029418,TRUE,2021-09-27T08:11:34Z,NA,NA,NA,NA
tri00116,ChiCTR2000030165,TRUE,2021-09-27T08:12:52Z,NA,NA,NA,Found 'recovery of four patients' with appropriate authors and institution which show the study was done\n\nAlso found another single case report preprint (via keyword search on Europe PMC) but cannot access it full pdf and not sure if it is necessary to include? https://europepmc.org/article/PPR/PPR240350
tri00176,ChiCTR2000029978,TRUE,2021-09-22T00:05:37Z,NA,NA,NA,NA
tri00187,ChiCTR2000029781,TRUE,2021-09-22T00:06:19Z,NA,NA,NA,NA
tri00243,ChiCTR2000030215,TRUE,2021-09-22T00:07:13Z,NA,NA,NA,NA
tri00270,ChiCTR2000030627,TRUE,2021-09-27T08:18:02Z,NA,NA,NA,"Pre-print has not been peer-reviewed. The full results publication is in chinese via a chinese publisher, only the abstract is available in english. \n\nresults comment: Trial registration had control. Full results preprint does NOT have control, but same study."
tri00308,ChiCTR2000030467,TRUE,2021-09-22T00:08:34Z,NA,NA,NA,NA
tri00491,ChiCTR2000030996,TRUE,2021-09-23T08:33:06Z,NA,NA,NA,"1. To explore the effect of Auricular point pressing on insomnia, anxiety, depression and comfort of 2019 new coronavirus pneumonia between the intervention group and the control group before and after intervention."
tri00627,ChiCTR2000031540,TRUE,2021-09-22T00:09:54Z,NA,NA,NA,rehab outcomes
tri00807,ACTRN12620000470998,TRUE,2021-09-22T00:35:29Z,NA,NA,NA,NA
tri00810,ACTRN12620000478910,TRUE,2021-09-30T08:10:01Z,NA,NA,NA,NA
tri00812,ChiCTR2000032098,TRUE,2021-10-29T01:33:34Z,NA,NA,NA,"we marked the results as full results because it looks like the study is finished, even though they talked about 100 patients instead of the 300 they were aiming for, not to say clearly because result is mostly in Mandarin"
tri00829,ChiCTR2000029434,TRUE,2021-09-27T08:23:41Z,NA,NA,NA,NA
tri00830,ChiCTR2000029433,TRUE,2021-09-22T00:21:11Z,NA,NA,NA,Not sure what the difference between this trial and ChiCTR2000029434 beside 'suspected' in title. Similar results are found with keyword searches. \nSame as http://www.chictr.org.cn/showproj.aspx?proj=48889?
tri01049,ChiCTR2000032399,TRUE,2021-09-27T08:24:27Z,NA,NA,NA,NA
tri01263,ChiCTR2000031174,TRUE,2021-09-22T00:22:32Z,NA,NA,NA,NA
tri01384,ACTRN12620000524998,TRUE,2021-09-27T08:27:15Z,NA,NA,NA,NA
tri02006,ChiCTR2000033049,TRUE,2021-09-22T00:23:51Z,NA,NA,NA,NA
tri02214,ISRCTN15254871,TRUE,2021-09-22T00:24:16Z,NA,NA,NA,NA
tri02772,IRCT20200128046294N2,TRUE,2021-09-22T00:25:14Z,NA,NA,NA,NA
tri02773,IRCT20200314046774N1,TRUE,2021-09-22T00:25:37Z,NA,NA,NA,NA
tri03171,ISRCTN33578935,TRUE,2021-09-30T08:18:24Z,NA,NA,NA,Cannot find EUCTR2020-002326-90 in registry 2021-09-30.
tri01068,ISRCTN16912075,TRUE,2021-12-01T05:34:00Z,NA,NA,NA,Full secondary follow-up was not well defined in the paper.
tri04046,ISRCTN67000769,TRUE,2022-03-01T03:45:10Z,NA,NA,NA,This actually is excluded because it is an ongoing pneumonia adaptive trial from before COVID. This ISRCTN registration was just done later so it passed our automated screening.
tri00711,ChiCTR2000031672,TRUE,2021-09-23T08:55:29Z,NA,NA,NA,"It's a rehab study, confirmed by this protocol: https://europepmc.org/article/PPR/PPR317973"
tri00820,ChiCTR2000031955,TRUE,2021-09-22T00:28:03Z,NA,NA,NA,NA
tri04094,IRCT20131112015390N5,TRUE,2021-09-23T08:56:45Z,NA,NA,NA,Molly found results: https://www.sciencedirect.com/science/article/abs/pii/S1744388121000347?via%3Dihub
tri04105,IRCT20201001048893N1,TRUE,2021-09-22T00:36:14Z,NA,NA,NA,Comparison of the Effectiveness of Online Multimedia Psycho-educational Interventions with routine Psychological Care on the Perceived Stress and Resilience of hospitalized Patients with COVID-19
tri04274,DRKS00022305,TRUE,2021-10-07T09:21:58Z,NA,NA,NA,NA
tri04310,DRKS00023406,TRUE,2021-09-22T00:37:53Z,NA,NA,NA,"Human subjects in this trial are the doctors, and they receive the intervention of which intubation strategy to perform. However the intubation is done on puppets and not COVID patients, per the German language protocol available at DRKS."
tri04338,DRKS00023171,TRUE,2021-10-07T09:23:36Z,NA,NA,NA,NA
tri04360,DRKS00022958,TRUE,2021-10-07T09:24:27Z,NA,NA,NA,NA
tri04385,IRCT20160919029870N3,TRUE,2021-09-22T00:38:46Z,NA,NA,NA,NA
tri02907,RPCEC00000306,TRUE,2021-10-14T08:47:00Z,NA,NA,NA,Primary outcome: Activation of markers of the innate immune system
tri02917,RPCEC00000316,TRUE,2021-09-27T08:28:58Z,NA,NA,NA,NA
tri04439,RPCEC00000330,TRUE,2021-09-22T00:42:14Z,NA,NA,NA,NA
tri04442,RPCEC00000335,TRUE,2021-09-22T00:43:58Z,NA,NA,NA,NA
tri04443,RPCEC00000337,TRUE,2021-09-22T00:44:15Z,NA,NA,NA,NA
tri01756,CTRI/2020/04/024883,TRUE,2021-09-27T08:29:29Z,NA,NA,NA,The registry had a results summary. A prior version of it looked like it would have counted but the current version lacks baselines characteristics which is a requirement for results for us. Therefore we are not counting as results.\n\nHistory of field here:\nhttp://www.ctri.nic.in/Clinicaltrials/pviewmod.php?trialid=43168&blid=28&EncHid=&modid=&compid=
tri04525,CTRI/2020/05/025273,TRUE,2021-09-27T08:32:18Z,NA,NA,NA,NA
tri04698,CTRI/2020/06/026222,TRUE,2021-09-23T09:11:47Z,NA,NA,NA,NA
tri04722,CTRI/2020/07/026354,TRUE,2021-09-22T00:46:16Z,NA,NA,NA,NA
tri04739,CTRI/2020/07/026469,TRUE,2021-10-14T08:48:58Z,NA,NA,NA,NA
tri04775,CTRI/2020/07/026601,TRUE,2021-09-23T09:14:26Z,NA,NA,NA,Short paragraph about results on registry: http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=45564\n\nThis does not meet a minimum standard of what ICTRP results need to include.
tri04826,CTRI/2020/07/026840,TRUE,2021-09-23T09:15:53Z,NA,NA,NA,NA
tri04886,CTRI/2020/08/027085,TRUE,2021-09-27T08:32:43Z,NA,NA,NA,NA
tri01242,ISRCTN17898730,TRUE,2021-09-22T00:48:22Z,NA,NA,NA,NA
tri05250,ChiCTR2000038256,TRUE,2021-09-22T00:48:31Z,NA,NA,NA,NA
tri01482,NCT04251871,TRUE,2021-09-22T00:49:12Z,NA,NA,NA,NA
tri00329,NCT04296643,TRUE,2021-09-22T00:49:45Z,NA,NA,NA,NA
tri00546,NCT04304313,TRUE,2021-09-22T00:50:11Z,NA,NA,NA,NA
tri00552,NCT04313322,TRUE,2021-09-22T00:50:29Z,NA,NA,NA,NA
tri03025,NCT04315987,TRUE,2021-09-22T00:50:51Z,NA,NA,NA,NA
tri02323,NCT04317040,TRUE,2021-09-27T08:34:13Z,NA,NA,NA,NA
tri01087,NCT04319445,TRUE,2021-09-27T08:34:51Z,NA,NA,NA,NA
tri02324,NCT04321421,TRUE,2021-09-27T08:37:31Z,NA,NA,NA,results comment: Protocol; pre-published date
tri02935,NCT04321928,TRUE,2022-02-02T09:33:01Z,NA,NA,NA,"A bit odd but I think it counts as their outcome is covid admissions directly. They are seeing if education prevents disease, which I think we should treat like any other preventative intervention."
tri00914,NCT04326426,TRUE,2021-09-27T08:48:48Z,NA,NA,NA,NA
tri02325,NCT04327206,TRUE,2021-09-22T00:53:48Z,NA,NA,NA,NA
tri01278,NCT04328441,TRUE,2021-10-11T08:34:14Z,NA,NA,NA,"protocol: https://doi.org/10.1186/s13063-020-04389-w; This is marginal, as the primary outcome is not specific to Covid but some of the secondary outcomes are."
tri02328,NCT04328493,TRUE,2021-09-22T00:54:57Z,NA,NA,NA,NA
tri01094,NCT04329572,TRUE,2021-09-22T00:55:45Z,NA,NA,NA,"Suspended (Azidus, the CRO hired for this study by Prevent Senior has lost the interest to conduct this study.)"
tri03292,NCT04331366,TRUE,2021-11-02T06:41:49Z,NA,NA,NA,NA
tri00677,NCT04331613,TRUE,2021-09-22T00:56:17Z,NA,NA,NA,NA
tri01099,NCT04332835,TRUE,2021-09-22T00:56:50Z,NA,NA,NA,NA
tri03029,NCT04334460,TRUE,2021-09-22T00:57:47Z,NA,NA,NA,NA
tri00776,NCT04337541,TRUE,2021-09-27T08:52:48Z,NA,NA,NA,NA
tri02455,NCT04337788,TRUE,2021-11-11T01:03:03Z,NA,NA,NA,NA
tri03296,NCT04337918,TRUE,2021-09-22T00:59:48Z,NA,NA,NA,NA
tri01283,NCT04338958,TRUE,2021-09-22T01:02:19Z,NA,NA,NA,Preceded by https://doi.org/10.1038/s41375-020-0891-0
tri01887,NCT04340349,TRUE,2021-09-27T08:54:27Z,NA,NA,NA,NA
tri03200,NCT04340414,TRUE,2021-10-11T08:41:27Z,NA,NA,NA,NA
tri02023,NCT04341389,TRUE,2021-10-11T08:42:22Z,NA,NA,NA,NA
tri02097,NCT04341675,TRUE,2021-09-27T08:54:55Z,NA,NA,NA,NA
tri03299,NCT04341688,TRUE,2021-09-22T01:06:23Z,NA,NA,NA,NA
tri01493,NCT04341870,TRUE,2021-09-22T01:23:44Z,NA,NA,NA,Sub-trial of NCT04324047/EUCTR2020-001246-18 (tri00659) observational supra-'trial' (excluded)
tri00935,NCT04342650,TRUE,2021-09-22T01:24:37Z,NA,NA,NA,We know it happened b/c they gave data here: nature.com/articles/s41467-021-22446-z
tri01889,NCT04342728,TRUE,2021-09-27T08:57:29Z,NA,NA,NA,NA
tri03301,NCT04342897,TRUE,2021-09-27T08:58:50Z,NA,NA,NA,Terminated (Trial terminated for futility.)
tri00944,NCT04343963,TRUE,2021-09-27T09:01:33Z,NA,NA,NA,NA
tri01497,NCT04344041,TRUE,2021-09-22T01:27:33Z,NA,NA,NA,NA
tri02457,NCT04344600,TRUE,2021-09-22T01:28:37Z,NA,NA,NA,NA
tri00967,NCT04346017,TRUE,2021-10-04T08:40:28Z,NA,NA,NA,NA
tri02942,NCT04346589,TRUE,2021-11-05T06:14:35Z,NA,NA,NA,NA
tri00985,NCT04347941,TRUE,2022-09-09T12:24:53Z,NA,NA,NA,This 'meta-trial' of 6 trials on prone positioning was collapsed into a single record of a mutli-site trial with extraction data collected under tri00985/NCT04347941 for tri05731/NCT04477655; tri02158/NCT04395144; tri03220/NCT04391140; tri01296/NCT04358939; tri03027/NCT04325906.
tri02461,NCT04348513,TRUE,2021-10-11T08:43:14Z,NA,NA,NA,NA
tri00995,NCT04348877,TRUE,2021-09-22T01:31:27Z,NA,NA,NA,NA
tri01120,NCT04348929,TRUE,2021-09-22T01:32:09Z,NA,NA,NA,NA
tri01010,NCT04351620,TRUE,2021-10-04T08:44:58Z,NA,NA,NA,NA
tri03204,NCT04353128,TRUE,2021-09-22T01:33:17Z,NA,NA,NA,NA
tri03316,NCT04353180,TRUE,2021-09-22T01:33:48Z,NA,NA,NA,NA
tri01292,NCT04353271,TRUE,2021-09-22T01:34:42Z,NA,NA,NA,Terminated (FDA recommendations to not use outside of the hospital setting or in a clinical trial due to the risk of cardiac arrhythmias)
tri01131,NCT04354870,TRUE,2021-09-22T01:35:08Z,NA,NA,NA,NA
tri01030,NCT04355247,TRUE,2021-10-04T08:46:30Z,NA,NA,NA,NA
tri01505,NCT04355637,TRUE,2021-10-29T01:48:17Z,NA,NA,NA,NA
tri01147,NCT04357106,TRUE,2021-10-04T08:48:04Z,NA,NA,NA,NA
tri02951,NCT04357444,TRUE,2021-10-11T08:46:54Z,NA,NA,NA,NA
tri03331,NCT04357730,TRUE,2021-10-11T08:48:36Z,NA,NA,NA,"Follow-up for secondary outcome was unclear in preprint. Clear primary outcome at 2 days, only clear secondary endpoint was at 28 days but at least one measure (ICU days) had at least 30.5 days of follow-up (see control IQR in Table 4)"
tri01161,NCT04358406,TRUE,2021-10-04T08:49:42Z,NA,NA,NA,NA
tri03336,NCT04359277,TRUE,2021-10-14T08:13:57Z,NA,NA,NA,"Terminated (the PROTECT study is being transitioned to ACTIV4 ACUTE anticoagulation inpatient study) so results could be published with ACTIV4 ACUTE.\nShould this be considered cross-registered? I don't see a trial id for ACTIV4 ACUTE in this trials registration, but found via Cochrane: NCT04505774\nShould we consider publications for ACTIV4 ACUTE as for this trial? For now, not included but could be added. https://covid-19.cochrane.org/studies/crs-14265935\nDidn't do keyword search since preprint and full article for ACTIV4 ACUTE"
tri01170,NCT04359290,TRUE,2021-09-30T08:16:19Z,NA,NA,NA,Trial preceded by case study: 10.1038/s41375-020-0907-9
tri01435,NCT04361032,TRUE,2021-09-22T01:38:06Z,NA,NA,NA,NA
tri01210,NCT04362358,TRUE,2021-09-22T01:38:21Z,NA,NA,NA,NA
tri05375,NCT04363177,TRUE,2021-09-22T01:38:32Z,NA,NA,NA,NA
tri01909,NCT04364009,TRUE,2021-09-22T01:38:55Z,NA,NA,NA,Terminated (Efficiency and safety reasons)
tri01230,NCT04365699,TRUE,2021-10-26T05:31:34Z,NA,NA,NA,NA
tri01366,NCT04369378,TRUE,2021-09-22T01:41:07Z,NA,NA,NA,NA
tri02957,NCT04370223,TRUE,2021-10-04T08:57:05Z,NA,NA,NA,NA
tri01442,NCT04370288,TRUE,2021-10-11T08:54:11Z,NA,NA,NA,Used the Approved for publication date as publication date as nothing more specific was provided.
tri01472,NCT04374149,TRUE,2021-11-10T02:08:14Z,NA,NA,NA,The registration clearly contains the details of the second publication. The first publication is a pilot study. They double-dipped on the same registration but the first one is technically unregistered. It does not appear that they used the same 10 people from the pilot in the subsequent study so it is not interim. We are therefore calling that &quot;Other&quot; and calling the result actually linked to the registration as &quot;Full&quot;
tri02258,NCT04374591,TRUE,2021-09-22T01:42:19Z,NA,NA,NA,NA
tri01562,NCT04377802,TRUE,2021-10-11T08:54:32Z,NA,NA,NA,NA
tri01564,NCT04377997,TRUE,2021-09-22T01:42:51Z,NA,NA,NA,NA
tri05392,NCT04380701,TRUE,2021-10-07T09:26:37Z,NA,NA,NA,no primary efficacy outcome
tri03380,NCT04380818,TRUE,2021-11-02T06:45:05Z,NA,NA,NA,NA
tri01848,NCT04382131,TRUE,2021-10-11T08:56:43Z,NA,NA,NA,NA
tri03071,NCT04382768,TRUE,2021-10-11T08:59:48Z,NA,NA,NA,This trial has substantially different enrollment. They also included a control group but this is explained in the piece.\n\nThe paper doesn't identify a primary outcome nor is it clear about follow-up.
tri01861,NCT04383574,TRUE,2021-10-11T09:00:59Z,NA,NA,NA,NA
tri01937,NCT04385095,TRUE,2022-03-02T06:37:46Z,NA,NA,NA,"As they directly call this a Pilot on the publication, which suggests more trials, and they registered their pilot and pivotal trials in the same registration with the same outcomes, we are going to call this interim to follow our rules."
tri05399,NCT04386668,TRUE,2021-09-22T01:44:24Z,NA,NA,NA,NA
tri02597,NCT04389580,TRUE,2021-09-22T01:44:59Z,NA,NA,NA,NA
tri02136,NCT04390022,TRUE,2021-09-30T08:38:48Z,NA,NA,NA,"Study follow-up listed as 28 days and some plots go through 28 days, though last pre-specified secondary outcome is 21 days"
tri02058,NCT04390217,TRUE,2021-09-22T01:45:52Z,NA,NA,NA,NA
tri02061,NCT04390464,TRUE,2021-11-02T06:19:20Z,NA,NA,NA,NA
tri03081,NCT04391127,TRUE,2021-10-25T08:26:12Z,NA,NA,NA,"preprint: 'Based on the Ethics Committee's recommendations, we decided to end recruitment and conduct an analysis with the data obtained as of August 15, 2020'"
tri02267,NCT04392869,TRUE,2021-09-22T01:47:43Z,NA,NA,NA,NA
tri02149,NCT04393792,TRUE,2021-09-22T01:49:27Z,NA,NA,NA,NA
tri03414,NCT04399317,TRUE,2021-10-25T08:46:14Z,NA,NA,NA,NA
tri02366,NCT04401046,TRUE,2021-09-22T01:50:15Z,NA,NA,NA,observational: Survey to assess Post-traumatic stress and anxiety at inclusion and 6 months later
tri02513,NCT04408456,TRUE,2021-10-25T08:23:39Z,NA,NA,NA,NA
tri02529,NCT04410328,TRUE,2021-09-22T01:51:17Z,NA,NA,NA,NA
tri02535,NCT04410562,TRUE,2021-09-22T01:51:56Z,NA,NA,NA,NA
tri02539,NCT04411433,TRUE,2021-09-22T01:52:14Z,NA,NA,NA,NA
tri03439,NCT04411628,TRUE,2021-10-25T09:06:55Z,NA,NA,NA,NA
tri02984,NCT04418128,TRUE,2021-09-22T01:53:54Z,NA,NA,NA,Case report by same trialists: https://www.researchsquare.com/article/rs-37580/v1
tri03454,NCT04420741,TRUE,2021-09-22T01:54:39Z,NA,NA,NA,Recruitment confirmed in the protocol
tri03120,NCT04424082,TRUE,2021-10-25T08:27:17Z,NA,NA,NA,NA
tri03133,NCT04425707,TRUE,2021-09-22T01:55:03Z,NA,NA,NA,NA
tri03244,NCT04427865,TRUE,2021-09-22T01:55:19Z,NA,NA,NA,NA
tri03270,NCT04434131,TRUE,2021-11-02T06:40:07Z,NA,NA,NA,Results submitted but not final posted to ClinicalTrials.gov as of 2 November 2021 https://clinicaltrials.gov/ct2/show/results/NCT04434131
tri05433,NCT04439825,TRUE,2021-09-22T01:56:05Z,NA,NA,NA,NA
tri05474,NCT04452799,TRUE,2021-09-22T01:57:20Z,NA,NA,NA,NA
tri05500,NCT04454606,TRUE,2021-11-03T13:06:12Z,NA,NA,NA,NA
tri05504,NCT04455360,TRUE,2021-09-22T01:57:56Z,NA,NA,NA,NA
tri05526,NCT04457609,TRUE,2021-11-03T13:08:11Z,NA,NA,NA,NA
tri05544,NCT04459520,TRUE,2021-09-22T01:58:19Z,NA,NA,NA,NA
tri05569,NCT04460703,TRUE,2021-09-22T01:58:32Z,NA,NA,NA,NA
tri05638,NCT04469114,TRUE,2021-11-03T13:10:17Z,NA,NA,NA,NA
tri05640,NCT04469179,TRUE,2021-10-07T08:53:16Z,NA,NA,NA,No primary efficacy outcome
tri05687,NCT04473599,TRUE,2021-09-22T01:59:33Z,NA,NA,NA,NA
tri05688,NCT04473898,TRUE,2021-09-30T08:35:24Z,NA,NA,NA,NA
tri05704,NCT04475185,TRUE,2021-11-03T13:11:38Z,NA,NA,NA,NA
tri05713,NCT04475913,TRUE,2021-09-22T02:00:20Z,NA,NA,NA,NA
tri05717,NCT04476667,TRUE,2021-09-22T02:00:34Z,NA,NA,NA,"Psychotherapy related to covid, not covid."
tri05786,NCT04483375,TRUE,2021-09-22T02:01:01Z,NA,NA,NA,Phase 1 biological trial in healthy adults with not efficacy endpoints
tri05818,NCT04487574,TRUE,2021-09-22T02:01:29Z,NA,NA,NA,NA
tri05858,NCT04492228,TRUE,2021-11-03T13:13:44Z,NA,NA,NA,NA
tri05885,NCT04494984,TRUE,2021-11-03T13:14:59Z,NA,NA,NA,NA
tri05907,NCT04497415,TRUE,2021-09-22T02:02:21Z,NA,NA,NA,NA
tri05956,NCT04502342,TRUE,2021-09-22T02:03:04Z,NA,NA,NA,NA
tri05957,NCT04502433,TRUE,2021-09-22T02:03:37Z,NA,NA,NA,NA
tri06086,NCT04521309,TRUE,2021-11-02T06:58:49Z,NA,NA,NA,NA
tri06094,NCT04522466,TRUE,2021-11-03T13:22:31Z,NA,NA,NA,The primary outcomes are measuring hydroxychloroquine blood concentrations
tri06140,NCT04527575,TRUE,2021-11-02T07:01:44Z,NA,NA,NA,There was no clear publication date for the full results publication. I took a shot at finding one by adding to to my ref manager it and showed 24 March 2021 which aligns with the accepted date of 17 March 2021.
tri06157,NCT04530357,TRUE,2021-11-03T13:28:05Z,NA,NA,NA,"Two completion dates: From 23.09.2020 to 19.03.2021 we performed a randomised, single-blind, placebo-controlled phase 1 clinical trial and from 18.10.2020 to 17.04.2021 an open-label phase 2 clinical trials of the QazCovid-in vaccine.\nTwo enrollment dates: Between Sept 19 and Sept 23, 2020, 104 potential participants aged 18-50 years were screened, of whom 44 were enrolled into the phase 1 clinical trial. For the phase 2 clinical trial, 447 participants were recruited and screened for eligibility between Oct 15 and Oct 20, 2020"
tri06167,NCT04530578,TRUE,2021-09-22T02:05:53Z,NA,NA,NA,NA
tri06169,NCT04530617,TRUE,2021-09-22T02:06:26Z,NA,NA,NA,NA
tri06189,NCT04533347,TRUE,2021-09-22T02:06:45Z,NA,NA,NA,NA
tri06213,NCT04535869,TRUE,2022-03-02T06:27:34Z,NA,NA,NA,This study: https://www.tandfonline.com/doi/full/10.1080/14787210.2021.1950532 is very similar with the same PI but the expected enrollment and the dates are all off and it is randomized which the registration isn't. The article itself doesn't contain a registration number. The article study went from Feb to Oct 2020 but the registry says that trial didn't even start until Dec 2020 (and it was updated in Feb 2021). We do NOT count this as a result for this registration.
tri06221,NCT04536935,TRUE,2021-09-22T02:07:16Z,NA,NA,NA,NA
tri06273,NCT04542876,TRUE,2022-03-02T06:26:11Z,NA,NA,NA,Cross-registration (CTRI/2020/05/025370) found during keyword searches and matched to NCT04542876 based on trial details
tri06313,NCT04548934,TRUE,2021-09-22T02:08:26Z,NA,NA,NA,Primary goal is to investigate whether wearing PPE has an effect on the quality of chest compressions
tri06337,NCT04552951,TRUE,2021-09-22T02:09:08Z,NA,NA,NA,NA
tri06359,NCT04557241,TRUE,2021-11-10T01:05:09Z,NA,NA,NA,"While sort of preventative, not the focus of the study"
tri06408,NCT04564040,TRUE,2021-10-07T09:32:23Z,NA,NA,NA,no primary efficay outcome
tri06412,NCT04565379,TRUE,2021-09-22T02:10:47Z,NA,NA,NA,NA
tri06460,NCT04570462,TRUE,2021-09-22T02:12:14Z,NA,NA,NA,"Withdrawn (The study was opened at the close of the peak of COVID. At our institution, there are significantly less COVID patients admitted who qualify for the study)"
tri06465,NCT04572399,TRUE,2021-11-03T13:33:58Z,NA,NA,NA,NA
tri06549,NCT04584580,TRUE,2021-10-26T05:24:34Z,NA,NA,NA,NA
tri06620,NCT04595136,TRUE,2021-09-22T02:13:17Z,NA,NA,NA,NA
tri06662,NCT04602832,TRUE,2021-09-22T02:13:34Z,NA,NA,NA,NA
tri06716,NCT04610541,TRUE,2021-09-22T02:14:16Z,NA,NA,NA,NA
tri06845,NCT04632043,TRUE,2021-09-22T02:14:37Z,NA,NA,NA,NA
tri06851,NCT04632602,TRUE,2021-09-22T02:15:06Z,NA,NA,NA,NA
tri06854,NCT04632719,TRUE,2021-10-06T02:34:24Z,NA,NA,NA,MentalPlus digital game for assessment and rehabilitation of cognitive function after remission of the symptoms of COVID-19
tri07277,NCT04335552,TRUE,2021-11-11T01:25:20Z,NA,NA,NA,"Terminated (Poor recruitment, strong evidence from larger trials of no therapeutic benefit)\n\nResults have been submitted to registry but not published"
tri07248,NL8787,TRUE,2021-09-22T02:18:05Z,NA,NA,NA,"This is looking at the rate and management of VTE from covid, I don't think it meets our criteria as not treatment is even specified."
tri07114,NCT04652648,TRUE,2021-11-05T03:16:32Z,NA,NA,NA,NA
tri07063,NCT04634409,TRUE,2021-11-03T13:40:34Z,NA,NA,NA,NA
tri07051,NCT04608097,TRUE,2021-09-22T02:18:41Z,NA,NA,NA,Mental trauma
tri07030,NCT04583592,TRUE,2021-11-03T13:39:46Z,NA,NA,NA,NA
tri07018,NCT04565197,TRUE,2021-09-22T02:19:11Z,NA,NA,NA,NA
tri03606,NCT04445194,TRUE,2021-11-03T13:53:19Z,NA,NA,NA,Phase 1 safety outcomes
tri03262,NCT04431856,TRUE,2021-09-22T02:20:30Z,NA,NA,NA,NA
tri02120,NCT04368000,TRUE,2021-10-25T08:15:15Z,NA,NA,NA,Terminated (Study was terminated due to lack of adherence to the protocol in the intervention arm.) AND Estimated publication date (August 2021).
tri01300,NCT04359797,TRUE,2021-09-22T02:21:18Z,NA,NA,NA,NA
tri03197,NCT04312009,TRUE,2021-11-02T06:30:31Z,NA,NA,NA,NA
tri01092,NCT04326920,TRUE,2021-10-26T05:29:58Z,NA,NA,NA,EUCTR completion date: 2021-02-26
tri03207,NCT04369066,TRUE,2021-09-23T06:56:34Z,NA,NA,NA,diagnostic testing without consequences = not interventional?
tri01932,NCT04384900,TRUE,2021-09-23T06:56:55Z,NA,NA,NA,Withdrawn (Primary investigators)
tri03489,NCT04433013,TRUE,2021-09-23T06:57:19Z,NA,NA,NA,NA
tri06091,NCT04522089,TRUE,2021-09-23T06:57:56Z,NA,NA,NA,NA
tri00686,ACTRN12620000443998,TRUE,2021-10-14T03:22:03Z,NA,NA,NA,Rehab
tri00075,ChiCTR2000029601,TRUE,2021-10-11T08:15:45Z,NA,NA,NA,NA
tri00509,ChiCTR2000030933,TRUE,2021-10-11T08:18:02Z,NA,NA,NA,Excluding based on results: ttps://europepmc.org/article/MED/33578552?singleResult=true which confirms that this is measuring rehabilitation effects on discharged COVID-19 patients.
tri01059,ChiCTR2000032214,TRUE,2021-10-11T08:18:59Z,NA,NA,NA,NA
tri02866,JPRN-UMIN000040407,TRUE,2021-10-11T08:20:00Z,NA,NA,NA,Study objectives are: hematological and immunological parameters of healthy individuals are affected by the administration of JHQG Granule
tri04711,CTRI/2020/07/026337,TRUE,2021-10-11T08:21:30Z,NA,NA,NA,NA
tri04723,CTRI/2020/07/026353,TRUE,2021-10-11T08:21:47Z,NA,NA,NA,NA
tri04766,CTRI/2020/07/026579,TRUE,2021-10-11T08:22:31Z,NA,NA,NA,NA
tri01330,NCT04366856,TRUE,2021-10-21T09:38:59Z,NA,NA,NA,NA
tri05799,NCT04485130,TRUE,2021-10-14T08:49:42Z,NA,NA,NA,primary outcome: Change in plasma inflammatory biomarker levels
tri00107,ChiCTR2000029381,TRUE,2021-12-09T06:25:41Z,NA,NA,NA,NA
tri00320,ChiCTR2000029580,TRUE,2021-11-11T01:12:13Z,NA,NA,NA,NA
tri00365,ChiCTR2000030832,TRUE,2021-10-14T03:21:01Z,NA,NA,NA,NA
tri00453,ChiCTR2000030187,TRUE,2021-10-14T03:21:34Z,NA,NA,NA,NA
tri03881,ACTRN12620000737932,TRUE,2021-12-09T05:22:11Z,NA,NA,NA,Feasibility study with primary outcome being feasibility of intervention and NOT COVID prevention
tri04043,ACTRN12620000779976,TRUE,2022-02-10T05:53:26Z,NA,NA,NA,NA
tri00328,NCT04295551,TRUE,2021-10-14T08:43:51Z,NA,NA,NA,NA
tri02578,NCT04356482,TRUE,2021-10-14T08:44:51Z,NA,NA,NA,NA
tri04537,CTRI/2020/05/025299,TRUE,2021-10-14T08:47:48Z,NA,NA,NA,NA
tri02167,NCT04395976,TRUE,2021-10-21T08:10:08Z,NA,NA,NA,NA
tri02180,NCT04397666,TRUE,2021-10-21T08:10:32Z,NA,NA,NA,NA
tri03488,NCT04432987,TRUE,2021-10-21T08:12:03Z,NA,NA,NA,NA
tri05570,NCT04461340,TRUE,2021-10-21T08:12:39Z,NA,NA,NA,NA
tri05890,NCT04495816,TRUE,2021-10-21T08:13:17Z,NA,NA,NA,"This is just symptomatic relief, not treatment of Covid directly."
tri04156,ChiCTR2000039592,TRUE,2021-10-21T08:52:30Z,NA,NA,NA,NA
tri01787,CTRI/2020/05/025114,TRUE,2021-10-21T08:53:16Z,NA,NA,NA,NA
tri04523,CTRI/2020/05/025254,TRUE,2021-10-21T09:25:48Z,NA,NA,NA,NA
tri04622,CTRI/2020/06/025704,TRUE,2021-10-21T09:30:39Z,NA,NA,NA,NA
tri00732,NCT04261517,TRUE,2021-10-25T08:08:29Z,NA,NA,NA,NA
tri03276,NCT04304053,TRUE,2021-12-09T03:11:20Z,NA,NA,NA,The publication date for the SSRN preprint and full-results article are the same; results comment: Early Treatment
tri00906,NCT04323345,TRUE,2021-10-21T09:35:01Z,NA,NA,NA,NA
tri01420,NCT04333550,TRUE,2021-10-21T09:35:22Z,NA,NA,NA,NA
tri00920,NCT04333628,TRUE,2021-10-21T09:35:38Z,NA,NA,NA,NA
tri00947,NCT04344210,TRUE,2021-10-21T09:35:57Z,NA,NA,NA,NA
tri01005,NCT04350931,TRUE,2021-10-21T09:36:17Z,NA,NA,NA,NA
tri01290,NCT04351191,TRUE,2021-10-21T09:36:38Z,NA,NA,NA,Terminated (Poor accrual)
tri01428,NCT04354597,TRUE,2021-10-21T09:36:52Z,NA,NA,NA,NA
tri01029,NCT04355026,TRUE,2021-10-21T09:37:07Z,NA,NA,NA,NA
tri03332,NCT04358068,TRUE,2021-10-21T09:37:52Z,NA,NA,NA,Terminated (Slow enrollment and lack of community enthusiasm)
tri02583,NCT04361838,TRUE,2021-10-21T09:38:40Z,NA,NA,NA,Podcast? https://scholarworks.wmich.edu/religion-pandemic-health/5/
tri01365,NCT04369365,TRUE,2021-10-21T09:39:21Z,NA,NA,NA,NA
tri01444,NCT04371367,TRUE,2021-10-21T09:40:11Z,NA,NA,NA,NA
tri05395,NCT04383548,TRUE,2021-10-21T09:40:34Z,NA,NA,NA,NA
tri02595,NCT04385940,TRUE,2021-11-05T06:13:14Z,NA,NA,NA,NA
tri02062,NCT04390477,TRUE,2021-10-21T09:41:26Z,NA,NA,NA,NA
tri01978,NCT04394039,TRUE,2021-10-21T09:41:39Z,NA,NA,NA,observational
tri02273,NCT04397497,TRUE,2021-10-21T09:41:58Z,NA,NA,NA,NA
tri03223,NCT04397562,TRUE,2021-10-25T08:28:50Z,NA,NA,NA,NA
tri02364,NCT04397692,TRUE,2021-10-21T09:42:47Z,NA,NA,NA,NA
tri03443,NCT04412668,TRUE,2022-03-02T06:08:42Z,NA,NA,NA,Primary outcome is safety (incidence of adverse events)
tri03520,NCT04435717,TRUE,2021-11-05T06:24:06Z,NA,NA,NA,PO Change in IL-12 values in the 3 study groups
tri03533,NCT04437875,TRUE,2021-10-21T09:43:39Z,NA,NA,NA,NA
tri03617,NCT04445376,TRUE,2021-10-21T09:43:51Z,NA,NA,NA,NA
tri05482,NCT04453514,TRUE,2021-10-21T09:44:04Z,NA,NA,NA,NA
tri05633,NCT04468646,TRUE,2021-11-05T06:30:16Z,NA,NA,NA,NA
tri05680,NCT04473170,TRUE,2021-11-05T06:42:33Z,NA,NA,NA,NA
tri05743,NCT04479163,TRUE,2021-10-21T09:45:11Z,NA,NA,NA,NA
tri05845,NCT04490824,TRUE,2021-11-05T06:30:39Z,NA,NA,NA,NA
tri05902,NCT04497298,TRUE,2021-11-03T13:15:42Z,NA,NA,NA,phase 1 vaccine safety
tri05904,NCT04497324,TRUE,2022-03-02T06:07:50Z,NA,NA,NA,Primary outcomes are safety
tri05930,NCT04498936,TRUE,2021-10-21T09:46:00Z,NA,NA,NA,NA
tri06036,NCT04514705,TRUE,2022-02-10T06:06:48Z,NA,NA,NA,NA
tri06055,NCT04516954,TRUE,2021-11-03T13:20:25Z,NA,NA,NA,Phase 1 safety outcomes
tri06087,NCT04521322,TRUE,2021-11-03T13:21:32Z,NA,NA,NA,NA
tri06188,NCT04533048,TRUE,2021-11-03T13:26:43Z,NA,NA,NA,Safety and tolerability outcomes in healthy subjects
tri06212,NCT04535856,TRUE,2021-11-03T13:28:41Z,NA,NA,NA,Primary outcome is safety
tri06219,NCT04536363,TRUE,2021-10-21T09:47:10Z,NA,NA,NA,NA
tri06220,NCT04536441,TRUE,2021-10-21T09:47:24Z,NA,NA,NA,NA
tri06245,NCT04539873,TRUE,2021-11-05T06:32:38Z,NA,NA,NA,NA
tri06310,NCT04548557,TRUE,2021-10-21T09:48:07Z,NA,NA,NA,NA
tri06373,NCT04558476,TRUE,2021-10-21T09:48:28Z,NA,NA,NA,NA
tri06519,NCT04581291,TRUE,2021-11-03T13:35:39Z,NA,NA,NA,NA
tri06592,NCT04591600,TRUE,2021-11-03T13:38:00Z,NA,NA,NA,Journal article does not have publication date. Preprint is still under peer review.
tri06721,NCT04611256,TRUE,2021-10-21T09:49:16Z,NA,NA,NA,NA
tri02444,NCT04283461,TRUE,2021-10-29T02:09:27Z,NA,NA,NA,"Phase I, PO is adverse events only"
tri07133,NCT04656626,TRUE,2021-10-21T09:49:47Z,NA,NA,NA,NA
tri07210,NCT04666116,TRUE,2021-10-21T09:50:11Z,NA,NA,NA,NA
tri00070,ChiCTR2000029621,TRUE,2021-11-05T14:17:53Z,NA,NA,NA,NA
tri00076,ChiCTR2000029600,TRUE,2021-11-22T10:10:04Z,NA,NA,NA,NA
tri00123,ChiCTR2000030116,TRUE,2021-11-05T14:19:14Z,NA,NA,NA,NA
tri00211,ChiCTR2000030386,TRUE,2021-11-22T10:12:44Z,NA,NA,NA,NA
tri00230,ChiCTR2000030261,TRUE,2021-11-22T10:15:27Z,NA,NA,NA,Interestingly one preprint contains 6 subjects and the other 7. ResearchSquare preprint under review at Stem Cell Research & Therapy.
tri00238,ChiCTR2000030225,TRUE,2021-11-05T14:20:22Z,NA,NA,NA,NA
tri00502,ChiCTR2000030946,TRUE,2021-11-05T14:20:36Z,NA,NA,NA,NA
tri01052,ChiCTR2000032346,TRUE,2021-11-05T14:20:49Z,NA,NA,NA,NA
tri01736,CTRI/2020/04/024659,TRUE,2021-11-05T14:21:11Z,NA,NA,NA,NA
tri01790,CTRI/2020/05/025161,TRUE,2021-11-22T10:45:44Z,NA,NA,NA,NA
tri00731,NCT04252274,TRUE,2021-11-05T14:23:04Z,NA,NA,NA,NA
tri00193,NCT04275245,TRUE,2021-12-09T03:46:16Z,NA,NA,NA,"Preprint (10.1101/2020.03.21.20040691) reports phase 2 only and article (10.1038/s41392-021-00603-6) reports both phase 1 and 2. We consider these to be matching, i.e., that preprint converted into article. The final enrollment date was taken from preprint as it was not reported in full results."
tri03277,NCT04308668,TRUE,2021-12-09T03:41:36Z,NA,NA,NA,NA
tri00739,NCT04315480,TRUE,2022-07-01T09:48:48Z,NA,NA,NA,NA
tri01277,NCT04321096,TRUE,2021-11-22T10:37:03Z,NA,NA,NA,NA
tri02017,NCT04325893,TRUE,2021-11-22T11:00:15Z,NA,NA,NA,Terminated (decrease in number of eligible patients)
tri03291,NCT04329611,TRUE,2021-12-09T04:08:33Z,NA,NA,NA,NA
tri00685,NCT04335201,TRUE,2021-11-05T14:26:54Z,NA,NA,NA,NA
tri05347,NCT04336748,TRUE,2021-11-05T14:27:12Z,NA,NA,NA,NA
tri01169,NCT04359251,TRUE,2021-11-22T10:34:55Z,NA,NA,NA,NA
tri02037,NCT04371952,TRUE,2021-12-01T09:10:49Z,NA,NA,NA,NA
tri01566,NCT04378257,TRUE,2021-11-05T14:28:00Z,NA,NA,NA,NA
tri03218,NCT04388709,TRUE,2021-11-05T14:28:19Z,NA,NA,NA,"Withdrawn (Due to the number of competing trials at their site, the study team has closed enrollment and withdrawn this trial.)"
tri02615,NCT04411667,TRUE,2021-12-01T09:16:55Z,NA,NA,NA,NA
tri03132,NCT04425538,TRUE,2021-11-05T14:29:14Z,NA,NA,NA,NA
tri03246,NCT04428268,TRUE,2021-11-05T14:29:29Z,NA,NA,NA,NA
tri03564,NCT04441918,TRUE,2021-12-06T09:02:29Z,NA,NA,NA,NA
tri03602,NCT04444674,TRUE,2021-12-09T03:28:01Z,NA,NA,NA,NA
tri03613,NCT04445285,TRUE,2021-11-05T14:30:26Z,NA,NA,NA,NA
tri05442,NCT04449718,TRUE,2021-12-06T09:13:46Z,NA,NA,NA,NA
tri05612,NCT04466670,TRUE,2021-11-05T14:31:12Z,NA,NA,NA,NA
tri05672,NCT04472585,TRUE,2021-12-06T09:18:49Z,NA,NA,NA,NA
tri05683,NCT04473261,TRUE,2021-11-05T14:32:04Z,NA,NA,NA,NA
tri05878,NCT04494386,TRUE,2021-12-06T09:19:54Z,NA,NA,NA,NA
tri05947,NCT04501783,TRUE,2021-12-06T09:22:20Z,NA,NA,NA,NA
tri05980,NCT04507867,TRUE,2021-12-06T09:24:19Z,NA,NA,NA,NA
tri06158,NCT04530370,TRUE,2021-11-05T14:34:32Z,NA,NA,NA,NA
tri06293,NCT04545749,TRUE,2021-11-05T14:34:56Z,NA,NA,NA,Phase 1 safety outcomes
tri06516,NCT04581161,TRUE,2021-11-05T14:35:17Z,NA,NA,NA,NA
tri06578,NCT04590209,TRUE,2021-12-09T04:13:15Z,NA,NA,NA,NA
tri06644,NCT04598763,TRUE,2021-11-05T14:35:51Z,NA,NA,NA,NA
tri06870,NCT04635943,TRUE,2021-11-05T14:36:12Z,NA,NA,NA,NA
tri06910,NCT04643561,TRUE,2021-12-06T09:30:53Z,NA,NA,NA,NA
tri02035,NCT04370782,TRUE,2021-11-05T14:36:45Z,NA,NA,NA,NA
tri06973,NCT04497948,TRUE,2021-12-01T09:46:41Z,NA,NA,NA,NA
tri06988,NCT04523181,TRUE,2021-11-05T14:37:11Z,NA,NA,NA,NA
tri07054,NCT04609969,TRUE,2021-11-05T14:37:26Z,NA,NA,NA,diagnostic
tri03710,NL8521,TRUE,2021-11-05T14:37:41Z,NA,NA,NA,NA
tri03053,NCT04356495,TRUE,2021-11-05T14:38:20Z,NA,NA,NA,NA
tri00010,ChiCTR2000029947,TRUE,2021-11-21T22:05:14Z,NA,NA,NA,NA
tri00019,ChiCTR2000029869,TRUE,2021-11-22T10:06:54Z,NA,NA,NA,The second result is the preprint of protocol
tri00043,ChiCTR2000029777,TRUE,2021-11-25T03:42:21Z,NA,NA,NA,NA
tri00045,ChiCTR2000029769,TRUE,2021-11-21T22:06:37Z,NA,NA,NA,NA
tri00049,ChiCTR2000029763,TRUE,2022-01-31T09:42:45Z,NA,NA,NA,NA
tri00055,ChiCTR2000029742,TRUE,2021-11-21T22:07:53Z,NA,NA,NA,NA
tri00062,ChiCTR2000029656,TRUE,2021-12-09T06:18:10Z,TRUE,FALSE,https://jamanetwork.com/journals/jama/fullarticle/2770279 : 'Other trials were excluded because their investigators confirmed that they had not recruited any patients (ChiCTR2000029656 ... ',a precedent article that may be associated with the study (but no results): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7159292/
tri00071,ChiCTR2000029609,TRUE,2021-11-25T03:47:50Z,NA,NA,NA,NA
tri00073,ChiCTR2000029603,TRUE,2021-11-21T22:09:08Z,NA,NA,NA,NA
tri00083,ChiCTR2000029544,TRUE,2022-02-10T05:13:56Z,NA,NA,NA,NA
tri00100,ChiCTR2000029436,TRUE,2021-11-25T03:51:52Z,NA,NA,NA,result from Keyword search / pubmed was translated automatically; original: http://rs.yiigle.com/CN121430202008/1251056.htm
tri00109,ChiCTR2000030188,TRUE,2021-11-21T22:09:59Z,NA,NA,NA,NA
tri00125,ChiCTR2000030113,TRUE,2021-11-21T22:10:26Z,NA,NA,NA,"same author, but different outcome measures https://pubmed.ncbi.nlm.nih.gov/33930706/"
tri00144,ChiCTR2000030034,TRUE,2021-11-21T22:10:41Z,NA,NA,NA,NA
tri00145,ChiCTR2000030033,TRUE,2021-11-21T22:10:59Z,NA,NA,NA,NA
tri00160,ChiCTR2000030006,TRUE,2021-12-09T06:26:43Z,NA,NA,NA,NA
tri00163,ChiCTR2000030002,TRUE,2021-11-21T22:11:29Z,NA,NA,NA,NA
tri00164,ChiCTR2000030001,TRUE,2022-02-02T09:19:55Z,NA,NA,NA,NA
tri00173,ChiCTR2000029988,TRUE,2021-11-21T22:12:14Z,NA,NA,NA,NA
tri00177,ChiCTR2000029974,TRUE,2021-11-21T22:12:45Z,NA,NA,NA,NA
tri00188,ChiCTR2000029780,TRUE,2021-11-21T22:12:59Z,NA,NA,NA,NA
tri00189,ChiCTR2000029740,TRUE,2021-11-21T22:13:13Z,NA,NA,NA,NA
tri00222,ChiCTR2000030314,TRUE,2021-11-21T22:13:27Z,NA,NA,NA,NA
tri00248,ChiCTR2000030022,TRUE,2021-11-22T10:22:36Z,NA,NA,NA,"I am not convinced that the results publication listed here is the same as what is on the registry (Huatanzhike granules vs low-dose emetine) ...however, the publication states the corresponding registry number."
tri00251,ChiCTR2000029975,TRUE,2021-11-21T22:14:53Z,NA,NA,NA,NA
tri00255,ChiCTR2000029898,TRUE,2021-11-21T22:15:11Z,NA,NA,NA,NA
tri00286,ChiCTR2000030535,TRUE,2021-11-21T22:15:27Z,NA,NA,NA,NA
tri00293,ChiCTR2000030490,TRUE,2021-11-21T22:15:43Z,NA,NA,NA,NA
tri00295,ChiCTR2000030487,TRUE,2021-11-21T22:15:59Z,NA,NA,NA,NA
tri00409,ChiCTR2000030744,TRUE,2021-11-21T22:16:19Z,NA,NA,NA,NA
tri00426,ChiCTR2000030701,TRUE,2021-12-09T06:36:25Z,NA,NA,NA,NA
tri00521,ChiCTR2000030254,TRUE,2021-11-25T03:55:13Z,NA,NA,NA,NA
tri00526,ChiCTR2000029868,TRUE,2021-11-22T10:20:32Z,NA,NA,NA,analysis cut-off date was 2020-03-14
tri00594,ChiCTR2000030923,TRUE,2021-11-21T22:17:45Z,NA,NA,NA,NA
tri00596,ChiCTR2000030704,TRUE,2021-12-09T06:41:55Z,NA,NA,NA,NA
tri00598,ChiCTR2000030288,TRUE,2021-11-25T03:58:45Z,NA,NA,NA,NA
tri00689,ACTRN12620000447954,TRUE,2021-11-22T10:24:02Z,NA,NA,NA,NA
tri01048,ChiCTR2000032400,TRUE,2021-11-25T04:09:09Z,NA,NA,NA,NA
tri01051,ChiCTR2000032367,TRUE,2021-11-21T22:19:23Z,NA,NA,NA,NA
tri01053,ChiCTR2000032314,TRUE,2021-11-21T22:19:41Z,NA,NA,NA,NA
tri01054,ChiCTR2000032313,TRUE,2021-11-21T22:19:56Z,NA,NA,NA,NA
tri01241,ISRCTN13311119,TRUE,2021-11-21T22:20:18Z,NA,NA,NA,NA
tri01260,ChiCTR2000032135,TRUE,2021-11-21T22:20:30Z,NA,NA,NA,NA
tri02205,ChiCTR2000033320,TRUE,2021-11-25T04:30:46Z,NA,NA,NA,results linked in registry under download are non-english
tri02207,ChiCTR2000033318,TRUE,2021-11-21T22:20:58Z,NA,NA,NA,This appears almost identical to: https://www.chictr.org.cn/showprojen.aspx?proj=52972
tri02785,IRCT20200217046526N1,TRUE,2022-02-02T09:30:59Z,NA,NA,NA,"This should be excluded b/c just safety outcome.\n\nHowever, results are here: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7844804/"
tri03856,IRCT20150107020592N26,TRUE,2021-11-21T22:21:23Z,NA,NA,NA,NA
tri02674,EUCTR2020-001270-29,TRUE,2021-11-21T22:21:54Z,NA,NA,NA,NA
tri00026,ChiCTR2000029822,TRUE,2021-12-09T06:14:17Z,NA,NA,NA,NA
tri04021,IRCT20090304001739N3,TRUE,2021-12-10T06:24:29Z,NA,NA,NA,"https://issuu.com/iranwire/docs/corona_report pages: 44-45/60\nIndicated on Google that there might be information related to the trial, no English version though"
tri00808,ACTRN12620000473965,TRUE,2021-11-21T22:23:24Z,NA,NA,NA,NA
tri04194,IRCT20201003048905N1,TRUE,2021-11-21T22:23:38Z,NA,NA,NA,NA
tri02435,EUCTR2020-001546-19,TRUE,2021-12-01T09:15:25Z,NA,NA,NA,Safety and tolerability
tri04236,EUCTR2020-002456-21,TRUE,2021-11-21T22:24:04Z,NA,NA,NA,NA
tri01611,IRCT20160131026298N2,TRUE,2021-11-21T22:24:20Z,NA,NA,NA,NA
tri02915,RPCEC00000314,TRUE,2021-11-21T22:24:37Z,NA,NA,NA,NA
tri02918,RPCEC00000317,TRUE,2021-11-26T03:38:27Z,NA,NA,NA,NA
tri04524,CTRI/2020/05/025276,TRUE,2021-11-25T04:25:00Z,NA,NA,NA,NA
tri04540,CTRI/2020/05/025317,TRUE,2022-02-07T04:24:37Z,NA,NA,NA,Primary outcome is &quot;Clinical acceptability of turmeric lozenges in COVID-19 healthcare teams&quot; and NOT covid prevention/treatment
tri04546,CTRI/2020/05/025338,TRUE,2021-11-26T03:51:47Z,NA,NA,NA,NA
tri04562,CTRI/2020/05/025385,TRUE,2021-11-21T22:25:48Z,NA,NA,NA,NA
tri04568,CTRI/2020/05/025397,TRUE,2021-11-21T22:26:18Z,NA,NA,NA,NA
tri04650,CTRI/2020/06/025855,TRUE,2021-12-06T09:12:00Z,NA,NA,NA,NA
tri04699,CTRI/2020/06/026227,TRUE,2022-02-10T05:26:36Z,NA,NA,NA,NA
tri04707,CTRI/2020/06/026262,TRUE,2021-11-21T22:27:06Z,NA,NA,NA,NA
tri04735,CTRI/2020/07/026462,TRUE,2021-11-21T22:27:21Z,NA,NA,NA,NA
tri04764,CTRI/2020/07/026570,TRUE,2021-11-21T22:27:45Z,NA,NA,NA,NA
tri04828,CTRI/2020/07/026839,TRUE,2021-11-26T03:55:39Z,NA,NA,NA,NA
tri04999,CTRI/2020/09/027775,TRUE,2021-11-21T22:28:19Z,NA,NA,NA,NA
tri03193,NCT04244591,TRUE,2021-11-21T22:28:37Z,NA,NA,NA,NA
tri00005,NCT04260594,TRUE,2021-11-21T22:29:09Z,NA,NA,NA,NA
tri00606,NCT04305106,TRUE,2021-11-21T22:29:26Z,NA,NA,NA,NA
tri02014,NCT04313127,TRUE,2022-09-09T12:28:56Z,NA,NA,NA,Excluded at further discussion because Phase 1 only safety outcomes.
tri00740,NCT04317092,TRUE,2021-12-09T06:52:41Z,NA,NA,NA,NA
tri00902,NCT04320277,TRUE,2021-12-13T01:24:23Z,NA,NA,NA,not sure if result indeed is an interim result or belongs to this study: NCT04358614 as referenced in https://www.journalofinfection.com/article/S0163-4453(20)30433-3/fulltext
tri01798,NCT04322396,TRUE,2022-09-09T12:39:31Z,NA,NA,NA,Registry summary results found via cross-registration: EUCTR2020-001198-55 (tri01265)
tri02558,NCT04326114,TRUE,2021-11-21T22:31:09Z,NA,NA,NA,NA
tri00666,NCT04327349,TRUE,2021-11-21T22:31:29Z,NA,NA,NA,NA
tri01880,NCT04328961,TRUE,2021-11-22T10:55:34Z,NA,NA,NA,NA
tri00751,NCT04330495,TRUE,2021-11-21T22:32:17Z,NA,NA,NA,NA
tri00756,NCT04331834,TRUE,2021-11-25T04:05:07Z,NA,NA,NA,"we found another preprint, that is the same as the one that we already found (https://www.researchsquare.com/article/rs-350749/v1) but has a different DOI: https://www.researchsquare.com/article/rs-72132/v1"
tri02562,NCT04332081,TRUE,2021-11-26T03:37:15Z,NA,NA,NA,Terminated (The IRB has determined that the design of this trial should be changed to a randomized controlled trial. A new record will be created for the redesigned study.)
tri01486,NCT04333225,TRUE,2021-11-21T22:33:11Z,NA,NA,NA,NA
tri01487,NCT04333355,TRUE,2021-11-22T10:44:21Z,NA,NA,NA,Safety outcomes
tri01101,NCT04334265,TRUE,2021-11-21T22:33:45Z,NA,NA,NA,NA
tri01281,NCT04334928,TRUE,2021-11-21T22:34:20Z,NA,NA,NA,NA
tri01105,NCT04335123,TRUE,2021-11-22T10:34:22Z,NA,NA,NA,Safety outcomes
tri03030,NCT04335786,TRUE,2021-11-21T22:35:10Z,NA,NA,NA,NA
tri00766,NCT04336254,TRUE,2021-11-21T22:35:44Z,NA,NA,NA,NA
tri00770,NCT04336904,TRUE,2021-11-21T22:36:01Z,NA,NA,NA,NA
tri03033,NCT04338074,TRUE,2021-12-01T09:24:31Z,NA,NA,NA,Terminated (Lack of recruitment)
tri00782,NCT04338802,TRUE,2021-11-21T22:36:33Z,NA,NA,NA,NA
tri01886,NCT04340050,TRUE,2022-02-14T01:45:12Z,NA,NA,NA,"Abstract says that parameters were assessed at 28 days or more, therefore we put the study completion rather than as primary. \n\nThe preprint decisions were difficult here as they both talk about the primary outcome of feasibility of the program. The medrxiv one contains more results about clinical predictors and matches a journal article. Bith deal with the same 10 people. We ended up putting them both as full results preprints thinking of them more as different versions of the same preprint."
tri01109,NCT04341493,TRUE,2021-11-21T22:37:40Z,NA,NA,NA,NA
tri00931,NCT04341584,TRUE,2021-12-09T06:58:26Z,NA,NA,NA,Sub-trial of NCT04324047/EUCTR2020-001246-18 (tri00659) observational supra-'trial' (excluded)
tri02024,NCT04341935,TRUE,2021-11-21T22:38:25Z,NA,NA,NA,NA
tri02025,NCT04342182,TRUE,2021-11-22T11:01:46Z,NA,NA,NA,NA
tri02099,NCT04342663,TRUE,2021-12-01T09:14:03Z,NA,NA,NA,NA
tri01425,NCT04345614,TRUE,2021-11-22T10:43:13Z,NA,NA,NA,NA
tri02940,NCT04345653,TRUE,2021-12-01T09:18:19Z,NA,NA,NA,NA
tri01114,NCT04345679,TRUE,2021-11-25T04:13:20Z,NA,NA,NA,NA
tri03202,NCT04346446,TRUE,2021-11-21T22:41:03Z,NA,NA,NA,NA
tri02943,NCT04347382,TRUE,2021-12-01T09:21:51Z,NA,NA,NA,NA
tri00986,NCT04347980,TRUE,2021-11-21T22:42:10Z,NA,NA,NA,NA
tri03312,NCT04349241,TRUE,2021-12-01T09:41:03Z,NA,NA,NA,Publication was retracted
tri01017,NCT04352400,TRUE,2021-11-21T22:42:38Z,NA,NA,NA,NA
tri01291,NCT04352465,TRUE,2021-11-21T22:42:55Z,NA,NA,NA,NA
tri01897,NCT04352933,TRUE,2021-11-22T10:58:01Z,NA,NA,NA,NA
tri01132,NCT04355052,TRUE,2021-11-21T22:43:23Z,NA,NA,NA,NA
tri01036,NCT04356508,TRUE,2021-11-21T22:44:02Z,NA,NA,NA,NA
tri03326,NCT04356534,TRUE,2021-12-01T09:42:36Z,NA,NA,NA,NA
tri03328,NCT04357028,TRUE,2022-02-10T05:55:07Z,NA,NA,NA,Suspended (Failure of subject recruitment)
tri01153,NCT04357613,TRUE,2021-11-21T22:45:07Z,NA,NA,NA,EUCTR completion date: 2021-01-29
tri01164,NCT04358614,TRUE,2021-12-13T01:24:12Z,NA,NA,NA,"registry talks about 12 patients, but in the papers it looks like they had around 200 with the same TRN"
tri01431,NCT04358926,TRUE,2021-11-21T22:45:53Z,NA,NA,NA,NA
tri01174,NCT04359615,TRUE,2021-11-21T22:46:07Z,NA,NA,NA,NA
tri01193,NCT04360980,TRUE,2021-11-21T22:46:36Z,NA,NA,NA,NA
tri01195,NCT04361318,TRUE,2021-11-21T22:46:49Z,NA,NA,NA,NA
tri01201,NCT04361526,TRUE,2021-11-21T22:47:02Z,NA,NA,NA,NA
tri01305,NCT04361942,TRUE,2021-11-21T22:47:18Z,NA,NA,NA,NA
tri01215,NCT04363372,TRUE,2021-11-21T22:47:34Z,NA,NA,NA,NA
tri02468,NCT04363827,TRUE,2021-11-21T22:47:57Z,NA,NA,NA,NA
tri01228,NCT04365439,TRUE,2021-11-21T22:48:12Z,NA,NA,NA,NA
tri01320,NCT04366063,TRUE,2021-11-25T04:25:21Z,NA,NA,NA,NA
tri01321,NCT04366089,TRUE,2021-11-21T22:48:55Z,NA,NA,NA,NA
tri03060,NCT04366232,TRUE,2021-11-26T03:48:34Z,NA,NA,NA,Terminated (investigator decision)
tri01327,NCT04366739,TRUE,2021-11-22T10:38:34Z,NA,NA,NA,NA
tri01520,NCT04370015,TRUE,2021-11-21T22:49:30Z,NA,NA,NA,NA
tri01446,NCT04371510,TRUE,2021-11-22T10:43:48Z,NA,NA,NA,NA
tri01465,NCT04373291,TRUE,2021-11-25T04:26:50Z,NA,NA,NA,NA
tri01528,NCT04374032,TRUE,2021-11-21T22:50:04Z,NA,NA,NA,NA
tri03211,NCT04376814,TRUE,2021-11-21T22:50:25Z,NA,NA,NA,NA
tri01557,NCT04377503,TRUE,2021-11-21T22:50:58Z,NA,NA,NA,NA
tri03067,NCT04377711,TRUE,2021-11-26T03:45:43Z,NA,NA,NA,NA
tri02043,NCT04377789,TRUE,2021-12-01T09:12:31Z,NA,NA,NA,[Left blank]
tri01841,NCT04381338,TRUE,2021-11-21T22:52:31Z,NA,NA,NA,NA
tri01868,NCT04384380,TRUE,2021-11-22T10:52:07Z,NA,NA,NA,NA
tri02592,NCT04384458,TRUE,2021-11-21T22:53:25Z,NA,NA,NA,NA
tri01935,NCT04385043,TRUE,2021-11-21T22:53:42Z,NA,NA,NA,NA
tri05398,NCT04385810,TRUE,2021-11-21T22:54:30Z,NA,NA,NA,"observational, Ophthalmologic exam"
tri01964,NCT04388410,TRUE,2021-11-21T22:55:10Z,NA,NA,NA,NA
tri01970,NCT04389294,TRUE,2021-11-21T22:56:06Z,NA,NA,NA,diagnostic test
tri02057,NCT04390152,TRUE,2021-11-21T22:56:25Z,NA,NA,NA,NA
tri02599,NCT04393246,TRUE,2021-11-21T22:57:16Z,NA,NA,NA,NA
tri02189,NCT04399746,TRUE,2021-11-21T22:57:32Z,NA,NA,NA,NA
tri02282,NCT04399798,TRUE,2021-11-21T22:57:48Z,NA,NA,NA,NA
tri02316,NCT04403477,TRUE,2021-11-21T22:58:14Z,NA,NA,NA,NA
tri03427,NCT04405934,TRUE,2021-12-01T09:47:05Z,NA,NA,NA,NA
tri03432,NCT04407689,TRUE,2021-11-21T22:59:32Z,NA,NA,NA,NA
tri03436,NCT04410159,TRUE,2021-11-21T23:00:30Z,NA,NA,NA,NA
tri03440,NCT04412291,TRUE,2021-11-21T23:00:48Z,NA,NA,NA,NA
tri02549,NCT04412395,TRUE,2021-11-21T23:01:43Z,NA,NA,NA,NA
tri03099,NCT04414618,TRUE,2021-12-01T09:22:14Z,NA,NA,NA,NA
tri02981,NCT04415879,TRUE,2021-11-21T23:02:16Z,NA,NA,NA,NA
tri02643,NCT04416113,TRUE,2021-11-21T23:02:44Z,NA,NA,NA,NA
tri02982,NCT04416399,TRUE,2021-11-26T03:42:20Z,NA,NA,NA,Terminated (Independent statistical review advice)
tri03011,NCT04421664,TRUE,2021-12-01T09:23:46Z,NA,NA,NA,Terminated (Request of Health Canada after publication of https://doi.org/10.7326/M20-4207)
tri03245,NCT04427878,TRUE,2021-11-25T04:26:57Z,NA,NA,NA,"observational, analysis of biopsies"
tri03516,NCT04435353,TRUE,2021-11-21T23:04:10Z,NA,NA,NA,NA
tri03541,NCT04438837,TRUE,2021-11-21T23:04:19Z,NA,NA,NA,NA
tri03591,NCT04443881,TRUE,2021-11-21T23:04:54Z,NA,NA,NA,NA
tri03614,NCT04445311,TRUE,2021-11-21T23:05:10Z,NA,NA,NA,NA
tri03629,NCT04445623,TRUE,2021-11-21T23:05:25Z,NA,NA,NA,NA
tri03658,NCT04448769,TRUE,2021-11-21T23:05:37Z,NA,NA,NA,"epidemiologically, Anti-SARS-CoV-2 IgT seropositivity"
tri05462,NCT04452474,TRUE,2021-11-21T23:06:00Z,NA,NA,NA,NA
tri05577,NCT04462757,TRUE,2021-12-06T09:16:13Z,NA,NA,NA,Terminated (Lack of patients in the trial population from which to recruit and lack of funding)
tri05592,NCT04464408,TRUE,2021-11-21T23:07:06Z,NA,NA,NA,NA
tri05604,NCT04466280,TRUE,2021-11-21T23:07:26Z,NA,NA,NA,NA
tri05617,NCT04467047,TRUE,2021-11-21T23:07:48Z,NA,NA,NA,NA
tri05627,NCT04468139,TRUE,2021-12-06T09:18:00Z,NA,NA,NA,NA
tri05636,NCT04468958,TRUE,2021-12-06T09:18:22Z,NA,NA,NA,NA
tri05750,NCT04479358,TRUE,2021-11-21T23:08:59Z,NA,NA,NA,NA
tri05758,NCT04480333,TRUE,2021-11-21T23:09:18Z,NA,NA,NA,Adverse Events
tri05830,NCT04488484,TRUE,2021-11-21T23:09:33Z,NA,NA,NA,NA
tri05852,NCT04491240,TRUE,2021-11-25T04:22:48Z,NA,NA,NA,PO: adverse events only
tri05881,NCT04494724,TRUE,2021-11-25T04:22:07Z,NA,NA,NA,adverse events
tri05911,NCT04497519,TRUE,2021-12-06T09:20:24Z,NA,NA,NA,NA
tri05987,NCT04508868,TRUE,2021-11-21T23:10:04Z,NA,NA,NA,Terminated (Study terminated due to changes in government restrictions. Collected data to be presented as a pilot study.)
tri06016,NCT04511949,TRUE,2021-11-21T23:10:16Z,NA,NA,NA,no intervention; just testing
tri06048,NCT04516811,TRUE,2021-12-06T09:22:41Z,NA,NA,NA,NA
tri06061,NCT04517422,TRUE,2021-12-06T09:24:58Z,NA,NA,NA,NA
tri06069,NCT04519125,TRUE,2021-11-21T23:11:09Z,NA,NA,NA,NA
tri06077,NCT04519411,TRUE,2021-11-21T23:11:23Z,NA,NA,NA,observational: Diagnostic Test: Transpulmonary pressure measurements\nTranspulmonary pressure measurements
tri06085,NCT04521296,TRUE,2021-11-21T23:11:44Z,NA,NA,NA,NA
tri06109,NCT04524598,TRUE,2021-11-21T23:11:52Z,NA,NA,NA,NA
tri06114,NCT04525378,TRUE,2021-11-21T23:12:08Z,NA,NA,NA,NA
tri06136,NCT04527432,TRUE,2021-11-21T23:12:18Z,NA,NA,NA,NA
tri06241,NCT04539626,TRUE,2021-11-21T23:12:33Z,NA,NA,NA,NA
tri06252,NCT04540926,TRUE,2021-12-06T09:28:58Z,NA,NA,[Left blank],NA
tri06271,NCT04542694,TRUE,2021-12-13T01:33:39Z,NA,NA,NA,"result according to Cochrane but I cannot access the link: https://www.embase.com/search/results?subaction=viewrecord&id=L2011742737\nalso, non-english-result: https://www.pharmpharm.ru/jour/article/view/709"
tri06272,NCT04542850,TRUE,2021-11-25T04:20:21Z,NA,NA,NA,adverse events
tri06304,NCT04547634,TRUE,2021-11-21T23:13:14Z,NA,NA,NA,NA
tri06309,NCT04548544,TRUE,2021-11-21T23:13:23Z,NA,NA,NA,NA
tri06316,NCT04549376,TRUE,2021-11-21T23:13:58Z,NA,NA,NA,NA
tri06324,NCT04551274,TRUE,2021-11-21T23:14:10Z,NA,NA,NA,NA
tri06332,NCT04551898,TRUE,2021-11-21T23:14:43Z,NA,NA,NA,NA
tri06336,NCT04552483,TRUE,2021-12-06T09:31:55Z,NA,NA,NA,NA
tri06339,NCT04553705,TRUE,2021-11-21T23:16:01Z,NA,NA,NA,NA
tri06345,NCT04555005,TRUE,2021-11-21T23:16:16Z,NA,NA,NA,NA
tri06361,NCT04557605,TRUE,2021-11-21T23:16:24Z,NA,NA,NA,NA
tri06368,NCT04558411,TRUE,2021-11-21T23:16:32Z,NA,NA,NA,NA
tri06382,NCT04560231,TRUE,2021-11-21T23:16:45Z,NA,NA,NA,NA
tri06396,NCT04561219,TRUE,2022-02-10T05:28:35Z,NA,NA,NA,Other result is results but is a conference abstract.
tri06443,NCT04568863,TRUE,2021-11-25T04:19:38Z,NA,NA,NA,NA
tri06445,NCT04568889,TRUE,2021-11-21T23:17:19Z,NA,NA,NA,NA
tri06488,NCT04576312,TRUE,2021-11-25T04:15:34Z,NA,NA,NA,NA
tri06561,NCT04587219,TRUE,2021-11-26T03:55:04Z,NA,NA,NA,NA
tri06566,NCT04587414,TRUE,2021-11-21T23:17:47Z,NA,NA,NA,NA
tri06572,NCT04589104,TRUE,2021-12-09T05:38:39Z,NA,NA,[Left blank],NA
tri06604,NCT04593641,TRUE,2021-12-06T09:27:54Z,NA,NA,NA,Safety and tolerability outcomes
tri06609,NCT04594330,TRUE,2021-11-21T23:18:37Z,NA,NA,NA,NA
tri06631,NCT04597034,TRUE,2021-11-26T03:53:33Z,NA,NA,NA,NA
tri06655,NCT04602000,TRUE,2021-11-25T04:13:02Z,NA,NA,NA,NA
tri06809,NCT04625985,TRUE,2021-11-21T23:19:28Z,NA,NA,NA,NA
tri06815,NCT04627467,TRUE,2021-11-21T23:20:03Z,NA,NA,NA,NA
tri06833,NCT04629755,TRUE,2021-11-21T23:20:18Z,NA,NA,NA,NA
tri06841,NCT04631536,TRUE,2021-11-21T23:20:33Z,NA,NA,NA,NA
tri06922,NCT04644328,TRUE,2021-12-09T05:40:16Z,NA,NA,NA,NA
tri00745,NCT04324021,TRUE,2021-11-21T23:21:05Z,NA,NA,NA,Standard of care evolved during the timeframe of the study and had critical impact on recruitment.\n\nEarly termination is not based on safety reasons but because of recruitment issues.\n\nPatients ongoing will be completed. Planned LPLV 25Jan2021
tri02311,NCT04402983,TRUE,2021-11-21T23:21:27Z,NA,NA,NA,NA
tri03429,NCT04407130,TRUE,2021-11-26T03:49:06Z,NA,NA,NA,NA
tri03470,NCT04427501,TRUE,2021-12-01T09:52:13Z,NA,NA,NA,NA
tri03647,NCT04447534,TRUE,2021-11-25T04:25:47Z,NA,NA,NA,NA
tri06949,NCT04453384,TRUE,2021-12-01T09:47:33Z,NA,NA,NA,NA
tri06955,NCT04466085,TRUE,2021-11-26T04:00:27Z,NA,NA,NA,NA
tri06991,NCT04527081,TRUE,2021-12-01T09:45:27Z,NA,NA,NA,phase 1 safety outcomes
tri06992,NCT04527471,TRUE,2021-11-21T23:23:24Z,NA,NA,NA,NA
tri07009,NCT04558372,TRUE,2021-12-11T00:38:06Z,NA,NA,NA,Primary outcomes are diagnostic accuracy
tri03168,ISRCTN89951424,TRUE,2021-12-09T04:05:10Z,NA,NA,NA,ClinicalTrials.gov completion date: September 2021
tri03164,ACTRN12620000501943,TRUE,2021-11-21T23:24:15Z,NA,NA,NA,NA
tri07276,NCT04323527,TRUE,2021-12-01T09:42:03Z,NA,NA,NA,NA
tri01802,NCT04340544,TRUE,2022-02-10T06:40:29Z,NA,NA,NA,"Terminated (It appeared to be impossible for the study centres to recruit the targeted number of patients, due to reduced incidence and reduced acceptance to IMP)"
tri00191,NCT04273529,TRUE,2021-11-22T04:58:16Z,NA,NA,NA,NA
tri00656,NCT04320238,TRUE,2021-12-09T03:52:47Z,NA,NA,NA,"Can't access full-text of article but abstract, authors, medrxiv etc link it to preprint."
tri02929,TCTR20200404004,TRUE,2021-11-22T05:08:29Z,NA,NA,NA,NA
tri02914,RPCEC00000313,TRUE,2021-12-01T09:20:32Z,NA,NA,NA,NA
tri04065,ACTRN12620000834954,TRUE,2021-12-06T09:09:25Z,NA,NA,NA,Safety outcomes
tri03964,IRCT20200705048013N1,TRUE,2021-11-22T05:04:40Z,NA,NA,NA,NA
tri03883,ChiCTR2000034795,TRUE,2021-12-10T06:23:33Z,NA,NA,NA,NA
tri00825,ChiCTR2000031888,TRUE,2021-12-01T09:04:29Z,NA,NA,NA,NA
tri00593,ChiCTR2000030936,TRUE,2021-11-22T05:09:48Z,NA,NA,NA,NA
tri00529,ChiCTR2000029573,TRUE,2021-11-22T05:10:23Z,NA,NA,NA,NA
tri00427,ChiCTR2000030700,TRUE,2021-11-22T05:10:36Z,NA,NA,NA,NA
tri00162,ChiCTR2000030003,TRUE,2021-11-22T21:11:41Z,NA,NA,NA,NA
tri02563,NCT04333654,TRUE,2021-11-22T21:13:37Z,NA,NA,NA,Terminated (Rate of enrollment too slow to allow completion in a reasonable timeframe)
tri00763,NCT04334382,TRUE,2021-11-22T21:13:53Z,NA,NA,NA,NA
tri00938,NCT04343183,TRUE,2021-11-22T21:14:09Z,NA,NA,NA,NA
tri02569,NCT04343248,TRUE,2021-11-22T21:14:32Z,NA,NA,NA,NA
tri03047,NCT04348409,TRUE,2022-02-02T09:36:29Z,NA,NA,NA,NA
tri01427,NCT04350320,TRUE,2021-12-01T09:09:08Z,NA,NA,NA,NA
tri01135,NCT04355429,TRUE,2021-11-22T21:15:24Z,NA,NA,NA,NA
tri01358,NCT04368377,TRUE,2021-12-10T06:12:43Z,NA,NA,NA,NA
tri01559,NCT04377646,TRUE,2021-11-22T21:16:04Z,NA,NA,NA,NA
tri02264,NCT04381884,TRUE,2021-12-01T09:14:56Z,NA,NA,NA,NA
tri03386,NCT04383613,TRUE,2021-12-01T09:34:35Z,NA,NA,NA,NA
tri02372,NCT04403646,TRUE,2021-11-22T21:16:50Z,NA,NA,NA,Terminated (low rate of covid patients)
tri02374,NCT04403685,TRUE,2022-02-02T09:29:12Z,NA,NA,NA,Used accepted date for protocol pub date as no other date available.
tri02380,NCT04405271,TRUE,2021-11-22T21:17:21Z,NA,NA,NA,NA
tri02518,NCT04409509,TRUE,2021-11-22T21:17:38Z,NA,NA,NA,NA
tri02542,NCT04411602,TRUE,2021-11-22T21:17:51Z,NA,NA,NA,Withdrawn (No participants due to waning pandemic.)
tri02631,NCT04414098,TRUE,2021-11-22T21:18:08Z,NA,NA,NA,NA
tri03135,NCT04425772,TRUE,2021-11-22T21:18:28Z,NA,NA,NA,NA
tri03502,NCT04434248,TRUE,2021-11-22T21:19:07Z,NA,NA,NA,NA
tri03583,NCT04443270,TRUE,2021-11-22T21:19:23Z,NA,NA,NA,NA
tri05522,NCT04457349,TRUE,2021-11-22T21:19:49Z,NA,NA,NA,NA
tri05641,NCT04469621,TRUE,2021-11-22T21:20:20Z,NA,NA,NA,NA
tri05711,NCT04475588,TRUE,2022-09-09T12:46:44Z,NA,NA,NA,Full results preprint and journal article found via automated search of cross-registration CTRI/2020/05/024959 (tri01763)
tri05800,NCT04485169,TRUE,2021-11-22T21:21:06Z,NA,NA,NA,NA
tri06812,NCT04626089,TRUE,2021-11-22T21:21:21Z,NA,NA,NA,Withdrawn (Administrative decision of the company)
tri00031,ChiCTR2000029813,TRUE,2021-12-08T05:09:48Z,NA,NA,NA,NA
tri00047,ChiCTR2000029765,TRUE,2021-12-09T06:15:54Z,NA,NA,NA,Only able to access the abstract for the journal article
tri00085,ChiCTR2000029541,TRUE,2021-11-30T07:13:26Z,NA,NA,NA,NA
tri00091,ChiCTR2000029487,TRUE,2021-11-30T07:13:47Z,NA,NA,NA,NA
tri00092,ChiCTR2000029468,TRUE,2021-11-30T07:14:11Z,NA,NA,NA,NA
tri00102,ChiCTR2000029432,TRUE,2021-11-30T07:14:26Z,NA,NA,NA,NA
tri00115,ChiCTR2000030166,TRUE,2021-11-30T07:14:39Z,NA,NA,NA,NA
tri00132,ChiCTR2000030089,TRUE,2021-11-30T07:14:52Z,NA,NA,NA,NA
tri00159,ChiCTR2000030007,TRUE,2021-11-30T07:15:16Z,NA,NA,NA,NA
tri00171,ChiCTR2000029990,TRUE,2021-12-08T05:12:16Z,NA,NA,NA,NA
tri00178,ChiCTR2000029972,TRUE,2021-12-09T06:28:01Z,NA,NA,NA,NA
tri00185,ChiCTR2000029851,TRUE,2021-12-08T05:14:58Z,NA,NA,NA,NA
tri00235,ChiCTR2000030255,TRUE,2021-11-30T07:16:37Z,NA,NA,NA,NA
tri00244,ChiCTR2000030196,TRUE,2021-11-30T07:16:54Z,NA,NA,NA,NA
tri00299,ChiCTR2000030481,TRUE,2021-12-09T06:31:22Z,TRUE,FALSE,"Might be withdrawn, http://doi.org/10.1001/jama.2020.17023",NA
tri00305,ChiCTR2000030471,TRUE,2021-11-30T07:17:34Z,NA,NA,NA,NA
tri00343,ChiCTR2000030864,TRUE,2021-12-08T05:18:01Z,NA,NA,NA,NA
tri00373,ChiCTR2000030810,TRUE,2021-12-10T08:10:00Z,NA,NA,NA,NA
tri00392,ChiCTR2000030773,TRUE,2021-12-08T05:19:53Z,NA,NA,NA,NA
tri00418,ChiCTR2000030718,TRUE,2021-12-09T06:34:07Z,NA,NA,NA,NA
tri00507,ChiCTR2000030939,TRUE,2021-11-30T07:18:42Z,NA,NA,NA,NA
tri00582,ChiCTR2000031204,TRUE,2021-11-30T07:18:57Z,NA,NA,NA,NA
tri00590,ChiCTR2000030940,TRUE,2021-11-30T07:19:12Z,NA,NA,NA,NA
tri00601,ChiCTR2000030028,TRUE,2021-11-30T07:19:26Z,NA,NA,NA,NA
tri00805,ACTRN12620000472976,TRUE,2022-02-07T04:17:52Z,NA,NA,NA,Primary outcome is 'Patient comfort and tolerability' not COVID
tri00822,ChiCTR2000031944,TRUE,2021-11-30T07:19:47Z,NA,NA,NA,NA
tri01258,ChiCTR2000032456,TRUE,2021-11-30T07:20:03Z,NA,NA,NA,NA
tri01596,ChiCTR2000030262,TRUE,2022-03-02T06:23:29Z,NA,NA,NA,Same registration for both a pilot and main study. 10.1016/j.eclinm.2020.100478 coded as interim results since just pilot and primary outcome of safety. 10.1016/j.eclinm.2020.100547 coded as full results sinnce reports results from main study and efficacy primary outcome ('time until a viral RNA negative conversion').
tri02845,IRCT20200523047550N1,TRUE,2021-11-30T07:20:57Z,NA,NA,NA,NA
tri00232,ChiCTR2000030259,TRUE,2021-12-09T06:29:38Z,NA,NA,NA,NA
tri03933,ACTRN12620000786998,TRUE,2021-11-30T07:21:19Z,NA,NA,NA,NA
tri03934,ACTRN12620000795998,TRUE,2021-11-30T07:21:28Z,NA,NA,NA,NA
tri01651,IRCT20200404046937N2,TRUE,2021-11-30T07:21:50Z,NA,NA,NA,can not open this (from TRN Google): https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwj-xP_V_r30AhXqSvEDHVehA_4QFnoECBgQAQ&url=https%3A%2F%2Fwww.medrxiv.org%2Fhighwire%2Ffilestream%2F81619%2Ffield_highwire_adjunct_files%2F1%2F2020.05.14.20101758-2.txt&usg=AOvVaw1iwGXLETMO9JCXAT4PeFVY
tri03988,ACTRN12620000840987,TRUE,2022-05-16T09:48:34Z,NA,NA,NA,primary outcomes: Safety and tolerability of MSC - collected CRP and D-dimer but in the context of safety (primary outcome 3). All efficacy outcomes were secondary.
tri01988,ISRCTN44152751,TRUE,2022-03-02T06:14:58Z,TRUE,TRUE,"Tweet by study lead indicates 'The planned randomized trial of reopening of schools in Norway isn't happening, but we will publish the protocol after ethical approval, hoping that other countries can make use of it.': https://twitter.com/atlefretheim/status/1258725059071545346 -> We decided to update screening decision since announcement of withdrawal by trial lead (although not in publication, but by trial lead, not a secondary source such as a review)","Tweet by study lead indicates 'The planned randomized trial of reopening of schools in Norway isn't happening, but we will publish the protocol after ethical approval, hoping that other countries can make use of it.': https://twitter.com/atlefretheim/status/1258725059071545346 -> We decided to update screening decision since announcement of withdrawal by trial lead (although not in publication, but by trial lead, not a secondary source such as a review)"
tri00287,ChiCTR2000030522,TRUE,2021-11-30T07:22:30Z,NA,NA,NA,NA
tri04394,IRCT20201012049010N1,TRUE,2022-02-07T04:22:01Z,NA,NA,NA,Primary outcomes include blood oxygen
tri02908,RPCEC00000307,TRUE,2021-12-09T05:21:02Z,NA,NA,NA,"10.1101/2020.07.29.20164251 is 'preliminary results': 'After a preliminary exploratory analysis of the outcomes of the first 79 patients, the monitoring board considered a preliminary report and early publication of the RT-PCR results from the 63 patients with available throat swabs, due to the significant effect of HeberFERON on the reduction of the time to viral clearance. The trial finally included 134 patients from whom samples are now in the process of data collection for definitive processes and analysis.'\nPress release probably of same study: https://temas.sld.cu/coronavirus/2021/10/26/confirma-cigb-la-superioridad-del-heberferon-en-la-negativizacion-del-sars-cov-2/"
tri04436,RPCEC00000321,TRUE,2022-02-10T05:57:33Z,NA,NA,NA,NA
tri04437,RPCEC00000322,TRUE,2021-12-08T05:34:27Z,NA,NA,NA,Treatment of lung lesions with autologous stem cells in patients RECOVERED from COVID-19 (COVID-19)
tri04459,TCTR20200819003,TRUE,2021-11-30T07:23:35Z,NA,NA,NA,NA
tri04481,JPRN-UMIN000040744,TRUE,2021-12-10T06:26:06Z,NA,NA,NA,"measuring antibodies = observational study??\n&quot;We examine how many patients without any clinical symptoms related to SARS-CoV-2 have NP antibody. In addition, we will examine the relationship between NP antibody and neutralizing activity in patients with subclinical infections by conducting antibody tests over time.&quot;"
tri04482,JPRN-UMIN000041421,TRUE,2022-03-02T06:04:21Z,NA,NA,NA,observational study using fitbit
tri04593,CTRI/2020/06/025523,TRUE,2021-11-30T07:24:15Z,NA,NA,NA,NA
tri04599,CTRI/2020/06/025556,TRUE,2021-11-30T07:24:30Z,NA,NA,NA,NA
tri04660,CTRI/2020/06/025977,TRUE,2022-02-10T06:00:52Z,NA,NA,NA,Summary results added to 'Brief Summary' but do NOT meet minimum ICTRP standard so count as 'other'\nPublication does not seems to be planned per the registry on 2021-11-30: 'No any publication planned yet.'\nFound result publication for related trial (CTRI/2020/05/025161): 10.1016/j.conctc.2021.100755
tri04733,CTRI/2020/07/026433,TRUE,2021-11-30T07:25:07Z,NA,NA,NA,NA
tri04853,CTRI/2020/08/026999,TRUE,2021-11-30T07:25:18Z,NA,NA,NA,NA
tri04882,CTRI/2020/08/027061,TRUE,2021-11-30T07:25:31Z,NA,NA,NA,NA
tri05242,ISRCTN31062548,TRUE,2021-11-30T07:26:35Z,NA,NA,NA,NA
tri05251,ChiCTR2000038255,TRUE,2021-12-09T05:33:50Z,NA,NA,NA,"Unclear whether simply observational (survey, interview) or interventional (grief training) based on description; we decide to count as interventional: 'This project is a multi-perspective and multi-level systematic study. Using questionnaire assessments, structured interviews and action research to investigate the competence of counselors, and the psychological status of the bereaved people in China. Then developing professional grief training programs for the counselors and professional grief intervention for the bereaved.'"
tri00534,NCT04254874,TRUE,2021-12-10T08:11:38Z,NA,NA,NA,NA
tri00536,NCT04261270,TRUE,2021-11-30T07:27:06Z,NA,NA,NA,NA
tri00007,NCT04261907,TRUE,2022-03-02T06:05:15Z,NA,NA,NA,NA
tri00537,NCT04263402,TRUE,2021-11-30T07:27:28Z,NA,NA,NA,NA
tri00473,NCT04264533,TRUE,2021-12-08T05:22:21Z,NA,NA,NA,"Terminated (the study was started in the second half of the outbreak, and the number of qualifying COVID-19 patients decreased with the control of the epidemic so that we had to stop our trial before reaching the predefined sample size.)"
tri00108,NCT04268537,TRUE,2021-11-30T07:28:01Z,NA,NA,NA,same authors but different sample size? https://pubmed.ncbi.nlm.nih.gov/33208294/
tri00192,NCT04273581,TRUE,2021-11-30T07:28:32Z,NA,NA,NA,NA
tri00654,NCT04275414,TRUE,2021-12-08T05:24:53Z,NA,NA,NA,NA
tri00896,NCT04276688,TRUE,2021-12-09T06:54:48Z,NA,NA,NA,NA
tri00265,NCT04276987,TRUE,2021-11-30T07:29:50Z,NA,NA,NA,NA
tri00738,NCT04310228,TRUE,2021-12-09T06:44:41Z,NA,NA,NA,NA
tri00900,NCT04315896,TRUE,2021-12-08T05:27:58Z,NA,NA,NA,NA
tri00609,NCT04319900,TRUE,2021-11-30T07:30:44Z,NA,NA,NA,NA
tri00660,NCT04324528,TRUE,2021-12-09T06:43:04Z,NA,NA,NA,Primary Outcome: interleukin-6 (IL-6) level after 72 hours [ Time Frame: 72 hours ]
tri02327,NCT04328467,TRUE,2021-12-08T05:40:51Z,NA,NA,NA,NA
tri01098,NCT04332380,TRUE,2021-12-11T00:40:39Z,NA,NA,NA,NA
tri03294,NCT04332991,TRUE,2021-12-01T09:39:54Z,NA,NA,NA,NA
tri00762,NCT04334005,TRUE,2021-11-30T07:31:49Z,NA,NA,NA,NA
tri00921,NCT04334044,TRUE,2021-11-30T07:32:05Z,NA,NA,NA,NA
tri00767,NCT04336462,TRUE,2021-11-30T07:32:18Z,NA,NA,NA,NA
tri00787,NCT04339660,TRUE,2022-02-10T05:15:03Z,NA,NA,NA,NA
tri03037,NCT04343651,TRUE,2022-01-31T09:37:44Z,NA,NA,NA,NA
tri00948,NCT04344236,TRUE,2021-11-30T07:32:50Z,NA,NA,NA,NA
tri05351,NCT04344379,TRUE,2021-11-30T07:33:14Z,NA,NA,NA,NA
tri05352,NCT04344665,TRUE,2021-11-30T07:33:34Z,NA,NA,NA,"Does not seem to be a covid trial, but rather that covid was added as a secondary outcome measure"
tri00962,NCT04345523,TRUE,2022-10-06T08:09:27Z,NA,NA,NA,"Preprint (10.1101/2020.08.26.20182444) coded as interim since stopped 2020-07-10 due to decrease in COVID, then restarted data collection and article (10.1172/JCI152740) includes patients through 2021-02-05."
tri03042,NCT04345861,TRUE,2021-11-30T07:34:15Z,NA,NA,NA,Terminated (halted prematurely.)\n
tri00973,NCT04346329,TRUE,2021-11-30T07:34:24Z,NA,NA,NA,NA
tri00975,NCT04346368,TRUE,2021-11-30T07:34:38Z,NA,NA,NA,NA
tri01806,NCT04347915,TRUE,2021-11-30T07:34:59Z,NA,NA,NA,NA
tri03311,NCT04347954,TRUE,2021-12-10T06:20:51Z,NA,NA,NA,NA
tri05359,NCT04349592,TRUE,2021-12-08T05:14:25Z,NA,NA,NA,NA
tri01289,NCT04349631,TRUE,2021-11-30T07:35:39Z,NA,NA,NA,NA
tri01003,NCT04350671,TRUE,2021-12-10T06:08:25Z,NA,NA,NA,NA
tri01004,NCT04350684,TRUE,2021-12-10T06:09:46Z,NA,NA,NA,NA
tri01125,NCT04352608,TRUE,2022-03-01T05:45:29Z,NA,NA,NA,"we choose to include 10.1016/S1473-3099(20)30843-4 as full result journal article, because all patients and almost all outcomes are reported except the secondary: Other secondary endpoints are listed in the appendix 2 (p 4), including 6 month outcomes that are not available yet, which will be reported elsewhere."
tri03319,NCT04353674,TRUE,2021-11-30T07:36:54Z,NA,NA,NA,"Study completion not yet reached, no full search"
tri03052,NCT04355351,TRUE,2021-12-01T09:25:13Z,NA,NA,NA,NA
tri02465,NCT04357340,TRUE,2021-12-08T05:30:40Z,NA,NA,NA,NA
tri01903,NCT04357457,TRUE,2021-11-30T07:37:35Z,NA,NA,NA,NA
tri02111,NCT04358081,TRUE,2022-02-02T09:25:29Z,NA,NA,NA,The study was terminated but it looks like there was enrollment: https://www.novartis.com/news/media-releases/novartis-discontinues-hydroxychloroquine-clinical-trial-based-slow-enrollment-remains-comm
tri05372,NCT04359303,TRUE,2021-11-30T07:37:57Z,NA,NA,NA,NA
tri01182,NCT04360356,TRUE,2021-11-30T07:38:11Z,NA,NA,NA,NA
tri02338,NCT04362059,TRUE,2021-11-30T07:38:31Z,NA,NA,NA,NA
tri03341,NCT04362332,TRUE,2021-12-08T05:16:51Z,NA,NA,NA,"terminated with 25 patients: https://www.umcutrecht.nl/en/over-ons/nieuws/infection-and-immunity/jun-10-dutch-study-into-anti-malarial-drug-against-covid-19-discontinued\n\nTerminated (Currently, almost no patients admitted to Dutch hospitals. If any effect of HCQ is to be expected we need more than 1000 inclusions)"
tri01311,NCT04363060,TRUE,2021-11-30T07:39:21Z,NA,NA,NA,NA
tri01911,NCT04364802,TRUE,2021-11-30T07:39:45Z,NA,NA,NA,the registry entry is only a review (https://clinicaltrials.gov/ct2/bye/rQoPWwoRrXS9-i-wudNgpQDxudhWudNzlXNiZip9Ei7ym67VZRFnxRFBxg45A6h9Ei4L3BUgWwNG0it.)
tri03349,NCT04364893,TRUE,2021-12-01T09:43:51Z,NA,NA,NA,NA
tri03350,NCT04365101,TRUE,2022-01-31T09:39:32Z,NA,NA,NA,NA
tri02116,NCT04365153,TRUE,2021-12-10T06:16:27Z,NA,NA,NA,NA
tri01315,NCT04365309,TRUE,2021-11-30T07:40:32Z,NA,NA,NA,NA
tri01812,NCT04366271,TRUE,2021-11-30T07:40:53Z,NA,NA,NA,NA
tri01332,NCT04366908,TRUE,2021-12-08T05:36:02Z,NA,NA,NA,NA
tri01341,NCT04367636,TRUE,2021-11-30T07:41:15Z,NA,NA,NA,NA
tri02121,NCT04368845,TRUE,2021-11-30T07:41:25Z,NA,NA,NA,rehabilitation study
tri03357,NCT04368923,TRUE,2021-11-30T07:41:48Z,NA,NA,NA,"primary outcomes related to 'arterial blood gases (abg)'\nResults publication (10.2196/23446) does not provide enrollment date or clear follow-up time (aside from CT scan 14 days after last treatment, but unclear how many treatments; also additional self-monitoring)"
tri01363,NCT04369274,TRUE,2022-02-05T04:10:45Z,NA,NA,NA,NA
tri05383,NCT04371107,TRUE,2021-11-30T07:42:06Z,NA,NA,NA,NA
tri01452,NCT04371965,TRUE,2022-02-10T05:44:45Z,NA,NA,NA,NA
tri02960,NCT04372017,TRUE,2021-11-30T07:42:41Z,NA,NA,NA,NA
tri01459,NCT04372680,TRUE,2022-01-26T16:48:55Z,NA,NA,[Left blank],Primary outcome is time on ventilation: 'Delay from the start of Mechanical Ventilation weaning process to extubation'
tri02345,NCT04373200,TRUE,2021-11-30T07:42:56Z,NA,NA,NA,No intervention; only collection blood and saliva samples to analyze antibodies
tri01536,NCT04374942,TRUE,2021-11-30T07:43:26Z,NA,NA,NA,"Terminated (Due to unproven issues associated with hydroxychloroquine use and safety, further complicated by media and political misinformation which in effect rendered all global studies on HCQ to stop enrolling participants.)"
tri03065,NCT04375098,TRUE,2021-12-10T05:17:01Z,NA,NA,NA,NA
tri02040,NCT04375124,TRUE,2021-11-30T07:43:55Z,NA,NA,NA,NA
tri02261,NCT04379375,TRUE,2022-02-07T04:18:21Z,NA,NA,NA,Primary outcome is handwashing behavior not covid
tri01826,NCT04380376,TRUE,2021-11-30T07:44:14Z,NA,NA,NA,NA
tri01583,NCT04380519,TRUE,2021-11-30T07:44:35Z,NA,NA,NA,non-english: https://www.clinvest.ru/jour/article/view/530
tri01834,NCT04380935,TRUE,2021-11-30T07:44:49Z,NA,NA,NA,NA
tri01837,NCT04381052,TRUE,2021-12-08T05:25:08Z,NA,NA,NA,adverse events
tri02590,NCT04382066,TRUE,2022-03-02T06:06:43Z,NA,NA,NA,"Safety primary outcomes so excluded. Preprint from Cochrane here: https://www.medrxiv.org/content/10.1101/2021.05.25.21257505v1 and registry results here: https://clinicaltrials.gov/ct2/show/results/NCT04382066. Couldn't find any full article. Searched:  Vicente Estrada AND Covid, Plitidepsin AND Covid, Jose Barberan AND Covid, and title of preprint."
tri02591,NCT04382950,TRUE,2021-11-30T07:45:10Z,NA,NA,NA,NA
tri03213,NCT04383535,TRUE,2021-12-08T05:18:50Z,NA,NA,NA,NA
tri02478,NCT04385849,TRUE,2021-11-30T07:45:36Z,NA,NA,NA,NA
tri02133,NCT04386447,TRUE,2021-11-30T07:45:42Z,NA,NA,NA,NA
tri03074,NCT04386694,TRUE,2022-02-10T05:23:46Z,NA,NA,NA,NA
tri01976,NCT04390178,TRUE,2021-11-30T07:46:16Z,NA,NA,NA,NA
tri05401,NCT04392115,TRUE,2021-11-30T07:46:26Z,NA,NA,NA,NA
tri02598,NCT04392414,TRUE,2021-12-08T05:45:39Z,NA,NA,NA,russian: https://cyberleninka.ru/article/n/predvaritelnye-itogi-issledovaniya-bezopasnosti-i-effektivnosti-plazmy-rekonvalestsentov-v-terapii-covid-19
tri03402,NCT04392973,TRUE,2021-12-01T09:46:30Z,NA,NA,NA,NA
tri02151,NCT04393818,TRUE,2021-11-30T07:46:58Z,NA,NA,NA,NA
tri02085,NCT04394169,TRUE,2021-11-30T07:47:05Z,NA,NA,NA,NA
tri02155,NCT04394403,TRUE,2021-11-30T07:47:13Z,NA,NA,NA,NA
tri02600,NCT04394416,TRUE,2021-11-30T07:47:27Z,NA,NA,NA,NA
tri02157,NCT04394442,TRUE,2021-11-30T07:47:36Z,NA,NA,NA,NA
tri03221,NCT04394455,TRUE,2021-11-30T07:47:44Z,NA,NA,NA,NA
tri03085,NCT04395170,TRUE,2021-11-30T07:47:56Z,NA,NA,NA,NA
tri05405,NCT04395599,TRUE,2021-12-09T05:35:30Z,NA,NA,NA,Measuring COVID in air during planned surgery (no intervention)
tri02188,NCT04398303,TRUE,2021-11-30T07:48:12Z,NA,NA,NA,NA
tri02281,NCT04399681,TRUE,2021-11-30T07:48:20Z,NA,NA,NA,evaluation of diagnostic device
tri02603,NCT04400279,TRUE,2021-11-30T07:48:27Z,NA,NA,NA,NA
tri03419,NCT04402866,TRUE,2021-12-08T05:37:11Z,NA,NA,NA,NA
tri02386,NCT04405999,TRUE,2021-12-08T05:23:49Z,NA,NA,NA,NA
tri02497,NCT04407182,TRUE,2021-12-10T06:18:26Z,NA,NA,NA,NA
tri02499,NCT04407208,TRUE,2021-12-08T05:22:35Z,NA,NA,NA,NA
tri02546,NCT04412343,TRUE,2021-11-30T07:49:58Z,NA,NA,NA,NA
tri02978,NCT04412356,TRUE,2022-02-10T05:19:49Z,NA,NA,NA,NA
tri02619,NCT04412538,TRUE,2021-12-08T05:50:00Z,NA,NA,NA,NA
tri02624,NCT04413006,TRUE,2021-11-30T07:50:26Z,NA,NA,NA,NA
tri02629,NCT04413968,TRUE,2021-12-10T06:19:23Z,NA,NA,NA,observational
tri02991,NCT04418531,TRUE,2021-11-30T07:50:47Z,NA,NA,NA,NA
tri02654,NCT04418947,TRUE,2021-11-30T07:50:58Z,NA,NA,NA,NA
tri03001,NCT04420390,TRUE,2022-01-31T09:31:20Z,NA,NA,NA,https://www.redjournal.org/article/S0360-3016(21)01303-1/fulltext is considered a full result because it provides all the information needed even as abstract
tri05423,NCT04422977,TRUE,2021-11-30T07:51:17Z,NA,NA,NA,diagnostic measurement
tri03122,NCT04424797,TRUE,2021-11-30T07:51:41Z,NA,NA,NA,NA
tri03249,NCT04429711,TRUE,2021-12-01T09:27:29Z,NA,NA,NA,NA
tri03252,NCT04429828,TRUE,2021-11-30T07:51:57Z,NA,NA,NA,NA
tri03253,NCT04429867,TRUE,2021-11-30T07:52:12Z,NA,NA,NA,NA
tri03261,NCT04431466,TRUE,2021-12-08T05:17:46Z,NA,NA,NA,NA
tri03265,NCT04432324,TRUE,2021-11-30T07:52:40Z,NA,NA,NA,NA
tri03514,NCT04435314,TRUE,2021-11-30T07:52:54Z,NA,NA,NA,NA
tri03556,NCT04441385,TRUE,2021-11-30T07:53:08Z,NA,NA,NA,NA
tri03557,NCT04441398,TRUE,2021-11-30T07:53:18Z,NA,NA,NA,NA
tri03565,NCT04441996,TRUE,2021-12-08T05:35:23Z,NA,NA,NA,NA
tri03567,NCT04442152,TRUE,2021-11-30T07:53:38Z,NA,NA,NA,NA
tri03569,NCT04442178,TRUE,2021-12-10T06:21:49Z,NA,NA,NA,NA
tri03579,NCT04442958,TRUE,2021-12-10T06:22:41Z,NA,NA,NA,NA
tri03631,NCT04445935,TRUE,2021-11-30T07:54:16Z,NA,NA,NA,NA
tri05445,NCT04449965,TRUE,2021-11-30T07:54:44Z,NA,NA,NA,NA
tri05461,NCT04452435,TRUE,2022-09-09T12:40:21Z,NA,NA,NA,NA
tri05496,NCT04454307,TRUE,2021-12-10T06:27:03Z,NA,NA,NA,NA
tri05502,NCT04455308,TRUE,2021-11-30T07:55:20Z,NA,NA,NA,NA
tri05512,NCT04456088,TRUE,2021-11-30T07:55:37Z,NA,NA,NA,NA
tri05515,NCT04456361,TRUE,2021-11-30T07:55:54Z,NA,NA,NA,NA
tri05523,NCT04457388,TRUE,2021-12-09T05:36:33Z,NA,NA,NA,NA
tri05554,NCT04460027,TRUE,2021-11-30T07:56:57Z,NA,NA,NA,NA
tri05582,NCT04463420,TRUE,2021-11-30T07:59:04Z,NA,NA,NA,NA
tri05589,NCT04463849,TRUE,2021-12-06T09:17:03Z,NA,NA,NA,NA
tri05599,NCT04465604,TRUE,2021-11-30T07:59:34Z,NA,NA,NA,NA
tri05609,NCT04466605,TRUE,2021-11-30T07:59:43Z,NA,NA,NA,NA
tri05650,NCT04470531,TRUE,2021-11-30T07:59:56Z,NA,NA,NA,NA
tri05657,NCT04470739,TRUE,2021-12-09T05:37:34Z,NA,NA,NA,NA
tri05682,NCT04473248,TRUE,2021-12-08T05:11:04Z,NA,NA,NA,NA
tri05709,NCT04475562,TRUE,2021-11-30T08:01:53Z,NA,NA,NA,diagnosis not treatment/prevention
tri05710,NCT04475575,TRUE,2021-12-01T05:35:09Z,NA,NA,NA,Diagnostic
tri05728,NCT04477083,TRUE,2021-11-30T08:02:14Z,NA,NA,NA,NA
tri05735,NCT04477954,TRUE,2021-11-30T08:02:31Z,NA,NA,NA,NA
tri05790,NCT04483830,TRUE,2022-09-09T12:57:17Z,NA,NA,NA,Results found via cross-registration: ISRCTN59048638 (tri02657)
tri05795,NCT04484207,TRUE,2021-11-30T08:02:57Z,NA,NA,NA,NA
tri05796,NCT04484493,TRUE,2021-11-30T08:03:17Z,NA,NA,NA,anosmia
tri05807,NCT04486313,TRUE,2022-02-02T09:37:35Z,NA,NA,NA,NA
tri05836,NCT04488796,TRUE,2021-11-30T08:03:35Z,NA,NA,NA,NA
tri05837,NCT04489446,TRUE,2021-12-10T05:21:04Z,NA,NA,NA,NA
tri05855,NCT04491994,TRUE,2021-12-10T05:22:23Z,NA,NA,NA,NA
tri05864,NCT04492410,TRUE,2021-11-30T08:04:08Z,NA,NA,NA,NA
tri05877,NCT04494204,TRUE,2022-09-09T12:59:27Z,NA,NA,NA,Press release about cross-registration CTRI/2020/08/026957 (tri04843): https://www.prnewswire.co.uk/news-releases/ayurvedic-remedy-outperforms-pharmaceuticals-in-coronavirus-comparative-clinical-trial-841491919.html
tri05883,NCT04494867,TRUE,2022-02-10T06:44:35Z,NA,NA,NA,NA
tri05913,NCT04497623,TRUE,2021-11-30T08:04:42Z,NA,NA,NA,NA
tri05927,NCT04498442,TRUE,2021-11-30T08:04:51Z,NA,NA,NA,NA
tri05965,NCT04504877,TRUE,2021-11-30T08:04:58Z,NA,NA,NA,NA
tri06018,NCT04512027,TRUE,2021-12-10T05:24:18Z,NA,NA,NA,NA
tri06075,NCT04519385,TRUE,2021-12-08T05:08:32Z,NA,NA,NA,NA
tri06095,NCT04522492,TRUE,2021-11-30T08:05:38Z,NA,NA,NA,NA
tri06135,NCT04527354,TRUE,2021-12-06T09:25:26Z,NA,NA,NA,NA
tri06201,NCT04534790,TRUE,2021-11-30T08:05:55Z,NA,NA,NA,NA
tri06203,NCT04535063,TRUE,2022-04-26T07:45:37Z,NA,NA,NA,result http://www.medicinabuenosaires.com/PMID/33481727.pdf is not fully available in English
tri06232,NCT04537663,TRUE,2021-11-30T08:06:34Z,NA,NA,NA,NA
tri06234,NCT04537858,TRUE,2021-12-06T09:26:45Z,NA,NA,NA,NA
tri06250,NCT04540419,TRUE,2021-11-30T08:07:03Z,NA,NA,NA,NA
tri06303,NCT04547283,TRUE,2021-12-10T05:27:02Z,NA,NA,NA,NA
tri06348,NCT04555148,TRUE,2021-11-30T08:07:29Z,NA,NA,NA,NA
tri06423,NCT04567810,TRUE,2021-11-30T08:07:56Z,NA,NA,NA,NA
tri06434,NCT04568356,TRUE,2021-12-09T04:11:53Z,NA,NA,NA,NA
tri06446,NCT04569188,TRUE,2021-12-10T06:32:12Z,NA,NA,NA,NA
tri06461,NCT04570488,TRUE,2021-12-10T08:13:29Z,NA,NA,NA,NA
tri06540,NCT04583449,TRUE,2021-11-30T08:08:38Z,NA,NA,NA,primary outcome: Face covering wearing consistency
tri06601,NCT04592835,TRUE,2021-11-30T08:08:52Z,NA,NA,NA,Primary Outcome: Incidence of Treatment-Emergent Adverse Events
tri06629,NCT04596839,TRUE,2021-11-30T08:09:12Z,NA,NA,NA,NA
tri06664,NCT04602884,TRUE,2021-11-30T08:09:27Z,NA,NA,NA,NA
tri06674,NCT04603794,TRUE,2021-11-30T08:09:52Z,NA,NA,NA,NA
tri06676,NCT04603963,TRUE,2021-11-30T08:10:10Z,NA,NA,NA,primary outcome: espiratory muscle training appears to impact functionality
tri06760,NCT04617483,TRUE,2021-12-06T09:28:42Z,NA,NA,NA,Immunogenicity and safety outcomes
tri06795,NCT04623385,TRUE,2021-11-30T08:10:27Z,NA,NA,NA,NA
tri06828,NCT04629157,TRUE,2021-12-08T05:06:48Z,NA,NA,NA,NA
tri06876,NCT04636333,TRUE,2021-12-06T09:29:44Z,NA,NA,NA,phase 1 safety outcomes
tri06902,NCT04642326,TRUE,2022-02-10T05:41:19Z,NA,NA,NA,NA
tri03208,NCT04370262,TRUE,2021-11-30T08:11:04Z,NA,NA,NA,NA
tri03394,NCT04388826,TRUE,2021-11-30T08:11:56Z,NA,NA,NA,Registry results submitted but not posted: https://clinicaltrials.gov/ct2/show/results/NCT04388826
tri03496,NCT04433546,TRUE,2021-11-30T08:12:11Z,NA,NA,NA,NA
tri07007,NCT04555096,TRUE,2021-12-10T06:36:36Z,NA,NA,NA,NA
tri07010,NCT04559113,TRUE,2021-11-30T08:12:33Z,NA,NA,NA,NA
tri07011,NCT04560205,TRUE,2021-11-30T08:13:05Z,NA,NA,NA,NA
tri07029,NCT04583189,TRUE,2021-12-01T09:44:43Z,NA,NA,NA,NA
tri07082,NCT04648800,TRUE,2021-11-30T08:13:28Z,NA,NA,NA,NA
tri07162,NCT04659772,TRUE,2021-12-08T05:05:57Z,NA,NA,NA,adverse events
tri07171,NCT04661527,TRUE,2021-11-30T08:13:49Z,NA,NA,NA,NA
tri07212,NCT04666233,TRUE,2021-12-01T09:43:53Z,NA,NA,NA,NA
tri07245,NL8726,TRUE,2021-12-01T09:43:03Z,NA,NA,NA,pharmcokinetic outcomes on healthy male volunteers
tri02289,NCT04400838,TRUE,2022-02-10T06:34:23Z,NA,NA,NA,Substudies/pooled analyses coded as 'other' since 'live' secondary analyses
tri00039,ChiCTR2000029788,TRUE,2021-12-07T03:59:06Z,NA,NA,NA,NA
tri00101,ChiCTR2000029435,TRUE,2021-12-07T03:59:42Z,NA,NA,NA,results comment: uploaded doc in chinese as registry results but seems to be protocol
tri00113,ChiCTR2000030170,TRUE,2022-01-31T09:45:12Z,NA,NA,NA,NA
tri00141,ChiCTR2000030043,TRUE,2021-12-07T04:01:11Z,NA,NA,NA,NA
tri00182,ChiCTR2000029954,TRUE,2021-12-07T04:01:44Z,NA,NA,NA,Other? https://www.nature.com/articles/s41421-020-00197-3
tri00233,ChiCTR2000030258,TRUE,2021-12-07T04:02:33Z,NA,NA,NA,NA
tri00254,ChiCTR2000029899,TRUE,2022-01-31T09:52:13Z,NA,NA,NA,NA
tri00261,ChiCTR2000029755,TRUE,2021-12-07T04:03:18Z,NA,NA,NA,NA
tri00317,ChiCTR2000029993,TRUE,2022-01-31T10:01:09Z,NA,NA,NA,NA
tri00352,ChiCTR2000030855,TRUE,2021-12-07T04:04:04Z,NA,NA,NA,NA
tri00399,ChiCTR2000030759,TRUE,2022-01-31T10:07:50Z,NA,NA,NA,NA
tri00425,ChiCTR2000030702,TRUE,2021-12-07T04:05:04Z,NA,NA,NA,NA
tri00842,EUCTR2020-001765-37,TRUE,2021-12-07T04:05:20Z,NA,NA,NA,NA
tri04400,IRCT20201015049036N1,TRUE,2021-12-07T04:06:13Z,NA,NA,NA,NA
tri00267,NCT04282902,TRUE,2022-01-31T10:01:40Z,NA,NA,NA,NA
tri00543,NCT04291053,TRUE,2021-12-07T04:06:54Z,NA,NA,NA,NA
tri00612,NCT04323332,TRUE,2021-12-07T04:07:10Z,NA,NA,NA,NA
tri00916,NCT04329650,TRUE,2021-12-07T04:07:34Z,NA,NA,NA,NA
tri00951,NCT04344548,TRUE,2021-12-07T04:08:00Z,NA,NA,NA,Withdrawn (The study did not get financed. Never get started.)
tri01116,NCT04346797,TRUE,2022-02-10T05:18:14Z,NA,NA,NA,Sub-trial of NCT04324047/EUCTR2020-001246-18 (tri00659) observational supra-'trial' (excluded)
tri01217,NCT04363528,TRUE,2022-01-31T10:16:47Z,NA,NA,NA,NA
tri01438,NCT04369456,TRUE,2021-12-07T04:08:54Z,NA,NA,NA,NA
tri01378,NCT04371523,TRUE,2022-01-31T10:17:29Z,NA,NA,NA,NA
tri01571,NCT04379037,TRUE,2022-01-31T10:20:14Z,NA,NA,NA,NA
tri03051,NCT04353596,TRUE,2022-01-31T07:06:42Z,NA,NA,NA,NA
tri03217,NCT04387409,TRUE,2022-09-09T13:13:36Z,NA,NA,NA,Prematurely ended according to cross-registration: EUCTR2020-001376-15 (tri02675). Discrepant completion dates across the registries: 2021-05-01 per ClinicalTrials.gov; 2021-04-28 per EUCTR summary results; 2020-09-03 per EUCTR registration.
tri06523,NCT04581863,TRUE,2022-01-31T07:14:07Z,NA,NA,NA,NA
tri07601,NCT04721457,TRUE,2022-01-31T07:23:05Z,NA,NA,NA,NA
tri06567,NCT04587921,TRUE,2022-02-02T09:09:04Z,NA,NA,NA,NA
tri06900,NCT04642040,TRUE,2022-02-02T09:09:30Z,NA,NA,NA,NA
tri07376,NCT04683328,TRUE,2022-02-02T09:11:15Z,NA,NA,NA,NA
tri07385,NCT04706416,TRUE,2022-03-02T06:13:27Z,NA,NA,NA,"Authors frame as 'observational cohort study' but based on methods and intervention, we include as 'single arm trial'"
tri06044,NCT04516512,TRUE,2022-02-02T09:15:40Z,NA,NA,NA,No intervention
tri06426,NCT04567953,TRUE,2022-02-02T09:16:24Z,NA,NA,NA,NA
tri06737,NCT04614883,TRUE,2022-02-02T09:17:07Z,NA,NA,NA,No intervention.
tri08966,NCT04813770,TRUE,2022-02-04T08:37:25Z,NA,NA,NA,Vaccination intention is too distant from treatment/prevention.
tri05660,NCT04471519,TRUE,2022-03-02T05:42:30Z,NA,NA,NA,"covaxin vaccine (india) registration for both phase 1 (primary outcome: safety) and 2 (primary outcome: neutralizing antibody titers), and later amended to include booster. We disregard phase 1 since safety only, so we consider those results 'other': 10.1016/S1473-3099(20)30942-7 (full result of phase 1, coded as interim result; and its preprint 10.1101/2020.12.11.20210419). We consider full results of the primary outcome of phase 2 as reported in the paper (4-week follow-up): 10.1016/S1473-3099(21)00070-0 (3-month follow-up of phase 1 and interim results of phase 2; and its preprint 10.1101/2020.12.21.20248643). We also consider full results of the primary outcome of the booster amendment: 10.1101/2022.01.05.22268777 (preprint about booster dose; registration was updated to reflect booster, however completion date not changed even though preprint posted on 2022-01-08 indicates trial is ongoing)"
tri02506,NCT04408131,TRUE,2022-02-04T08:44:57Z,NA,NA,NA,observational study of prognostic factors; no intervention
tri00274,ChiCTR2000030578,TRUE,2022-02-14T01:05:46Z,NA,NA,NA,Rehab
tri00336,ChiCTR2000030896,TRUE,2022-02-17T01:15:19Z,NA,NA,NA,NA
tri03884,ChiCTR2000034794,TRUE,2022-02-09T09:53:59Z,NA,NA,NA,Treatment for patients in covid-19 recovery
tri05237,ACTRN12620000788976,TRUE,2022-02-09T09:54:43Z,NA,NA,NA,In COVID patients but Primary endpoints are not treatment. Just safety and pharmacokinetics.
tri00759,NCT04333407,TRUE,2022-02-17T01:16:55Z,NA,NA,NA,NA
tri01896,NCT04352751,TRUE,2022-03-02T06:11:17Z,NA,NA,NA,"These seem like final results but substantially less people than are in the registrations, but matching TRN. No clear consistent outcome follow-up times given for outcomes. This trial clearly completed long before April 2021 (which is what it says on CTG) but we have no way to know."
tri01898,NCT04353206,TRUE,2022-02-09T09:57:07Z,NA,NA,NA,Outcome is just feasibility.
tri02262,NCT04380532,TRUE,2022-02-17T01:30:04Z,NA,NA,NA,Phase 1 laboratory parameters on healthy volunteers
tri02138,NCT04391101,TRUE,2022-02-17T01:28:27Z,NA,NA,NA,NA
tri02277,NCT04399109,TRUE,2022-02-09T09:59:06Z,NA,NA,NA,covid remote monitoring device with outcome measures of emergency room visits and death\nmiicrosoft  news piece about the study: https://news.microsoft.com/en-au/features/doctors-help-build-smartphone-app-leverage-cloud-to-monitor-covid-19-patients/
tri02367,NCT04402892,TRUE,2022-02-17T01:30:55Z,NA,NA,NA,No actual intervention. Just testing people.
tri02510,NCT04408209,TRUE,2022-02-17T01:38:40Z,NA,NA,NA,"Press release here: https://greece.greekreporter.com/2020/08/24/greek-plasma-therapy-trials-for-covid-19-show-promising-results/\n\nThe journal article also calls itself preliminary even though it reads a bit like a final report.\n\nAlso notable, the interim results journal article is a much more advanced analysis than the preprint (lots more patients).\n\nThere are various other secondary analyses from this trial regarding analysing the plasma from the donors, etc but they are not really relevant to us and would clog up the record so I've avoided putting them all as &quot;Other&quot; above.\n10.1186/s12916-021-02090-6 \n10.1016%2Fj.ejim.2021.05.010\n10.1101/2020.09.09.20191122\n10.3390/microorganisms9030546\nAbstracts here: 10.1097/HS9.0000000000000566\nand here: 10.1182/blood-2020-136940\n"
tri02979,NCT04413747,TRUE,2022-02-10T07:35:03Z,NA,NA,NA,"Primary outcome is all-cause mortality after 12 months, but intervention given during acute phase.\nLots of files on Italian webpage: http://www.giardinostlucia.it/\nThis may be a protocol as well? http://www.giardinostlucia.it/doc/GIARDINO_ST_LUCIA_COVID19_CNR_ISS.pdf\nInterim results? http://www.giardinostlucia.it/doc/GIARDINO_ST_LUCIA_COVID19_REPORT_3_mesi.pdf and http://www.giardinostlucia.it/doc/GIARDINO_ST_LUCIA_COVID19_REPORT_3_mesi.pdf and http://www.giardinostlucia.it/doc/GIARDINO_ST_LUCIA_COVID19_REPORT_001_3_mesi.pdf"
tri05665,NCT04471831,TRUE,2022-02-17T02:03:04Z,NA,NA,NA,NA
tri06193,NCT04534478,TRUE,2022-02-14T02:22:30Z,NA,NA,NA,Post COVID-19 Organized Pneumonia Diagnosis
tri06421,NCT04567173,TRUE,2022-02-14T02:23:14Z,NA,NA,NA,Incidence of serious adverse events
tri06750,NCT04615936,TRUE,2022-02-09T10:02:43Z,NA,NA,NA,More details here: https://sunnybrook.ca/media/item.asp?c=2&i=2155&f=research-fund-covid
tri06838,NCT04631367,TRUE,2022-02-09T10:03:18Z,NA,NA,NA,Outcome measures covid prevention practices but not medical measure of covid
tri07041,NCT04601077,TRUE,2022-02-14T02:36:33Z,NA,NA,NA,"The purpose of this study is to find out the side effects and ability to take the study drug, Nitric Oxide (NO) lozenges when taken twice daily by mouth. If this study shows that the drug has no or few, acceptable side effects, it will then include up to 840 participants to find out if the drug can reduce bad outcomes of COVID-19 infection (hospitalization, ICU admission, death)."
tri07145,NCT04658433,TRUE,2022-02-09T10:04:09Z,NA,NA,NA,Primary outcomes is assessing serum ACE levels
tri07346,NCT04696562,TRUE,2022-02-14T02:42:46Z,NA,NA,NA,NA
tri07356,NCT04699851,TRUE,2022-02-09T10:05:16Z,NA,NA,NA,"Some primary outcome measures related to prevention (e.g., mask wearing) but no medical measures"
tri03241,NCT04425252,TRUE,2022-02-09T10:05:30Z,NA,NA,NA,Safety and tolerability outcomes
tri06458,NCT04570397,TRUE,2022-02-17T01:46:43Z,NA,NA,NA,"While it is technically treating kidney failure, it's kidney failure as a direct result of COVID therefore I have included for now."
tri07400,NCT04712045,TRUE,2022-02-14T02:44:55Z,NA,NA,NA,NA
tri04760,CTRI/2020/07/026560,TRUE,2022-02-14T02:09:26Z,NA,NA,NA,https://www.researchgate.net/profile/Anil-Pandey-11/publication/351085520_Neem_Azadirachta_Indica_A_Juss_Capsules_for_Prophylaxis_of_COVID-19_Infection_A_Pilot_Double-Blind_Randomized_Controlled_Trial/links/6088581f8ea909241e2c5a7d/Neem-Azadirachta-Indica-A-Juss-Capsules-for-Prophylaxis-of-COVID-19-Infection-A-Pilot-Double-Blind-Randomized-Controlled-Trial.pdf
tri04809,CTRI/2020/07/026791,TRUE,2022-03-02T06:18:25Z,NA,NA,NA,There was a preprint but was removed: 10.2139/ssrn.3820512. This is called an Other result.
tri04902,CTRI/2020/08/027170,TRUE,2022-02-14T02:12:03Z,NA,NA,NA,NA
tri04952,CTRI/2020/08/027465,TRUE,2022-02-17T01:40:26Z,NA,NA,NA,Looks like they just changed follow-up mid-way through the trial to 5 days? (120 hours). Not sure I feel comfortable putting anything. No clue about secondary.
tri05064,CTRI/2020/10/028253,TRUE,2022-02-15T05:30:43Z,NA,NA,NA,NA
tri05105,CTRI/2020/10/028486,TRUE,2022-02-10T07:01:20Z,NA,NA,NA,NA
tri05117,CTRI/2020/10/028566,TRUE,2022-02-10T07:02:58Z,NA,NA,NA,NA
tri07595,NCT04719208,TRUE,2022-02-09T10:09:53Z,NA,NA,NA,NA
tri07657,NCT04730427,TRUE,2022-02-14T02:46:24Z,NA,NA,NA,"blood chemistry, adverse reactions, Dose limiting toxicity"
tri06887,NCT04639375,TRUE,2022-02-14T02:34:47Z,NA,NA,NA,NA
tri07669,NCT04668625,TRUE,2022-02-16T02:09:41Z,NA,NA,NA,NA
tri00996,NCT04349371,TRUE,2022-02-10T06:49:39Z,NA,NA,NA,NA
tri07776,NCT04751695,TRUE,2022-02-09T10:13:17Z,NA,NA,NA,NA
tri07777,NCT04751721,TRUE,2022-02-09T10:14:04Z,NA,NA,NA,NA
tri07798,IRCT20201122049463N1,TRUE,2022-02-09T10:14:34Z,NA,NA,NA,NA
tri07893,NCT04715854,TRUE,2022-02-15T02:57:14Z,NA,NA,NA,NA
tri07899,NCT04756323,TRUE,2022-09-17T06:27:35Z,NA,NA,NA,The reports have results for both phase 1 and 2
tri07914,NCT04758273,TRUE,2022-02-09T10:16:46Z,NA,NA,NA,Phase 1 safety outcomes
tri07919,NCT04760730,TRUE,2022-02-09T10:17:42Z,NA,NA,NA,NA
tri07922,NCT04760821,TRUE,2022-02-09T10:18:22Z,NA,NA,NA,NA
tri06817,NCT04627584,TRUE,2022-02-14T02:32:34Z,NA,NA,NA,NA
tri07978,NCT04770740,TRUE,2022-02-14T02:53:36Z,NA,NA,NA,Primary Outcome Measures :\n\n    Plasma desmosine levels [ Time Frame: Day 1 until day 28 or until discharge if this is earlier. ]\n    Plasma desmosine levels before and during vitamin K supplementation in intervention versus control patients.\n\n    Plasma dp-ucMGP levels [ Time Frame: Day 1 until day 28 or until discharge if this is earlier. ]\n    Plasma dp-uc MGP levels before and during vitamin K supplementation within the intervention group and in intervention versus control patients.
tri06162,NCT04530435,TRUE,2022-02-14T02:19:16Z,NA,NA,NA,NA
tri08055,NCT04788355,TRUE,2022-02-15T05:26:04Z,NA,NA,NA,NA
tri05999,NCT04510038,TRUE,2022-02-09T10:20:32Z,NA,NA,NA,NA
tri07216,NCT04666441,TRUE,2022-02-09T10:21:13Z,NA,NA,NA,NA
tri08068,NCT04671017,TRUE,2022-02-09T10:21:54Z,NA,NA,NA,Phase 1 safety outcomes
tri08099,NCT04792021,TRUE,2022-03-02T06:30:20Z,NA,NA,NA,TNF alpha primary outcome
tri08142,ChiCTR2000040632,TRUE,2022-02-09T10:22:42Z,NA,NA,NA,NA
tri02480,NCT04391179,TRUE,2022-02-09T10:23:10Z,NA,NA,NA,NA
tri03608,NCT04445220,TRUE,2022-02-09T10:23:33Z,NA,NA,NA,\n   PO:  Safety and tolerability as measured by incidence of IP-related serious adverse events [ Time Frame: Outcomes and Serious Adverse Events through Day 180 ]\n\n
tri06968,NCT04487691,TRUE,2022-02-09T10:23:56Z,NA,NA,NA,post-covid
tri06098,NCT04522986,TRUE,2022-02-09T10:24:20Z,NA,NA,NA,Primary Outcome Measures :\n\n    Safety: Adverse Event [ Time Frame: 12 weeks ]\n    Adverse events which appear in subjects with ADR-001 treatment are evaluated.
tri07189,NCT04663737,TRUE,2022-02-14T02:37:11Z,NA,NA,NA,adverse events
tri08279,NCT04695652,TRUE,2022-02-16T02:20:48Z,NA,NA,NA,NA
tri08318,NCT04810637,TRUE,2022-02-09T10:25:33Z,NA,NA,NA,Primary Outcome Measures :\n\n    Dose finding [ Time Frame: 9 weeks ]\n    MTD and RP2D based on safety profiles\n\n    Absolute lymphocyte count (ALC) [ Time Frame: 9 weeks ]\n    The change of absolute lymphocyte count from baseline
tri08319,NCT04810949,TRUE,2022-02-09T10:26:00Z,NA,NA,NA,NA
tri08346,NCT04816656,TRUE,2022-02-10T06:15:36Z,NA,NA,NA,NA
tri08355,NCT04818489,TRUE,2022-02-09T10:27:42Z,NA,NA,NA,linked in registry but not sure if it belongs to this study since the dosis of the medication given is slightly different: https://pubmed.ncbi.nlm.nih.gov/32579195/
tri08404,NCT04830943,TRUE,2022-02-09T10:28:04Z,NA,NA,NA,NA
tri00728,EUCTR2020-001307-16,TRUE,2022-02-09T10:28:26Z,NA,NA,NA,NA
tri08446,NCT04329195,TRUE,2022-02-16T03:24:03Z,NA,NA,NA,NA
tri06965,NCT04479644,TRUE,2022-02-14T02:35:43Z,NA,NA,NA,POs:\n\n    Incidence of adverse events (AEs) by CTCAE v5.0 [ Time Frame: up to 24 weeks ]\n    Proportion of subjects with SAEs [ Time Frame: up to 24 weeks ]\n    Proportion of subjects with infusion-related reactions [ Time Frame: up to 24 weeks ]\n    Proportion of subjects with hypersensitivity reactions [ Time Frame: up to 24 weeks ]\n\n
tri05726,NCT04476979,TRUE,2022-03-01T06:12:03Z,NA,NA,NA,Sub-trial of NCT04324047/EUCTR2020-001246-18 (tri00659) observational supra-'trial' (excluded)
tri05995,NCT04509947,TRUE,2022-02-09T10:30:07Z,NA,NA,NA,Phase 1 safety outcomes
tri08535,NCT04678830,TRUE,2022-02-15T02:19:19Z,NA,NA,NA,long covid
tri08546,NCT04810728,TRUE,2022-02-16T03:41:05Z,NA,NA,NA,NA
tri08746,NCT04681092,TRUE,2022-02-16T03:26:03Z,NA,NA,NA,"Primary outcome is just listed as safety, the Phase 2 part has an efficacy/immunogenicity component but listed as secondary outcome"
tri03124,NCT04424901,TRUE,2022-03-04T06:16:01Z,NA,NA,NA,"Primary outcomes are d-dimer and platelet count, so include"
tri07134,NCT04656691,TRUE,2022-02-09T10:31:37Z,NA,NA,NA,NA
tri07201,NCT04665193,TRUE,2022-02-10T06:11:07Z,NA,NA,NA,NA
tri08853,NCT04817319,TRUE,2022-02-09T10:32:32Z,NA,NA,NA,NA
tri08872,NCT04860739,TRUE,2022-02-17T01:49:18Z,NA,NA,NA,Results pub is full primary results data. It's 'ongoing' due to long-term secondary outcomes.
tri08929,ISRCTN10839729,TRUE,2022-02-16T02:33:50Z,NA,NA,NA,We found potentially a pilot study: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7986140/ \nDue to number of patients and registry/trial dates we will not include.
tri03422,NCT04405076,TRUE,2022-02-16T03:02:15Z,NA,NA,NA,All interim results for study but none of journal articles and preprints belong together.
tri03467,NCT04426695,TRUE,2022-02-14T02:01:23Z,NA,NA,NA,Preprint (10.1101/2021.11.05.21265656) and article (10.1093/infdis/jiac320) report interim results of 1336 patients. Registry summary results include 2203 patients.
tri05880,NCT04494646,TRUE,2022-02-17T01:45:55Z,NA,NA,NA,This is in Covid pts but the primary outcome is just safety. Has some efficacy secondary endpts but by our inclusion criteria that shouldn't count.
tri05618,NCT04467086,TRUE,2022-02-14T02:16:27Z,NA,NA,NA,NA
tri06522,NCT04581811,TRUE,2022-02-15T02:55:18Z,NA,NA,NA,NA
tri09384,NCT04699916,TRUE,2022-02-09T10:34:59Z,NA,NA,NA,NA
tri09407,NCT04790240,TRUE,2022-02-16T03:26:49Z,NA,NA,NA,NA
tri09492,NCT04898127,TRUE,2022-02-16T03:27:28Z,NA,NA,NA,NA
tri09557,ACTRN12621000532808,TRUE,2022-02-16T02:51:50Z,NA,NA,NA,NA
tri09595,NCT04773067,TRUE,2022-02-16T03:04:38Z,NA,NA,NA,NA
tri02278,NCT04399252,TRUE,2022-02-16T03:47:08Z,NA,NA,NA,NA
tri05649,NCT04470427,TRUE,2022-03-02T05:56:37Z,NA,NA,NA,"Primary outcome was reported in first NEJM publication (covid at least 14 days after 2nd shot), then longer term follow-up in other publication so both called full results for reporting of primary outcome as primary outcome had variable follow-up but the minimum was 14 days which is the 1st paper.\n\nFinal Enrollment date was 28 days after the date given for the final first shot."
tri02771,SLCTR/2020/011,TRUE,2022-03-01T05:57:16Z,NA,NA,NA,The registry reporting of https://slctr.lk/trials/slctr-2020-011/progresses does not count as results. It does not matter if it is underpowered. That's the whole point of the registry is to still have a place to put those results.
tri02886,PACTR202004893013257,TRUE,2022-02-15T02:29:09Z,NA,NA,NA,NA
tri04430,PACTR202010729372570,TRUE,2022-02-10T06:08:49Z,NA,NA,NA,"Primary outcomes are removed from COVID prevention/treatment (mask wearing, social distancing, hand washing)"
tri04434,PACTR202010718451278,TRUE,2022-02-14T02:04:23Z,NA,NA,NA,NA
tri04444,RPCEC00000338,TRUE,2022-02-09T10:37:52Z,NA,NA,NA,Phase 1 safety outcomes
tri10073,TCTR20210125002,TRUE,2022-02-16T02:44:05Z,NA,NA,NA,NA
tri01220,NCT04363749,TRUE,2022-02-09T10:38:49Z,NA,NA,NA,Measuring emotional responses
tri10131,NCT04728802,TRUE,2022-02-17T01:54:50Z,NA,NA,NA,"Preprint (10.1101/2021.06.22.21259318) of north (NCT04728802) only, whereas article (10.7759/cureus.20691) reports both north and south cohorts. Since north cohort is distinguishable in analysis, we consider the preprint to match."
tri10178,NCT04878809,TRUE,2022-02-16T03:28:31Z,NA,NA,NA,Diagnostic comparison study
tri10194,NCT04926428,TRUE,2022-02-09T10:40:14Z,NA,NA,NA,NA
tri10199,NCT04927169,TRUE,2022-02-16T03:32:13Z,NA,NA,NA,NA
tri10217,NCT04930861,TRUE,2022-02-16T02:41:52Z,NA,NA,NA,adverse events
tri10251,NCT04935515,TRUE,2022-02-16T03:33:56Z,NA,NA,NA,Excluded as CRP isn't outcome but rather trial uses CRP as diagnostic indicator - it's impact of CRP on outcomes for treatment
tri10318,NL9430,TRUE,2022-02-09T10:41:16Z,NA,NA,NA,NA
tri00149,ChiCTR2000030027,TRUE,2022-02-15T02:41:53Z,NA,NA,NA,NA
tri00205,ChiCTR2000030418,TRUE,2022-02-15T03:45:00Z,NA,NA,NA,Lung exercise rehab but primary outcome measures include 'clinical prognostic outcome' and 'IL-6'
tri01390,ChiCTR2000032737,TRUE,2022-02-15T01:14:19Z,NA,NA,NA,NA
tri02228,EUCTR2020-001739-28,TRUE,2022-02-15T01:16:57Z,NA,NA,NA,NA
tri03463,NCT04425720,TRUE,2022-02-10T06:59:50Z,NA,NA,NA,NA
tri05905,NCT04497389,TRUE,2022-02-10T07:32:30Z,NA,NA,NA,"Primary outcome measure is 'c-reactive protein' for inflammation, which we count as covid outcome measure."
tri07596,NCT04719234,TRUE,2022-02-10T06:12:00Z,NA,NA,NA,NA
tri07646,NCT04728594,TRUE,2022-02-10T07:07:40Z,NA,NA,NA,NA
tri05664,NCT04471766,TRUE,2022-02-10T06:09:48Z,NA,NA,NA,NA
tri08148,NCT04723459,TRUE,2022-02-10T02:23:14Z,NA,NA,NA,NA
tri08216,ACTRN12620001355965,TRUE,2022-02-10T02:23:46Z,NA,NA,NA,Behavioural intervention embedded within survey; primary outcome measure is intention to test
tri08825,NCT04668222,TRUE,2022-02-10T07:08:28Z,NA,NA,NA,"These all appear &quot;symptomatic&quot; outcomes, nothing really directly related to covid treatment"
tri09168,NCT04885517,TRUE,2022-02-10T07:09:15Z,NA,NA,NA,NA
tri09412,NCT04805931,TRUE,2022-02-10T07:09:40Z,NA,NA,NA,NA
tri09601,NCT04794400,TRUE,2022-02-15T01:24:14Z,NA,NA,NA,No completion or enrollment date in full-results article
tri05108,CTRI/2020/10/028485,TRUE,2022-02-10T07:36:12Z,NA,NA,NA,NA
tri07287,ChiCTR2000030136,TRUE,2022-03-01T06:04:57Z,NA,NA,NA,registry says Cancelled by the investigator
tri07290,ACTRN12620001371987,TRUE,2022-03-09T03:57:17Z,NA,NA,NA,NA
tri10000,LBCTR2021034768,TRUE,2022-04-05T07:18:14Z,NA,NA,NA,NA
tri06418,NCT04566276,TRUE,2022-05-16T10:13:06Z,NA,NA,NA,Included things like CRP in a primary outcome.
tri02881,JPRN-UMIN000040694,TRUE,2022-07-01T02:34:55Z,NA,NA,NA,NA
tri07325,JPRN-UMIN000042807,TRUE,2022-07-01T02:35:15Z,NA,NA,NA,NA
tri08245,JPRN-UMIN000043537,TRUE,2022-07-01T02:35:34Z,NA,NA,NA,NA
tri08248,JPRN-UMIN000043566,TRUE,2022-07-01T02:38:33Z,NA,NA,NA,NA
tri04138,JPRN-UMIN000041990,TRUE,2022-07-01T02:38:46Z,NA,NA,NA,NA
tri04488,JPRN-UMIN000042384,TRUE,2022-07-01T02:41:33Z,NA,NA,NA,NA
tri09113,JPRN-UMIN000043788,TRUE,2022-07-01T02:39:23Z,NA,NA,NA,NA
tri01722,JPRN-UMIN000040235,TRUE,2022-07-01T02:40:01Z,NA,NA,NA,NA
tri09704,JPRN-UMIN000042556,TRUE,2022-07-01T02:40:13Z,NA,NA,NA,NA
tri04509,CTRI/2020/05/025209,TRUE,2022-07-06T05:11:30Z,NA,NA,NA,NA
tri06468,NCT04573153,TRUE,2022-07-06T05:15:56Z,NA,NA,NA,NA
tri03444,EUCTR2020-002448-21,TRUE,2022-08-15T08:20:44Z,NA,NA,NA,"Not originally searched since not complete per EUCTR2020-002448-21, and we were not aware of the NCT04414267 cross-reg until additional post-hoc checks.\nResults search on same day as full results publication so no PMID yet"
tri07423,CTRI/2020/10/028731,TRUE,2022-08-15T08:35:02Z,NA,NA,NA,NA
tri03423,NCT04405570,TRUE,2022-08-15T08:44:31Z,NA,NA,NA,NA
tri07286,NCT04452318,TRUE,2022-08-15T09:09:52Z,NA,NA,NA,Trial has 2 full-result pairs. Encode pair with earlier publication (preprint) as group 1 even though later article date.
tri00908,NCT04324073,TRUE,2022-09-09T05:35:01Z,NA,NA,NA,"CORIMUNO-SARI (Sarilumab) was eventually split into two analyses and results publications: SARI-1 (moderate-to-severe pneumonia, 10.1016/S2665-9913(21)00315-5) and SARI-2 (critical pneumonia, 10.1183/13993003.02523-2021). In line with decisions about other CORIMUNO trials (i.e., tri01097/NCT04331808), we consider both of these full results (complete follow-up of all trial participants for at least one measure identified as a primary outcome). Sub-trial of NCT04324047/EUCTR2020-001246-18 (tri00659) observational supra-'trial' (excluded)"
tri05354,NCT04345991,TRUE,2022-09-07T08:35:42Z,NA,NA,NA,Sub-trial of NCT04324047/EUCTR2020-001246-18 (tri00659) observational supra-'trial' (excluded)
tri06615,NCT04594668,TRUE,2022-09-09T13:50:00Z,NA,NA,NA,NA
tri06191,NCT04533399,TRUE,2022-09-15T00:44:26Z,NA,NA,NA,"Both full results publications are presented as interim results as trial has long planned follow-up. Consider NEJM article as interim and Lancet as full since additional 26 participants; also primary outcomes of immunogenicity (primary outcomes 7,8,9 in the registration) fully reported at at least 35 days for everyone."
tri05702,NCT04475107,TRUE,2022-09-15T01:06:46Z,NA,NA,NA,NA
tri06956,NCT04466241,TRUE,2022-09-15T01:09:21Z,NA,NA,NA,NA
tri03086,NCT04399980,TRUE,2022-09-15T01:04:52Z,NA,NA,NA,Trial appears to have separate registrations (with different completion dates) for each site; we collapse all under this registration (tri03086/NCT04399980) for tri05866/NCT04492514 and tri05580/NCT04463004.
tri08957,NCT04746430,TRUE,2022-09-15T01:11:26Z,NA,NA,NA,NA
tri09585,NCT04710381,TRUE,2022-09-15T01:13:20Z,NA,NA,NA,NA
tri03455,NCT04421027,TRUE,2022-09-17T05:38:00Z,NA,NA,NA,"Preprint/article matches: 10.1101/2021.04.30.21255934 (preprint 1), 10.1016/S2213-2600(21)00331-3 (article 1), 10.1101/2021.10.11.21263897 (preprint 2), 10.1016/S2213-2600(22)00006-6 (article 2)"
tri08607,ISRCTN18304314,TRUE,2022-09-19T08:30:58Z,NA,NA,NA,NA
tri02961,NCT04374565,TRUE,2022-09-19T08:33:02Z,NA,NA,NA,NA
tri08350,NCT04816942,TRUE,2022-09-20T03:34:03Z,NA,NA,NA,NA
tri06142,NCT04527614,TRUE,2022-09-20T03:38:47Z,NA,NA,NA,NA
tri07001,NCT04545060,TRUE,2022-09-20T03:40:03Z,NA,NA,NA,NA
tri01108,NCT04339712,TRUE,2022-09-20T03:40:41Z,NA,NA,NA,NA
tri08138,ChiCTR2100041706,TRUE,2022-09-27T14:25:43Z,NA,NA,NA,Pubs combine results from ChiCTR2100041705 + ChiCTR2100041706 so we are combining.
tri00012,ChiCTR2000029939,FALSE,2021-09-23T14:03:42Z,NA,NA,NA,NA
tri00013,ChiCTR2000029935,FALSE,2021-09-23T14:10:53Z,NA,NA,NA,NA
tri00020,ChiCTR2000029867,FALSE,2021-09-23T13:47:27Z,NA,NA,NA,NA
tri00024,ChiCTR2000029849,FALSE,2021-09-23T13:16:36Z,NA,NA,NA,NA
tri00032,ChiCTR2000029811,FALSE,2021-09-27T03:05:02Z,NA,NA,NA,NA
tri00034,ChiCTR2000029806,FALSE,2021-09-23T07:55:36Z,NA,NA,NA,NA
tri00038,ChiCTR2000029789,FALSE,2021-11-05T03:24:27Z,NA,NA,NA,post-discharge so rehab symptoms
tri00054,ChiCTR2000029747,FALSE,2021-09-23T14:22:03Z,NA,NA,NA,NA
tri00078,ChiCTR2000029572,FALSE,2021-09-23T09:36:02Z,NA,NA,NA,NA
tri00079,ChiCTR2000029569,FALSE,2021-09-23T09:32:19Z,NA,NA,NA,NA
tri00086,ChiCTR2000029539,FALSE,2021-09-23T08:59:12Z,NA,NA,NA,NA
tri00129,ChiCTR2000030093,FALSE,2021-09-23T08:04:12Z,NA,NA,NA,NA
tri00186,ChiCTR2000029803,FALSE,2021-09-27T03:04:33Z,NA,NA,NA,NA
tri00220,ChiCTR2000030317,FALSE,2021-09-30T14:15:13Z,NA,NA,NA,NA
tri00227,ChiCTR2000030265,FALSE,2021-09-23T08:43:22Z,NA,NA,NA,NA
tri00231,ChiCTR2000030260,FALSE,2021-09-23T08:39:43Z,NA,NA,NA,NA
tri00263,ChiCTR2000029387,FALSE,2021-09-23T07:50:09Z,NA,NA,NA,NA
tri00264,ChiCTR2000029386,FALSE,2021-09-23T07:46:34Z,NA,NA,NA,NA
tri00269,NCT04286503,FALSE,2021-09-23T12:44:26Z,NA,NA,NA,NA
tri00297,ChiCTR2000030484,FALSE,2021-09-23T07:42:45Z,NA,NA,NA,NA
tri00301,ChiCTR2000030479,FALSE,2021-09-23T08:35:18Z,NA,NA,NA,NA
tri00319,ChiCTR2000029757,FALSE,2021-09-23T07:24:02Z,NA,NA,NA,NA
tri00324,ChiCTR2000029308,FALSE,2021-09-23T07:35:16Z,NA,NA,NA,primary outcome: time to clinical improvement with no follow-up time reported
tri00335,ChiCTR2000030897,FALSE,2021-10-18T10:55:11Z,NA,NA,NA,NA
tri00357,ChiCTR2000030849,FALSE,2021-09-23T08:03:52Z,NA,NA,NA,NA
tri00362,ChiCTR2000030835,FALSE,2021-09-23T07:12:28Z,NA,NA,NA,NA
tri00378,ChiCTR2000030804,FALSE,2021-09-30T14:25:13Z,NA,NA,NA,NA
tri00476,NCT04302519,FALSE,2021-11-08T11:44:05Z,NA,NA,NA,NA
tri00482,ChiCTR2000031139,FALSE,2021-09-30T14:58:40Z,NA,NA,NA,NA
tri00514,ChiCTR2000030920,FALSE,2021-10-18T10:49:02Z,NA,NA,NA,Outcomes are for COVID patients in recovery
tri00519,ChiCTR2000030539,FALSE,2021-09-30T15:13:03Z,NA,NA,NA,"Goal is to determine whether covid exists in the oral environment and the influence of oral gargle on covid. Therefore to provide reference for early diagnosis and prevention, however prevention is not primary outcome."
tri00530,ChiCTR2000029496,FALSE,2021-09-23T06:40:10Z,NA,NA,NA,NA
tri00549,NCT04308317,FALSE,2021-09-30T16:07:41Z,NA,NA,NA,NA
tri00574,ChiCTR2000031271,FALSE,2021-09-30T15:26:51Z,NA,NA,NA,NA
tri00613,NCT04323514,FALSE,2021-10-01T06:11:20Z,NA,NA,NA,NA
tri00622,ChiCTR2000031639,FALSE,2021-09-23T08:02:40Z,NA,NA,NA,NA
tri00650,NL8491,FALSE,2022-09-27T08:43:48Z,NA,NA,NA,Results linked through EUCTR. Completion date on NTR is clearly wrong. In the EUCTR it's 1 Feb 2021.
tri00655,NCT04298060,FALSE,2021-09-30T16:03:35Z,NA,NA,NA,Inclusion criteria does not included covid diagnosis just influenza?
tri00663,NCT04326075,FALSE,2021-10-01T06:39:56Z,NA,NA,NA,NA
tri00672,NCT04330144,FALSE,2021-10-01T06:47:39Z,NA,NA,NA,NA
tri00688,ACTRN12620000448943,FALSE,2021-09-23T09:59:15Z,NA,NA,NA,NA
tri00692,ACTRN12620000454976,FALSE,2021-09-30T15:59:26Z,NA,NA,NA,NA
tri00705,ChiCTR2000031735,FALSE,2021-09-23T07:07:43Z,NA,NA,NA,NA
tri00712,ChiCTR2000030750,FALSE,2021-09-23T07:03:45Z,NA,NA,NA,NA
tri00748,NCT04328012,FALSE,2021-11-06T10:52:18Z,NA,NA,NA,NA
tri00791,EUCTR2020-001250-21,FALSE,2022-09-26T07:15:23Z,NA,NA,NA,NA
tri00798,EUCTR2020-001224-33,FALSE,2021-10-15T01:35:00Z,NA,NA,NA,Prematurely Ended
tri00834,NCT04392531,FALSE,2022-09-26T06:16:47Z,NA,NA,NA,NA
tri00836,EUCTR2020-001406-27,FALSE,2021-09-17T09:15:09Z,NA,NA,NA,NA
tri00899,NCT04304690,FALSE,2021-10-17T08:32:22Z,NA,NA,NA,NA
tri00913,NCT04325633,FALSE,2021-10-29T05:59:48Z,NA,NA,NA,NA
tri00917,EUCTR2020-001306-35,FALSE,2022-09-26T06:34:01Z,NA,NA,NA,NA
tri00933,NCT04342169,FALSE,2021-10-17T08:50:42Z,NA,NA,NA,NA
tri00949,NCT04344444,FALSE,2021-10-26T04:07:36Z,NA,NA,NA,NA
tri00950,NCT04344535,FALSE,2021-09-26T12:48:02Z,NA,NA,NA,Registry results submitted but not posted at time of search: https://clinicaltrials.gov/ct2/show/results/NCT04344535
tri00988,NCT04348383,FALSE,2021-10-22T09:46:08Z,NA,NA,NA,https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8233188/ - this review reports the preliminary safety results?
tri00994,NCT04348864,FALSE,2021-11-08T08:46:24Z,NA,NA,NA,NA
tri01014,NCT04351763,FALSE,2021-10-01T07:01:03Z,NA,NA,NA,NA
tri01023,NCT04354155,FALSE,2021-10-31T07:46:07Z,NA,NA,NA,Only safety in primary outcome
tri01055,ChiCTR2000032242,FALSE,2021-10-18T10:45:58Z,NA,NA,NA,NA
tri01062,ChiCTR2000032165,FALSE,2021-09-30T15:43:26Z,NA,NA,NA,NA
tri01071,EUCTR2020-001391-15,FALSE,2021-10-20T02:55:39Z,NA,NA,NA,NA
tri01076,EUCTR2020-001659-42,FALSE,2021-09-29T03:41:28Z,NA,NA,NA,NA
tri01078,EUCTR2020-001440-26,FALSE,2021-09-24T15:01:15Z,NA,NA,NA,- Trial was Prematurely Ended\n- The description of the primary endpoint sounds like a result: Decrease of the contagion rate measured by RT-PCR of healthcare personnel who attends SARS-CoV-2 infected patients from 9% in control group to 3% in experimental group.
tri01079,EUCTR2020-001327-13,FALSE,2021-11-08T11:58:44Z,NA,NA,NA,NA
tri01085,NCT04318444,FALSE,2021-09-30T16:15:36Z,NA,NA,NA,NA
tri01089,NCT04320056,FALSE,2021-10-26T04:39:41Z,NA,NA,NA,NA
tri01122,NCT04350580,FALSE,2021-09-16T02:55:37Z,NA,NA,NA,NA
tri01128,NCT04353037,FALSE,2021-09-17T08:52:20Z,NA,NA,NA,NA
tri01129,NCT04353518,FALSE,2021-10-01T07:07:08Z,NA,NA,NA,NA
tri01149,NCT04357366,FALSE,2021-10-31T07:57:59Z,NA,NA,NA,Interim as in the first 130 pts...still recruiting
tri01167,NCT04358809,FALSE,2021-09-24T01:47:42Z,NA,NA,NA,NA
tri01179,NCT04359953,FALSE,2021-11-08T12:02:35Z,NA,NA,NA,NA
tri01185,NCT04360551,FALSE,2021-11-08T12:50:42Z,NA,NA,NA,NA
tri01188,NCT04360811,FALSE,2021-10-25T03:06:31Z,NA,NA,NA,This is diagnostic/observational
tri01208,NCT04362111,FALSE,2021-09-20T11:21:42Z,NA,NA,NA,NA
tri01234,NCT04366050,FALSE,2021-10-28T09:56:15Z,NA,NA,NA,NA
tri01238,ACTRN12620000516987,FALSE,2021-09-23T06:00:10Z,NA,NA,NA,NA
tri01239,ACTRN12620000517976,FALSE,2021-10-18T09:20:50Z,NA,NA,NA,NA
tri01246,ChiCTR2000032573,FALSE,2021-10-28T10:04:04Z,NA,NA,NA,NA
tri01257,ChiCTR2000032457,FALSE,2021-09-24T14:58:44Z,NA,NA,NA,Rehab study
tri01294,NCT04356833,FALSE,2021-10-20T07:31:20Z,NA,NA,NA,NA
tri01306,NCT04362176,FALSE,2021-10-28T03:25:37Z,NA,NA,NA,The preprint of the protocol was published on 2021-03-02: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7941637/\n\nCochrane has embase link that I cannot access for possible full results publication: https://www.embase.com/search/results?subaction=viewrecord&id=L636171613
tri01312,NCT04363450,FALSE,2021-10-01T07:53:55Z,NA,NA,NA,NA
tri01369,NCT04369794,FALSE,2021-11-08T12:58:25Z,NA,NA,NA,NA
tri01391,ChiCTR2000032717,FALSE,2021-09-23T04:11:37Z,NA,NA,NA,NA
tri01395,ChiCTR2000032635,FALSE,2021-09-30T15:30:56Z,NA,NA,NA,NA
tri01413,NL8504,FALSE,2022-09-27T08:33:49Z,NA,NA,NA,Big discrepancy between registry date and the date in the study. Either way should probably be included.
tri01453,NCT04371978,FALSE,2021-10-19T05:51:09Z,NA,NA,NA,NA
tri01476,NCT04374539,FALSE,2021-10-18T08:18:52Z,NA,NA,NA,NA
tri01481,NCT04375202,FALSE,2021-09-15T07:17:04Z,NA,NA,NA,This letter says the trials are ongoing: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7667946/
tri01489,NCT04336332,FALSE,2021-10-22T05:23:18Z,NA,NA,NA,NA
tri01496,NCT04343989,FALSE,2021-09-27T14:00:28Z,NA,NA,NA,NA
tri01504,NCT04354610,FALSE,2021-09-19T14:10:11Z,NA,NA,NA,NA
tri01508,NCT04357990,FALSE,2021-10-01T07:12:59Z,NA,NA,NA,NA
tri01513,NCT04363216,FALSE,2021-10-18T08:30:57Z,NA,NA,NA,NA
tri01524,NCT04372004,FALSE,2021-10-01T04:34:11Z,NA,NA,NA,Diagnostics
tri01552,NCT04377308,FALSE,2021-10-21T05:09:51Z,NA,NA,NA,NA
tri01577,NCT04379336,FALSE,2021-10-21T05:05:17Z,NA,NA,NA,NA
tri01591,ChiCTR2000032919,FALSE,2021-10-18T10:41:18Z,NA,NA,NA,"Outcomes are for improving symptoms of fatigue, digestion, etc, in the covid recovery period."
tri01598,ChiCTR2000029605,FALSE,2021-09-23T04:55:29Z,NA,NA,NA,NA
tri01601,ACTRN12620000557932,FALSE,2021-10-18T09:27:20Z,NA,NA,NA,NA
tri01634,IRCT20180429039463N2,FALSE,2021-09-15T13:51:30Z,NA,NA,NA,NA
tri01687,IRCT20140407017169N2,FALSE,2021-09-21T04:13:58Z,NA,NA,NA,NA
tri01717,KCT0005003,FALSE,2021-09-30T15:36:54Z,NA,NA,NA,NA
tri01742,CTRI/2020/04/024775,FALSE,2021-09-21T04:27:23Z,NA,NA,NA,NA
tri01745,CTRI/2020/04/024804,FALSE,2021-09-21T03:04:16Z,NA,NA,NA,NA
tri01788,CTRI/2020/05/025156,FALSE,2021-09-21T01:24:25Z,NA,NA,NA,NA
tri01803,NCT04344015,FALSE,2021-09-24T14:55:55Z,NA,NA,NA,NA
tri01804,NCT04346147,FALSE,2021-11-06T10:46:54Z,NA,NA,NA,NA
tri01811,NCT04365985,FALSE,2021-09-17T07:36:25Z,NA,NA,NA,NA
tri01815,NCT04373135,FALSE,2021-09-23T08:47:28Z,NA,NA,NA,NA
tri01818,NCT04376476,FALSE,2021-10-01T04:33:44Z,NA,NA,NA,Just taking blood. No real intervention being done here.
tri01833,NCT04380909,FALSE,2021-09-23T09:35:56Z,NA,NA,NA,NA
tri01843,NCT04381377,FALSE,2021-10-14T05:45:37Z,NA,NA,NA,NA
tri01871,NCT04384549,FALSE,2021-09-23T12:59:10Z,NA,NA,NA,NA
tri01872,NCT04384588,FALSE,2021-10-21T04:14:04Z,NA,NA,NA,One of the Other results also had a preprint.\nhttps://www.biorxiv.org/content/10.1101/2021.02.05.429566v1.abstract\n\nthe full results preprint is called the &quot;first results&quot; but it is the full reporting of the primary outcomes. It had no secondary outcomes in this report.
tri01888,NCT04341415,FALSE,2021-09-21T00:52:51Z,NA,NA,NA,NA
tri01893,NCT04347538,FALSE,2021-11-08T13:22:15Z,NA,NA,NA,NA
tri01915,NCT04365517,FALSE,2021-09-14T13:19:31Z,NA,NA,NA,NA
tri01925,NCT04381988,FALSE,2021-10-19T10:00:48Z,NA,NA,NA,NA
tri01934,NCT04385017,FALSE,2021-10-01T04:32:53Z,NA,NA,NA,Describing clinical characteristics.
tri01942,NCT04385771,FALSE,2021-10-12T03:16:38Z,NA,NA,NA,NA
tri01958,NCT04387292,FALSE,2021-10-01T04:35:11Z,NA,NA,NA,Just descriptive observation. No actual intervention.
tri01962,NCT04387955,FALSE,2021-10-18T14:50:41Z,NA,NA,NA,NA
tri01986,EUCTR2020-001684-89,FALSE,2023-01-05T06:24:21Z,NA,NA,NA,NA
tri02028,NCT04358783,FALSE,2021-10-27T06:47:01Z,NA,NA,NA,NA
tri02030,NCT04361253,FALSE,2021-11-08T13:28:12Z,NA,NA,NA,NA
tri02038,NCT04372979,FALSE,2021-10-18T08:25:57Z,NA,NA,NA,NA
tri02046,NCT04388683,FALSE,2021-10-22T09:35:34Z,NA,NA,NA,NA
tri02048,NCT04389372,FALSE,2021-09-30T16:22:28Z,NA,NA,NA,NA
tri02088,NCT04394208,FALSE,2021-09-20T11:41:16Z,NA,NA,NA,NA
tri02095,NCT04338828,FALSE,2021-10-22T05:18:53Z,NA,NA,NA,NA
tri02113,NCT04361214,FALSE,2021-09-24T01:49:32Z,NA,NA,NA,The primary outcomes are assessing tolerability of high dose leflunomide
tri02114,NCT04361344,FALSE,2021-09-21T02:17:35Z,NA,NA,NA,Trial is aims to - examine highly sensitive blood biomarkers of brain dysfunction in correlation with late clinical outcome
tri02168,NCT04396106,FALSE,2021-10-01T08:14:28Z,NA,NA,NA,NA
tri02175,NCT04397328,FALSE,2021-10-19T05:57:05Z,NA,NA,NA,NA
tri02177,NCT04397523,FALSE,2021-10-27T07:07:24Z,NA,NA,NA,NA
tri02186,NCT04398277,FALSE,2021-10-01T04:35:06Z,NA,NA,NA,NA
tri02190,NCT04400032,FALSE,2021-10-19T10:24:25Z,NA,NA,NA,Primary safety outcomes
tri02211,ChiCTR2000033261,FALSE,2021-09-23T02:36:11Z,NA,NA,NA,NA
tri02215,ISRCTN13447477,FALSE,2021-09-23T14:39:20Z,NA,NA,NA,NA
tri02242,NCT04305457,FALSE,2021-10-26T04:38:51Z,NA,NA,NA,"same group, pts from different study but references this study: https://www.sciencedirect.com/science/article/pii/S1089860320301828?via%3Dihub\n\nStudy ended early so they only reported the results from the people who received the intervention. I think this is acceptable to count as Full Results."
tri02252,NCT04348370,FALSE,2021-10-18T08:48:27Z,NA,NA,NA,NA
tri02266,NCT04390594,FALSE,2021-09-24T01:43:11Z,NA,NA,NA,NA
tri02275,NCT04398004,FALSE,2021-09-21T01:36:02Z,NA,NA,NA,NA
tri02279,NCT04399356,FALSE,2021-10-18T11:19:31Z,NA,NA,NA,NA
tri02291,NCT04400929,FALSE,2021-11-08T13:39:12Z,NA,NA,NA,NA
tri02303,NCT04401423,FALSE,2021-11-05T09:31:39Z,NA,NA,NA,NA
tri02314,NCT04403269,FALSE,2021-10-18T04:35:48Z,NA,NA,NA,NA
tri02319,NCT04403906,FALSE,2021-10-05T07:40:45Z,NA,NA,NA,Diagnostic
tri02329,NCT04334629,FALSE,2021-10-18T09:15:12Z,NA,NA,NA,NA
tri02333,NCT04345289,FALSE,2021-11-08T13:45:17Z,NA,NA,NA,NA
tri02342,NCT04366141,FALSE,2021-10-14T04:23:56Z,NA,NA,NA,NA
tri02354,NCT04382547,FALSE,2021-10-14T05:06:18Z,NA,NA,NA,NA
tri02357,NCT04386291,FALSE,2021-09-28T11:08:32Z,NA,NA,NA,NA
tri02360,NCT04388527,FALSE,2021-11-05T07:30:49Z,NA,NA,NA,NA
tri02378,NCT04404426,FALSE,2021-10-06T07:40:23Z,NA,NA,NA,NA
tri02383,NCT04405492,FALSE,2021-09-30T16:23:09Z,NA,NA,NA,NA
tri02394,NCT04406493,FALSE,2021-10-05T07:40:25Z,NA,NA,NA,Monitoring technique. Not treatment or prevention.
tri02409,NCT04408027,FALSE,2021-10-14T05:34:41Z,NA,NA,NA,NA
tri02412,NCT04408235,FALSE,2021-11-09T09:25:38Z,NA,NA,NA,NA
tri02419,ACTRN12620000634976,FALSE,2021-09-15T13:52:12Z,NA,NA,NA,NA
tri02438,EUCTR2020-002091-12,FALSE,2021-09-20T03:02:25Z,NA,NA,NA,NA
tri02452,NCT04334967,FALSE,2021-09-15T05:32:16Z,NA,NA,NA,NA
tri02471,NCT04370236,FALSE,2021-10-14T06:24:46Z,NA,NA,NA,NA
tri02473,NCT04373044,FALSE,2021-10-27T06:42:09Z,NA,NA,NA,NA
tri02475,NCT04377672,FALSE,2021-11-01T21:38:39Z,NA,NA,NA,NA
tri02483,NCT04397757,FALSE,2021-09-27T13:57:08Z,NA,NA,NA,NA
tri02484,NCT04397796,FALSE,2021-11-01T21:12:16Z,NA,NA,NA,NA
tri02486,NCT04401475,FALSE,2021-10-19T07:02:32Z,NA,NA,NA,NA
tri02492,NCT04405986,FALSE,2021-09-30T16:33:40Z,NA,NA,NA,NA
tri02501,NCT04407390,FALSE,2021-10-18T04:32:59Z,NA,NA,NA,NA
tri02511,NCT04408287,FALSE,2021-10-14T05:21:56Z,NA,NA,NA,NA
tri02556,NCT04311697,FALSE,2021-10-14T04:58:57Z,NA,NA,NA,Preprint with interim analysis was available until final preprint was published
tri02560,NCT04327505,FALSE,2021-10-10T02:01:48Z,NA,NA,NA,NA
tri02564,NCT04336410,FALSE,2021-10-31T08:12:58Z,NA,NA,NA,NA
tri02581,NCT04359680,FALSE,2021-10-01T12:53:57Z,NA,NA,NA,NA
tri02608,NCT04409496,FALSE,2021-09-22T02:58:12Z,NA,NA,NA,NA
tri02626,NCT04413838,FALSE,2021-11-09T09:41:29Z,NA,NA,NA,NA
tri02635,NCT04414631,FALSE,2021-11-06T10:39:20Z,NA,NA,NA,other result: 5 cases after which they decided to initiate this trial
tri02640,NCT04416048,FALSE,2021-10-10T04:38:43Z,NA,NA,NA,NA
tri02644,NCT04416139,FALSE,2021-10-18T14:37:03Z,NA,NA,NA,NA
tri02655,NCT04419025,FALSE,2021-10-27T06:36:59Z,NA,NA,NA,NA
tri02672,EUCTR2020-001257-51,FALSE,2021-09-30T06:17:49Z,NA,NA,NA,End of Trial Status: Prematurely Ended
tri02673,EUCTR2020-001363-85,FALSE,2021-11-04T03:53:01Z,NA,NA,NA,NA
tri02695,DRKS00021527,FALSE,2021-09-23T09:43:43Z,NA,NA,NA,NA
tri02703,DRKS00021585,FALSE,2021-09-23T09:44:30Z,NA,NA,NA,Diagnostic
tri02779,IRCT20190810044500N5,FALSE,2021-09-27T07:00:08Z,NA,NA,NA,NA
tri02852,JPRN-JapicCTI-205270,FALSE,2021-10-06T07:24:44Z,NA,NA,NA,NA
tri02882,PACTR202004801273802,FALSE,2021-10-28T01:37:43Z,NA,NA,NA,NA
tri02883,PACTR202004693933092,FALSE,2021-09-15T07:08:18Z,NA,NA,NA,NA
tri02884,PACTR202004761408382,FALSE,2021-09-21T04:08:50Z,NA,NA,NA,NA
tri02885,PACTR202005599385499,FALSE,2021-09-15T06:56:58Z,NA,NA,NA,NA
tri02888,PACTR202005622389003,FALSE,2021-09-20T14:07:03Z,NA,NA,NA,NA
tri02889,PACTR202006717277937,FALSE,2021-10-08T12:14:11Z,NA,NA,NA,Outcomes are for patients with post covid exposure
tri02890,PACTR202006899597082,FALSE,2021-09-21T00:47:25Z,NA,NA,NA,NA
tri02924,TCTR20200514001,FALSE,2021-10-06T08:07:07Z,NA,NA,NA,NA
tri02927,TCTR20200409006,FALSE,2021-10-26T12:23:44Z,NA,NA,NA,NA
tri02970,NCT04401293,FALSE,2021-10-17T08:43:40Z,NA,NA,NA,"The primary efficacy outcome was VTE (symptomatic upper or lower extremity deep vein thrombosis, asymptomatic lower extremity proximal deep vein thrombosis, symptomatic pulmonary embolism, splanchnic vein thrombosis, or cerebral sinus thrombosis), or ATE (myocardial infarction, ischemic stroke, peripheral or systemic ATE) or death from any cause within 30?+/-?2 days after randomization. Secondary outcomes included the composite primary outcome within 14 days after admission, progression to acute respiratory distress syndrome, new-onset atrial fibrillation, acute kidney injury, nonfatal cardiac arrest, endotracheal intubation, extracorporeal membrane oxygenation, and rehospitalization within 30?+/-?2 days. The principal safety outcome was major bleeding based on International Society on Thrombosis and Haemostasis criteria within 30?+/-?2 days after randomization.\n\n"
tri02972,NCT04402060,FALSE,2021-09-20T11:44:57Z,NA,NA,NA,NA
tri02995,NCT04419623,FALSE,2021-09-21T04:47:31Z,NA,NA,NA,NA
tri02996,NCT04420182,FALSE,2021-10-07T04:12:32Z,NA,NA,NA,Patient satisfaction is primary outcome.
tri02998,NCT04420273,FALSE,2021-10-06T04:57:19Z,NA,NA,NA,NA
tri03017,NCT04423042,FALSE,2021-11-09T09:53:10Z,NA,NA,NA,NA
tri03024,NCT04303507,FALSE,2021-11-01T06:58:42Z,NA,NA,NA,NA
tri03044,NCT04346628,FALSE,2021-10-19T10:27:32Z,NA,NA,NA,NA
tri03066,NCT04375735,FALSE,2021-09-20T11:36:47Z,NA,NA,NA,NA
tri03069,NCT04380961,FALSE,2021-09-16T02:47:54Z,NA,NA,NA,NA
tri03077,NCT04389450,FALSE,2021-10-18T09:30:10Z,NA,NA,NA,NA
tri03102,NCT04420299,FALSE,2021-10-01T08:22:15Z,NA,NA,NA,NA
tri03104,NCT04422509,FALSE,2021-09-27T14:11:43Z,NA,NA,NA,NA
tri03116,NCT04423861,FALSE,2021-10-14T04:03:54Z,NA,NA,NA,NA
tri03136,NCT04425837,FALSE,2021-09-23T11:55:29Z,NA,NA,NA,NA
tri03138,NCT04425915,FALSE,2021-09-24T14:25:59Z,NA,NA,NA,NA
tri03147,NCT04426318,FALSE,2021-09-22T02:59:54Z,NA,NA,NA,NA
tri03154,NCT04427631,FALSE,2021-09-18T02:41:38Z,NA,NA,NA,NA
tri03156,NCT04428021,FALSE,2021-10-06T06:40:36Z,NA,NA,NA,NA
tri03167,ACTRN12620000676910,FALSE,2021-11-09T10:05:26Z,NA,NA,NA,NA
tri03179,ChiCTR2000033936,FALSE,2021-09-23T09:31:33Z,NA,NA,NA,NA
tri03198,NCT04312243,FALSE,2021-10-22T11:02:26Z,NA,NA,NA,I was only able to access the abstract.
tri03199,NCT04333914,FALSE,2021-09-17T06:10:39Z,NA,NA,NA,"Note: The trial started off as being a trial of tocilizumab + nivolumab + GNS561 (as registered on the EUCTR, and initially on ClinicalTrials.gov) but then apparently switched to a trial of Avdoralimab, Monalizumab, and GNS561. \n\nCompletion date on EUCTR matches PCD on ClinicalTrials.gov (2021-07-06)"
tri03228,NCT04402957,FALSE,2021-10-22T11:09:44Z,NA,NA,NA,NA
tri03235,NCT04421404,FALSE,2021-10-19T06:39:23Z,NA,NA,NA,NA
tri03248,NCT04429555,FALSE,2021-11-06T10:17:55Z,NA,NA,NA,NA
tri03258,NCT04431297,FALSE,2021-10-18T14:02:45Z,NA,NA,NA,NA
tri03264,NCT04432272,FALSE,2021-09-21T00:14:11Z,NA,NA,NA,automated results had single case study that was involved in the trial
tri03289,NCT04328285,FALSE,2021-10-01T06:46:52Z,NA,NA,NA,NA
tri03300,NCT04342689,FALSE,2021-11-07T09:52:28Z,NA,NA,NA,NA
tri03306,NCT04344587,FALSE,2021-10-26T13:07:56Z,NA,NA,NA,NA
tri03313,NCT04350593,FALSE,2021-10-19T06:14:59Z,NA,NA,NA,NA
tri03317,NCT04353284,FALSE,2021-10-18T08:36:44Z,NA,NA,NA,NA
tri03325,NCT04355767,FALSE,2021-10-06T07:19:47Z,NA,NA,NA,NA
tri03337,NCT04360824,FALSE,2021-10-25T03:04:54Z,NA,NA,NA,Table 3 says primary and secondary outcomes assessed at 30 days.
tri03343,NCT04363203,FALSE,2021-10-01T07:50:04Z,NA,NA,NA,NA
tri03344,NCT04363385,FALSE,2021-10-01T04:34:44Z,NA,NA,NA,"Just sampling and describing, not really interventional."
tri03346,NCT04363853,FALSE,2021-11-09T10:09:04Z,NA,NA,NA,NA
tri03347,NCT04364737,FALSE,2021-10-06T07:30:59Z,NA,NA,NA,NA
tri03348,NCT04364763,FALSE,2021-11-09T10:12:42Z,NA,NA,NA,NA
tri03358,NCT04369742,FALSE,2021-09-15T07:34:14Z,NA,NA,NA,Suspended which does not mean withdrawn prior to enrolling any patients (so should still report)
tri03359,NCT04370834,FALSE,2021-09-22T03:48:20Z,NA,NA,NA,Basically withdrawn (only had 1 person enrolled) but they have results for that 1 person on the registry.
tri03361,NCT04371393,FALSE,2021-09-28T11:05:28Z,NA,NA,NA,"Press release announcing trial: https://investorsmedia.mesoblast.com/static-files/12fa62d6-49e1-4b1d-8fb7-0c3e184602ab\n\nOther results press releases:\nhttps://investorsmedia.mesoblast.com/static-files/f1092b15-6294-4b65-afc7-217f364a17ba\nhttps://investorsmedia.mesoblast.com/static-files/876a2e51-6238-4172-9504-fa246f303c1c\n\nTrial happened, was stopped early for futility but definitely had results. No publications though."
tri03368,NCT04373707,FALSE,2021-11-04T04:00:49Z,NA,NA,NA,NA
tri03369,NCT04373733,FALSE,2021-10-30T14:00:25Z,NA,NA,NA,NA
tri03371,NCT04375397,FALSE,2021-10-27T07:11:10Z,NA,NA,NA,NA
tri03378,NCT04377620,FALSE,2021-10-24T07:10:19Z,NA,NA,NA,NA
tri03381,NCT04382586,FALSE,2021-10-08T11:56:04Z,NA,NA,NA,NA
tri03382,NCT04382651,FALSE,2021-09-22T02:36:05Z,NA,NA,NA,NA
tri03390,NCT04386616,FALSE,2021-10-01T04:21:36Z,NA,NA,NA,EUCTR completion date matched SCD on CT.gov\n\nNot a result so keeping out of &quot;Other&quot; but news article about how it looks like this trial was probably negative since both drugs got dropped from the pipeline: https://www.biospace.com/article/roche-culls-two-covid-19-studies-during-first-quarter/
tri03392,NCT04387760,FALSE,2021-10-19T10:16:09Z,NA,NA,NA,NA
tri03396,NCT04389710,FALSE,2021-09-20T23:56:06Z,NA,NA,NA,NA
tri03405,NCT04394117,FALSE,2021-11-09T10:19:00Z,NA,NA,NA,NA
tri03412,NCT04397718,FALSE,2021-11-06T10:13:00Z,NA,NA,NA,NA
tri03416,NCT04399967,FALSE,2021-10-01T04:35:01Z,NA,NA,NA,NA
tri03424,NCT04405739,FALSE,2021-11-02T05:04:16Z,NA,NA,NA,NA
tri03425,NCT04405908,FALSE,2021-09-21T03:21:17Z,NA,NA,NA,NA
tri03435,NCT04409925,FALSE,2021-10-22T10:06:38Z,NA,NA,NA,Safety and feasibility study
tri03442,NCT04412330,FALSE,2021-09-23T09:41:10Z,NA,NA,NA,Rehab and just safety
tri03456,NCT04421508,FALSE,2021-09-19T14:45:40Z,NA,NA,NA,NA
tri03482,NCT04432766,FALSE,2021-09-20T11:46:02Z,NA,NA,NA,Withdrawn (strategic decision)
tri03484,NCT04432805,FALSE,2021-10-18T14:07:34Z,NA,NA,NA,NA
tri03513,NCT04435275,FALSE,2021-09-30T16:35:48Z,NA,NA,NA,NA
tri03519,NCT04435587,FALSE,2021-11-09T10:23:17Z,NA,NA,NA,NA
tri03532,NCT04437823,FALSE,2021-10-18T04:25:55Z,NA,NA,NA,NA
tri03540,NCT04438694,FALSE,2021-10-18T04:22:15Z,NA,NA,NA,NA
tri03553,NCT04440007,FALSE,2021-10-28T08:50:13Z,NA,NA,NA,NA
tri03570,NCT04442191,FALSE,2021-10-18T04:19:51Z,NA,NA,NA,NA
tri03573,NCT04442230,FALSE,2021-11-01T21:22:14Z,NA,NA,NA,NA
tri03585,NCT04443673,FALSE,2021-09-23T11:52:33Z,NA,NA,NA,NA
tri03590,NCT04443868,FALSE,2021-10-14T03:51:19Z,NA,NA,NA,NA
tri03599,NCT04444596,FALSE,2021-10-01T08:22:42Z,NA,NA,NA,NA
tri03610,NCT04445246,FALSE,2021-10-14T05:11:58Z,NA,NA,NA,NA
tri03618,NCT04445389,FALSE,2021-10-01T08:24:34Z,NA,NA,NA,Phase 1 vaccine safety
tri03638,NCT04446377,FALSE,2021-10-01T08:30:05Z,NA,NA,NA,NA
tri03650,NCT04448119,FALSE,2021-10-01T08:36:38Z,NA,NA,NA,NA
tri03674,ISRCTN54917435,FALSE,2021-10-30T12:53:55Z,NA,NA,NA,NA
tri03678,ISRCTN86534580,FALSE,2021-10-07T03:24:32Z,NA,NA,NA,I double-checked the PRINCIPLE website for results as well which is how I found the Colchicine preprint. Labeled as &quot;TRN search&quot;.
tri03682,ChiCTR2000034164,FALSE,2021-09-26T12:36:46Z,NA,NA,NA,NA
tri03687,EUCTR2020-001777-71,FALSE,2021-09-15T05:31:16Z,NA,NA,NA,The results posted for this trial confirm it did not recruit any patients.\nhttps://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001777-71/results
tri03718,NL8538,FALSE,2021-10-18T11:04:21Z,NA,NA,NA,NA
tri03726,NL8633,FALSE,2021-10-26T12:12:26Z,NA,NA,NA,NA
tri03730,NL8490,FALSE,2021-10-18T11:12:13Z,NA,NA,NA,NA
tri03871,EUCTR2020-001325-31,FALSE,2021-09-29T03:42:35Z,NA,NA,NA,This looks at a chemical to help with imaging and whether it works.
tri03914,ACTRN12620000787987,FALSE,2021-09-18T02:41:19Z,NA,NA,NA,NA
tri03937,ACTRN12620000811909,FALSE,2021-09-18T02:41:06Z,NA,NA,NA,NA
tri03979,EUCTR2020-002038-33,FALSE,2021-09-26T12:55:02Z,NA,NA,NA,NA
tri03983,ACTRN12620000816954,FALSE,2021-09-21T01:51:45Z,NA,NA,NA,NA
tri03997,ACTRN12620000876998,FALSE,2021-09-23T02:35:25Z,NA,NA,NA,NA
tri04003,JPRN-JapicCTI-205416,FALSE,2021-09-23T14:31:21Z,NA,NA,NA,Primary outcome is safety
tri04068,ISRCTN57085639,FALSE,2021-11-04T04:57:26Z,NA,NA,NA,NA
tri04112,ACTRN12620001048976,FALSE,2021-10-12T03:01:01Z,NA,NA,NA,NA
tri04115,ISRCTN14602359,FALSE,2021-10-01T13:49:15Z,NA,NA,NA,NA
tri04125,ISRCTN13177364,FALSE,2021-10-07T03:46:27Z,NA,NA,NA,NA
tri04173,ChiCTR2000036871,FALSE,2021-10-26T04:54:26Z,NA,NA,NA,NA
tri04202,EUCTR2020-001782-37,FALSE,2021-10-06T07:55:47Z,NA,NA,NA,NA
tri04213,EUCTR2020-002472-12,FALSE,2021-09-27T14:03:01Z,NA,NA,NA,NA
tri04227,ACTRN12620001249943,FALSE,2021-10-20T07:12:02Z,NA,NA,NA,Phase 1 safety outcomes
tri04229,ISRCTN12792822,FALSE,2021-11-08T08:03:04Z,NA,NA,NA,NA
tri04272,DRKS00022484,FALSE,2021-09-19T04:38:08Z,NA,NA,NA,NA
tri04320,DRKS00023500,FALSE,2021-09-21T03:11:39Z,NA,NA,NA,NA
tri04349,DRKS00023091,FALSE,2021-09-20T02:40:04Z,NA,NA,NA,NA
tri04415,PACTR202010519682638,FALSE,2021-10-28T01:30:14Z,NA,NA,NA,NA
tri04417,PACTR202007606032743,FALSE,2021-09-20T11:15:11Z,NA,NA,NA,Other is protocol to the metatrial this is part of - they state that this trial is registered individually
tri04419,PACTR202006760881890,FALSE,2021-09-20T02:25:38Z,NA,NA,NA,NA
tri04420,PACTR202006883882711,FALSE,2021-10-28T01:22:11Z,NA,NA,NA,NA
tri04422,PACTR202007611764617,FALSE,2021-09-21T01:55:44Z,NA,NA,NA,NA
tri04424,PACTR202008485004797,FALSE,2021-10-07T07:55:54Z,NA,NA,NA,NA
tri04426,PACTR202009769021840,FALSE,2021-09-24T14:28:39Z,NA,NA,NA,NA
tri04428,PACTR202010537777617,FALSE,2021-10-25T01:06:57Z,NA,NA,NA,NA
tri04429,PACTR202009483194545,FALSE,2021-10-07T07:56:59Z,NA,NA,NA,NA
tri04431,PACTR202010690466874,FALSE,2021-10-27T11:46:58Z,NA,NA,NA,NA
tri04433,PACTR202010472402152,FALSE,2021-10-18T11:21:36Z,NA,NA,NA,NA
tri04445,RPCEC00000340,FALSE,2021-10-30T13:16:54Z,NA,NA,NA,Phase 1 safety outcomes
tri04449,RPCEC00000345,FALSE,2021-10-26T12:43:02Z,NA,NA,NA,Phase 1 safety outcomes
tri04450,RPCEC00000346,FALSE,2021-10-26T12:42:15Z,NA,NA,NA,Phase 1 safety outcomes
tri04465,PER-034-20,FALSE,2021-10-18T11:01:35Z,NA,NA,NA,NA
tri04506,CTRI/2020/05/025214,FALSE,2021-09-21T04:32:45Z,NA,NA,NA,NA
tri04563,CTRI/2020/05/025369,FALSE,2021-09-21T02:52:25Z,NA,NA,NA,NA
tri04570,CTRI/2020/05/025429,FALSE,2021-10-22T10:50:37Z,NA,NA,NA,NA
tri04612,CTRI/2020/06/025664,FALSE,2021-09-21T03:57:22Z,NA,NA,NA,NA
tri04626,CTRI/2020/06/025766,FALSE,2021-10-31T08:38:36Z,NA,NA,NA,NA
tri04628,CTRI/2020/06/025768,FALSE,2021-09-30T07:55:43Z,NA,NA,NA,NA
tri04641,CTRI/2020/06/025803,FALSE,2021-09-30T07:34:44Z,NA,NA,NA,related (other)? https://pubmed.ncbi.nlm.nih.gov/34363351/
tri04643,CTRI/2020/06/025849,FALSE,2021-09-21T02:45:06Z,NA,NA,NA,NA
tri04647,CTRI/2020/06/025844,FALSE,2021-09-21T02:41:51Z,NA,NA,NA,NA
tri04659,CTRI/2020/06/025957,FALSE,2021-09-21T04:39:20Z,NA,NA,NA,NA
tri04818,CTRI/2020/07/026793,FALSE,2021-10-13T02:16:27Z,NA,NA,NA,there is a very short summary of results in the registry but like 6 sentences long..?
tri04829,CTRI/2020/07/026835,FALSE,2021-10-15T17:45:21Z,NA,NA,NA,NA
tri04860,CTRI/2020/08/027032,FALSE,2021-09-21T02:37:17Z,NA,NA,NA,NA
tri04912,CTRI/2020/08/027224,FALSE,2021-10-14T07:32:35Z,NA,NA,NA,NA
tri04913,CTRI/2020/08/027225,FALSE,2021-09-21T02:28:44Z,NA,NA,NA,NA
tri04931,CTRI/2020/08/027286,FALSE,2021-10-13T02:30:03Z,NA,NA,NA,NA
tri04991,CTRI/2020/09/027687,FALSE,2021-09-21T02:21:52Z,NA,NA,NA,NA
tri05017,CTRI/2020/09/027914,FALSE,2021-10-05T06:49:34Z,NA,NA,NA,Short results paragraph in the registry but does not include enough detail to count.
tri05043,CTRI/2020/09/028131,FALSE,2021-10-01T12:06:11Z,NA,NA,NA,NA
tri05076,CTRI/2020/10/028333,FALSE,2021-10-22T05:03:05Z,NA,NA,NA,NA
tri05083,CTRI/2020/10/028364,FALSE,2021-10-22T10:16:19Z,NA,NA,NA,NA
tri05116,CTRI/2020/10/028568,FALSE,2021-10-15T17:50:38Z,NA,NA,NA,NA
tri05118,CTRI/2020/10/028537,FALSE,2021-10-14T07:24:52Z,NA,NA,NA,NA
tri05143,CTRI/2020/11/028811,FALSE,2021-09-22T03:00:16Z,NA,NA,NA,Rehab
tri05153,CTRI/2020/11/028903,FALSE,2021-10-14T07:24:03Z,NA,NA,NA,NA
tri05179,CTRI/2020/11/029038,FALSE,2021-10-22T10:13:33Z,NA,NA,NA,NA
tri05203,CTRI/2020/11/029166,FALSE,2021-10-28T09:58:46Z,NA,NA,NA,NA
tri05213,CTRI/2020/11/029265,FALSE,2021-10-03T04:02:27Z,NA,NA,NA,Brief summary on registry has some results but does not meet ICTRP minimum criteria.
tri05239,ISRCTN11466448,FALSE,2021-09-23T09:43:09Z,NA,NA,NA,NA
tri05241,ISRCTN11970082,FALSE,2021-09-29T04:01:50Z,NA,NA,NA,can also access full journal article from July issue here: https://www.ima-india.org/ima/left-side-bar.php?pid=347\n\nCouldn't get an exact publication date but knew it was july and the paper said it was accepted on 2 July 2021 so that is marginally more accurate than defaulting to the 1st of the month.
tri05344,NCT04319731,FALSE,2021-09-30T16:21:16Z,NA,NA,NA,NA
tri05361,NCT04350723,FALSE,2021-11-01T05:46:46Z,NA,NA,NA,NA
tri05373,NCT04359862,FALSE,2021-10-01T07:34:30Z,NA,NA,NA,NA
tri05378,NCT04367168,FALSE,2021-10-25T02:52:18Z,NA,NA,NA,NA
tri05386,NCT04376034,FALSE,2021-10-01T08:01:18Z,NA,NA,NA,NA
tri05393,NCT04381845,FALSE,2021-09-23T09:31:01Z,NA,NA,NA,NA
tri05404,NCT04395430,FALSE,2021-10-29T00:42:58Z,NA,NA,NA,NA
tri05421,NCT04421612,FALSE,2021-09-22T03:01:07Z,NA,NA,NA,NA
tri05447,NCT04450004,FALSE,2021-10-31T08:37:12Z,NA,NA,NA,"While long-term secondary follow-up is ongoing, the published article includes full results for the primary outcomes which are through Day 21 for all expected pts."
tri05475,NCT04452812,FALSE,2021-10-01T08:50:37Z,NA,NA,NA,NA
tri05492,NCT04453852,FALSE,2021-09-27T14:07:05Z,NA,NA,NA,NA
tri05527,NCT04457726,FALSE,2021-10-01T08:54:28Z,NA,NA,NA,Primary outcome is safety measures
tri05530,NCT04458298,FALSE,2021-10-28T08:54:17Z,NA,NA,NA,Primary outcomes are safety and tolerability
tri05532,NCT04458363,FALSE,2021-09-21T04:02:03Z,NA,NA,NA,NA
tri05534,NCT04458948,FALSE,2021-10-01T09:00:23Z,NA,NA,NA,NA
tri05536,NCT04459286,FALSE,2021-10-01T13:00:14Z,NA,NA,NA,NA
tri05553,NCT04460014,FALSE,2021-10-01T10:07:51Z,NA,NA,NA,NA
tri05557,NCT04460183,FALSE,2021-09-19T03:20:21Z,NA,NA,NA,NA
tri05565,NCT04460651,FALSE,2021-11-01T21:08:19Z,NA,NA,NA,NA
tri05567,NCT04460677,FALSE,2021-09-30T16:24:13Z,NA,NA,NA,NA
tri05571,NCT04461379,FALSE,2021-09-20T11:48:28Z,NA,NA,NA,NA
tri05572,NCT04461925,FALSE,2021-10-18T04:17:28Z,NA,NA,NA,NA
tri05601,NCT04465695,FALSE,2021-10-26T09:43:12Z,NA,NA,NA,NA
tri05608,NCT04466540,FALSE,2021-09-20T11:50:19Z,NA,NA,NA,NA
tri05611,NCT04466657,FALSE,2021-09-23T11:46:28Z,NA,NA,NA,NA
tri05624,NCT04468009,FALSE,2021-10-01T18:23:31Z,NA,NA,NA,NA
tri05655,NCT04470622,FALSE,2021-11-06T10:06:57Z,NA,NA,NA,NA
tri05669,NCT04472494,FALSE,2021-09-19T04:15:34Z,NA,NA,NA,NA
tri05706,NCT04475302,FALSE,2021-10-30T13:54:19Z,NA,NA,NA,NA
tri05712,NCT04475601,FALSE,2021-10-26T09:58:32Z,NA,NA,NA,EUCTR completion date: 2021-05-26\n\nPreprint protocol here: 10.21203/rs.3.rs-229140/v1
tri05718,NCT04476680,FALSE,2021-10-20T07:46:32Z,NA,NA,NA,NA
tri05723,NCT04476927,FALSE,2021-10-18T04:14:42Z,NA,NA,NA,Device evaluation
tri05736,NCT04477993,FALSE,2021-10-06T06:42:44Z,NA,NA,NA,NA
tri05739,NCT04478539,FALSE,2021-11-09T15:38:48Z,NA,NA,NA,NA
tri05752,NCT04479540,FALSE,2021-10-18T04:13:59Z,NA,NA,NA,NA
tri05774,NCT04481685,FALSE,2021-10-08T06:17:24Z,NA,NA,NA,The trial's results was potentially published here: https://www.embase.com/search/results?subaction=viewrecord&id=L635308109 which was linked on cochrane but I am unable to access. \nAlso found an abstract with trial number: https://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2021.203.1_MeetingAbstracts.A1287
tri05782,NCT04482647,FALSE,2021-10-18T14:44:44Z,NA,NA,NA,NA
tri05788,NCT04483635,FALSE,2021-10-26T13:38:28Z,NA,NA,NA,NA
tri05789,NCT04483752,FALSE,2021-09-23T11:44:04Z,NA,NA,NA,NA
tri05810,NCT04486482,FALSE,2021-10-06T04:46:22Z,NA,NA,NA,NA
tri05816,NCT04487210,FALSE,2021-10-30T14:07:32Z,NA,NA,NA,Phase 1 safety outcomes
tri05817,NCT04487444,FALSE,2021-10-01T09:06:39Z,NA,NA,NA,NA
tri05867,NCT04492527,FALSE,2021-10-07T04:12:08Z,NA,NA,NA,NA
tri05886,NCT04495101,FALSE,2021-10-19T06:50:57Z,NA,NA,NA,NA
tri05891,NCT04495842,FALSE,2021-10-01T09:01:06Z,NA,NA,NA,NA
tri05897,NCT04496245,FALSE,2021-11-05T08:02:32Z,NA,NA,NA,NA
tri05917,NCT04497922,FALSE,2021-11-08T08:51:49Z,NA,NA,NA,NA
tri05918,NCT04497987,FALSE,2021-11-05T07:39:56Z,NA,NA,NA,NA
tri05938,NCT04500366,FALSE,2021-11-08T09:12:05Z,NA,NA,NA,NA
tri05945,NCT04501445,FALSE,2021-09-23T09:35:49Z,NA,NA,NA,NA
tri05959,NCT04502667,FALSE,2021-09-23T11:42:18Z,NA,NA,NA,NA
tri05971,NCT04505761,FALSE,2021-09-30T06:21:22Z,NA,NA,NA,NA
tri05982,NCT04508075,FALSE,2021-10-01T04:04:26Z,NA,NA,NA,This result is so recent it isn't even pubmed indexed yet at time of search. PMC ID: PMC8461222
tri05992,NCT04508985,FALSE,2021-09-20T14:03:51Z,NA,NA,NA,NA
tri06001,NCT04510207,FALSE,2021-11-05T07:57:24Z,NA,NA,NA,NA
tri06003,NCT04510402,FALSE,2021-09-23T11:40:14Z,NA,NA,NA,"healthy participants, no vaccination, no primary efficacy outcome"
tri06005,NCT04510454,FALSE,2021-10-28T09:31:03Z,NA,NA,NA,NA
tri06010,NCT04510662,FALSE,2021-10-01T09:17:49Z,NA,NA,NA,NA
tri06012,NCT04511650,FALSE,2021-10-07T03:10:42Z,NA,NA,NA,Leaving this out of the other category but there is some mention of the trial status here:\nhttps://last10k.com/sec-filings/arpo
tri06023,NCT04513184,FALSE,2021-10-01T09:21:17Z,NA,NA,NA,NA
tri06026,NCT04513470,FALSE,2021-09-19T04:11:52Z,NA,NA,NA,NA
tri06031,NCT04513990,FALSE,2021-11-08T09:08:42Z,NA,NA,NA,diagnostic evaluation
tri06034,NCT04514302,FALSE,2021-09-23T11:34:06Z,NA,NA,NA,NA
tri06038,NCT04514900,FALSE,2021-10-01T13:49:51Z,NA,NA,NA,NA
tri06045,NCT04516564,FALSE,2021-10-01T09:23:08Z,NA,NA,NA,Primary outcomes is incidence of adverse events in healthy subjects
tri06047,NCT04516759,FALSE,2021-10-19T06:01:48Z,NA,NA,NA,NA
tri06052,NCT04516915,FALSE,2021-10-18T04:01:26Z,NA,NA,NA,NA
tri06056,NCT04517006,FALSE,2021-09-28T11:10:35Z,NA,NA,NA,NA
tri06070,NCT04519216,FALSE,2021-10-14T05:12:27Z,NA,NA,NA,NA
tri06081,NCT04520620,FALSE,2022-10-04T10:30:20Z,NA,NA,NA,NA
tri06084,NCT04521036,FALSE,2021-11-09T15:40:29Z,NA,NA,NA,NA
tri06097,NCT04522830,FALSE,2021-10-13T02:35:10Z,NA,NA,NA,NA
tri06107,NCT04524507,FALSE,2021-09-26T12:36:06Z,NA,NA,NA,Non-results press release announcing trial: https://news.unchealthcare.org/2020/09/unc-ramps-up-convalescent-plasma-clinical-trial-to-fight-covid-19/
tri06110,NCT04524663,FALSE,2021-10-26T12:57:28Z,NA,NA,NA,NA
tri06120,NCT04525820,FALSE,2021-10-28T09:03:41Z,NA,NA,NA,Protocol is a preprint so not sure what publication type to select
tri06127,NCT04526821,FALSE,2021-10-14T05:31:31Z,NA,NA,NA,NA
tri06128,NCT04526912,FALSE,2021-10-08T11:56:26Z,NA,NA,NA,NA
tri06131,NCT04527198,FALSE,2021-10-18T14:06:56Z,NA,NA,NA,NA
tri06145,NCT04528641,FALSE,2021-10-14T05:46:26Z,NA,NA,NA,Vaccine phase 1 safety outcomes
tri06146,NCT04528667,FALSE,2021-10-28T09:37:53Z,NA,NA,NA,NA
tri06147,NCT04528771,FALSE,2021-10-01T09:27:05Z,NA,NA,NA,NA
tri06148,NCT04528888,FALSE,2021-11-01T21:38:03Z,NA,NA,NA,NA
tri06159,NCT04530396,FALSE,2021-10-28T09:49:34Z,NA,NA,NA,NA
tri06181,NCT04531774,FALSE,2021-09-23T09:30:35Z,NA,NA,NA,NA
tri06182,NCT04532294,FALSE,2021-11-04T04:58:01Z,NA,NA,NA,Primary outcomes only for safety in healthy participants.
tri06187,NCT04532931,FALSE,2021-11-09T15:47:25Z,NA,NA,NA,NA
tri06206,NCT04535167,FALSE,2021-10-30T13:15:15Z,NA,NA,NA,NA
tri06209,NCT04535700,FALSE,2021-10-01T09:34:21Z,NA,NA,NA,NA
tri06210,NCT04535778,FALSE,2021-09-23T09:35:30Z,NA,NA,NA,NA
tri06211,NCT04535791,FALSE,2021-10-07T02:55:03Z,NA,NA,NA,NA
tri06215,NCT04536090,FALSE,2021-10-14T03:50:26Z,NA,NA,NA,NA
tri06223,NCT04537130,FALSE,2021-11-09T15:48:00Z,NA,NA,NA,phase 1 safety outcomes
tri06224,NCT04537208,FALSE,2021-11-01T05:53:23Z,NA,NA,NA,NA
tri06235,NCT04537949,FALSE,2021-10-01T13:53:51Z,NA,NA,NA,Phase 1 safety outcomes
tri06240,NCT04539275,FALSE,2021-10-22T11:15:54Z,NA,NA,NA,NA
tri06243,NCT04539821,FALSE,2021-09-23T09:25:52Z,NA,NA,NA,NA
tri06248,NCT04540393,FALSE,2021-10-27T07:19:13Z,NA,NA,NA,Also withdrawn
tri06260,NCT04542122,FALSE,2021-11-08T09:05:17Z,NA,NA,NA,NA
tri06266,NCT04542408,FALSE,2021-10-14T03:52:43Z,NA,NA,NA,NA
tri06279,NCT04542993,FALSE,2021-10-05T07:42:36Z,NA,NA,NA,NA
tri06281,NCT04543760,FALSE,2021-09-22T02:54:24Z,NA,NA,NA,NA
tri06299,NCT04547127,FALSE,2021-10-05T07:39:35Z,NA,NA,NA,NA
tri06305,NCT04547660,FALSE,2021-10-01T16:17:22Z,NA,NA,NA,NA
tri06308,NCT04548531,FALSE,2021-11-08T09:02:57Z,NA,NA,NA,NA
tri06314,NCT04549337,FALSE,2021-11-08T08:17:14Z,NA,NA,NA,NA
tri06325,NCT04551339,FALSE,2021-11-05T09:52:02Z,NA,NA,NA,NA
tri06327,NCT04551547,FALSE,2021-10-18T11:15:46Z,NA,NA,NA,Phase 1 safety outcomes
tri06362,NCT04558021,FALSE,2021-09-19T04:09:17Z,NA,NA,NA,NA
tri06379,NCT04559074,FALSE,2021-11-08T09:01:22Z,NA,NA,NA,NA
tri06393,NCT04561154,FALSE,2021-09-23T09:30:15Z,NA,NA,NA,NA
tri06401,NCT04563208,FALSE,2021-09-23T11:30:41Z,NA,NA,NA,NA
tri06404,NCT04563650,FALSE,2021-09-23T09:29:44Z,NA,NA,NA,NA
tri06405,NCT04563676,FALSE,2021-09-23T09:29:24Z,NA,NA,NA,NA
tri06416,NCT04565665,FALSE,2021-10-19T10:42:19Z,NA,NA,NA,NA
tri06451,NCT04569383,FALSE,2021-10-14T03:39:56Z,NA,NA,NA,NA
tri06464,NCT04572360,FALSE,2021-10-18T14:56:36Z,NA,NA,NA,rehab
tri06466,NCT04572412,FALSE,2021-10-22T10:05:37Z,NA,NA,NA,Feasibility study
tri06476,NCT04573855,FALSE,2021-09-23T11:26:32Z,NA,NA,NA,NA
tri06481,NCT04574869,FALSE,2021-10-01T09:36:55Z,NA,NA,NA,Primary outcome is measuring frequency and severity of adverse events
tri06494,NCT04577534,FALSE,2021-10-30T13:14:36Z,NA,NA,NA,NA
tri06495,NCT04578158,FALSE,2021-10-06T07:04:46Z,NA,NA,NA,NA
tri06497,NCT04578210,FALSE,2021-09-20T11:59:33Z,NA,NA,NA,NA
tri06507,NCT04579640,FALSE,2021-10-30T14:36:59Z,NA,NA,NA,NA
tri06527,NCT04581954,FALSE,2021-10-30T14:30:03Z,NA,NA,NA,NA
tri06529,NCT04582214,FALSE,2021-09-20T11:55:46Z,NA,NA,NA,NA
tri06531,NCT04582318,FALSE,2021-10-30T07:42:01Z,NA,NA,NA,A primary endpoint for Part 2 is efficacy.\n\nThis is another study but cites the results from this study as &quot;on file&quot; https://www.sciencedirect.com/science/article/pii/S0002939421004414
tri06533,NCT04582344,FALSE,2021-10-14T05:11:18Z,NA,NA,NA,NA
tri06534,NCT04583228,FALSE,2021-10-13T07:22:54Z,NA,NA,NA,Safety only (DLT = dose-limiting toxicity) outcomes in phase 1 healthy adults.
tri06555,NCT04584710,FALSE,2021-10-14T05:39:52Z,NA,NA,NA,NA
tri06559,NCT04586153,FALSE,2021-10-13T07:07:00Z,NA,NA,NA,NA
tri06574,NCT04589936,FALSE,2021-11-09T15:55:33Z,NA,NA,NA,There is an embase link on cochrane: https://www.embase.com/search/results?subaction=viewrecord&id=L635307104
tri06576,NCT04590053,FALSE,2021-09-23T11:25:02Z,NA,NA,NA,"healthy participants, no vaccination, efficacy outcomes are secondary -> exclude"
tri06598,NCT04592354,FALSE,2021-11-08T09:00:38Z,NA,NA,NA,NA
tri06602,NCT04593069,FALSE,2021-09-23T13:01:31Z,NA,NA,NA,Neurocognitive assessment for long term covid side effects
tri06614,NCT04594525,FALSE,2021-10-14T05:33:28Z,NA,NA,NA,NA
tri06636,NCT04597775,FALSE,2021-09-19T03:52:19Z,NA,NA,NA,NA
tri06641,NCT04598581,FALSE,2021-10-19T10:38:26Z,NA,NA,NA,NA
tri06642,NCT04598594,FALSE,2021-10-18T11:15:09Z,NA,NA,NA,NA
tri06651,NCT04600999,FALSE,2021-11-09T19:03:59Z,NA,NA,NA,NA
tri06657,NCT04602286,FALSE,2021-10-18T14:51:26Z,NA,NA,NA,Pain
tri06658,NCT04602312,FALSE,2021-10-18T14:51:06Z,NA,NA,NA,NA
tri06663,NCT04602871,FALSE,2021-09-22T02:57:06Z,NA,NA,NA,NA
tri06675,NCT04603924,FALSE,2021-11-01T21:31:01Z,NA,NA,NA,NA
tri06679,NCT04604223,FALSE,2021-11-05T09:46:38Z,NA,NA,NA,NA
tri06681,NCT04604327,FALSE,2021-10-18T03:14:01Z,NA,NA,NA,I was only able to access the abstract.
tri06694,NCT04606563,FALSE,2021-11-09T19:09:07Z,NA,NA,NA,NA
tri06696,NCT04607915,FALSE,2021-10-01T10:05:33Z,NA,NA,NA,NA
tri06699,NCT04608214,FALSE,2021-10-18T14:19:32Z,NA,NA,NA,"From study leader, but not results. Says Phase 2 trials set to start soon:\nhttps://academic.oup.com/cid/article/71/16/2191/5837360"
tri06700,NCT04608305,FALSE,2021-10-14T05:53:02Z,NA,NA,NA,Safety and immunogenicity outcomes
tri06703,NCT04609371,FALSE,2021-09-30T16:24:37Z,NA,NA,NA,NA
tri06704,NCT04609423,FALSE,2021-10-18T13:28:59Z,NA,NA,NA,NA
tri06705,NCT04609462,FALSE,2021-09-28T10:49:58Z,NA,NA,NA,NA
tri06713,NCT04610489,FALSE,2021-09-19T03:47:45Z,NA,NA,NA,diagnostic\n
tri06724,NCT04611425,FALSE,2021-10-28T03:37:15Z,NA,NA,NA,NA
tri06736,NCT04614025,FALSE,2021-10-14T03:34:34Z,NA,NA,NA,NA
tri06745,NCT04615429,FALSE,2021-10-01T16:58:27Z,NA,NA,NA,NA
tri06748,NCT04615741,FALSE,2021-09-22T02:56:16Z,NA,NA,NA,NA
tri06753,NCT04616001,FALSE,2021-10-14T06:20:00Z,NA,NA,NA,I have included an abstract that I thought pertained to this trial? Also found the corresponding preprint (keywords on google scholar) but has different NCT number so maybe not: \nhttps://www.medrxiv.org/content/10.1101/2020.07.20.20157891v1.full-text
tri06757,NCT04616989,FALSE,2021-09-23T05:58:26Z,NA,NA,NA,NA
tri06758,NCT04617119,FALSE,2021-09-24T01:34:09Z,NA,NA,NA,NA
tri06762,NCT04618042,FALSE,2021-10-26T12:19:41Z,NA,NA,NA,NA
tri06771,NCT04619628,FALSE,2021-10-30T14:40:21Z,NA,NA,NA,Phase 1 safety outcomes
tri06774,NCT04619719,FALSE,2021-10-31T07:09:08Z,NA,NA,NA,NA
tri06777,NCT04621071,FALSE,2021-10-22T11:06:28Z,NA,NA,NA,NA
tri06779,NCT04621123,FALSE,2021-11-05T09:41:17Z,NA,NA,NA,NA
tri06780,NCT04621149,FALSE,2021-10-01T09:44:12Z,NA,NA,NA,NA
tri06782,NCT04621461,FALSE,2021-10-14T05:32:12Z,NA,NA,NA,NA
tri06787,NCT04622865,FALSE,2021-11-09T19:13:10Z,NA,NA,NA,NA
tri06789,NCT04623021,FALSE,2021-10-24T07:32:32Z,NA,NA,NA,NA
tri06796,NCT04623619,FALSE,2021-10-13T06:48:20Z,NA,NA,NA,NA
tri06814,NCT04627233,FALSE,2021-10-01T09:49:00Z,NA,NA,NA,NA
tri06823,NCT04628143,FALSE,2021-10-18T13:53:17Z,NA,NA,NA,NA
tri06834,NCT04629989,FALSE,2021-10-06T05:05:23Z,NA,NA,NA,NA
tri06836,NCT04630054,FALSE,2021-10-14T06:41:43Z,NA,NA,NA,NA
tri06839,NCT04631380,FALSE,2021-09-19T03:46:57Z,NA,NA,NA,NA
tri06849,NCT04632368,FALSE,2021-10-18T14:55:25Z,NA,NA,NA,NA
tri06853,NCT04632706,FALSE,2021-10-06T08:01:43Z,NA,NA,NA,Primary outcome is pharmokinetics
tri06856,NCT04633772,FALSE,2021-09-23T13:56:02Z,NA,NA,NA,NA
tri06861,NCT04634370,FALSE,2021-10-01T09:53:34Z,NA,NA,NA,NA
tri06862,NCT04634422,FALSE,2021-11-09T19:24:07Z,NA,NA,NA,NA
tri06864,NCT04635241,FALSE,2021-10-22T10:48:28Z,NA,NA,NA,NA
tri06875,NCT04636320,FALSE,2021-09-19T03:42:35Z,NA,NA,NA,diagnostic?
tri06883,NCT04637906,FALSE,2021-10-20T07:37:06Z,NA,NA,NA,NA
tri06884,NCT04638634,FALSE,2021-10-30T14:07:03Z,NA,NA,NA,NA
tri06886,NCT04639349,FALSE,2021-09-30T16:25:04Z,NA,NA,NA,NA
tri06890,NCT04640181,FALSE,2021-10-30T13:50:14Z,NA,NA,NA,NA
tri06892,NCT04640402,FALSE,2021-10-15T17:30:57Z,NA,NA,NA,"differnt trial result? https://www.nature.com/articles/s41392-021-00692-3 : Before the initiation of the phase 1 trial, an independent data and safety monitoring committee was established. The committee evaluated and reviewed the safety data within 7 days after the first dose vaccination to guarantee that sufficient waiting time was available between dose escalation. These two studies have been registered on ClinicalTrials.gov, NCT04530656 and NCT04640402"
tri06896,NCT04641481,FALSE,2021-10-01T03:54:15Z,NA,NA,NA,"Note, the abstract section on MedrXiv has both the wrong trial ID (that's the Phase 1/2 ID NCT04471519) and the correct one (NCT04641481) listed but the paper (and Phase) confirms this is NCT04641481.\n\nQuote for completion date: At the data cut-off date of May 7, 2021, a total of 23,803 (92.3%) participants had a median of 146 days of safety data available after the first dose.\n\nCross-reg noted here: https://covid19.trackvaccines.org/vaccines/9/"
tri06906,NCT04643054,FALSE,2021-09-23T12:49:05Z,NA,NA,NA,NA
tri06918,NCT04644185,FALSE,2021-11-05T07:10:48Z,NA,NA,NA,NA
tri06924,NCT04644705,FALSE,2021-10-12T03:57:56Z,NA,NA,NA,NA
tri06931,NCT04646044,FALSE,2021-10-26T13:30:17Z,NA,NA,NA,"Safety, tolerability, and pharmacokinetic outcomes"
tri06937,NCT04646655,FALSE,2021-10-18T13:43:36Z,NA,NA,NA,"I don't have access but from what Cochrane shows, this looks like an abstract explaining the trial, not actually results and not really a protocol so put as other:\nhttp://www.bloodtransfusion.it/articolo.aspx?idart=003341"
tri06938,NCT04647305,FALSE,2021-10-06T07:12:14Z,NA,NA,NA,NA
tri06939,NCT04647604,FALSE,2021-10-22T11:18:51Z,NA,NA,NA,NA
tri06952,NCT04456595,FALSE,2021-10-27T11:09:35Z,NA,NA,NA,NA
tri06954,NCT04463602,FALSE,2021-09-26T02:46:50Z,NA,NA,NA,NA
tri06960,NCT04472728,FALSE,2021-11-01T08:07:19Z,NA,NA,NA,NA
tri06964,NCT04479631,FALSE,2021-09-28T08:41:41Z,NA,NA,NA,Phase 1 healthy adults
tri06972,NCT04497649,FALSE,2021-10-22T10:44:30Z,NA,NA,NA,NA
tri06974,NCT04498247,FALSE,2021-10-01T10:04:08Z,NA,NA,NA,Phase 1 vaccine safety
tri06979,NCT04505722,FALSE,2021-10-29T06:22:34Z,NA,NA,NA,result or not? https://www.medrxiv.org/content/10.1101/2021.09.10.21263385v2
tri06983,PER-059-20,FALSE,2023-01-05T05:56:23Z,NA,NA,NA,NA
tri06998,NCT04539262,FALSE,2021-10-15T03:33:30Z,NA,NA,NA,"not able to contruct specific search strings (e.g. no author's name), therefore might be easy to miss results on this one?"
tri07005,NCT04552379,FALSE,2021-10-22T10:41:20Z,NA,NA,NA,NA
tri07015,NCT04564716,FALSE,2021-10-01T11:33:21Z,NA,NA,NA,NA
tri07020,NCT04568122,FALSE,2021-09-23T09:44:58Z,NA,NA,NA,diagnostics
tri07021,NCT04569786,FALSE,2021-10-05T04:06:49Z,NA,NA,NA,NA
tri07023,NCT04575038,FALSE,2021-10-22T05:03:12Z,NA,NA,NA,NA
tri07027,NCT04579393,FALSE,2021-10-06T07:32:06Z,NA,NA,NA,Primary outcome is incidence of SAEs
tri07043,NCT04602507,FALSE,2021-10-01T11:37:38Z,NA,NA,NA,NA
tri07046,NCT04604184,FALSE,2021-10-06T07:34:40Z,NA,NA,NA,NA
tri07047,NCT04605588,FALSE,2021-11-05T07:45:29Z,NA,NA,NA,NA
tri07050,NCT04606784,FALSE,2021-10-06T05:37:10Z,NA,NA,NA,Primary outcomes is incidence and severity of adverse events
tri07058,NCT04625725,FALSE,2021-10-26T13:34:33Z,NA,NA,NA,NA
tri07059,NCT04625972,FALSE,2021-10-19T06:55:53Z,NA,NA,NA,NA
tri07064,NCT04634903,FALSE,2021-09-30T16:34:20Z,NA,NA,NA,NA
tri07066,NCT04637867,FALSE,2021-10-07T03:45:51Z,NA,NA,NA,Seroprevalence
tri07067,NCT04638673,FALSE,2021-10-18T14:06:36Z,NA,NA,NA,rehab
tri07070,NCT04640168,FALSE,2021-10-22T04:48:41Z,NA,NA,NA,The press release notes the trial ended after meeting futility definition.
tri07074,NCT04643678,FALSE,2021-10-22T05:28:51Z,NA,NA,NA,NA
tri07080,NCT04647747,FALSE,2021-10-01T13:19:04Z,NA,NA,NA,NA
tri07090,NCT04649736,FALSE,2021-11-08T07:09:43Z,NA,NA,NA,"Post-hospital care, primary outcome is walk distance"
tri07104,NCT04651374,FALSE,2021-10-01T11:38:25Z,NA,NA,NA,Primary outcomes are safety and feasibility
tri07109,NCT04652102,FALSE,2021-10-12T02:41:18Z,NA,NA,NA,NA
tri07115,NCT04652674,FALSE,2021-10-18T14:52:01Z,NA,NA,NA,NA
tri07124,NCT04654481,FALSE,2021-09-24T01:54:42Z,NA,NA,NA,NA
tri07126,NCT04655586,FALSE,2021-10-20T07:26:42Z,NA,NA,NA,NA
tri07128,JPRN-jRCT2051200088,FALSE,2022-10-05T01:54:20Z,NA,NA,NA,I used the completion dates from clinicaltrials.gov because I could not find ones on JCRT link
tri07141,NCT04657497,FALSE,2021-10-07T02:57:14Z,NA,NA,NA,NA
tri07146,NCT04658979,FALSE,2021-09-30T16:26:59Z,NA,NA,NA,NA
tri07148,NCT04659122,FALSE,2021-11-09T19:30:34Z,NA,NA,NA,Safety and tolerability primary outcomes
tri07156,NCT04659460,FALSE,2021-10-01T11:42:58Z,NA,NA,NA,NA
tri07158,NCT04659486,FALSE,2021-10-22T10:37:07Z,NA,NA,NA,Occurring during recovery phase
tri07160,NCT04659746,FALSE,2021-09-23T08:46:41Z,NA,NA,NA,NA
tri07172,NCT04661540,FALSE,2021-10-28T08:58:38Z,NA,NA,NA,NA
tri07177,NCT04661930,FALSE,2021-10-22T10:36:15Z,NA,NA,NA,NA
tri07178,NCT04662021,FALSE,2021-09-23T08:44:33Z,NA,NA,NA,NA
tri07183,NCT04662671,FALSE,2021-10-29T00:24:46Z,NA,NA,NA,NA
tri07184,NCT04662684,FALSE,2021-10-19T10:21:39Z,NA,NA,NA,NA
tri07186,NCT04663555,FALSE,2021-11-01T06:40:15Z,NA,NA,NA,NA
tri07187,NCT04663594,FALSE,2021-09-30T16:29:07Z,NA,NA,NA,NA
tri07192,NCT04663945,FALSE,2021-10-18T14:05:08Z,NA,NA,NA,NA
tri07193,NCT04664010,FALSE,2021-09-19T03:40:54Z,NA,NA,NA,NA
tri07207,NCT04666012,FALSE,2021-10-01T13:40:01Z,NA,NA,NA,Phase 1 safety outcomes
tri07222,NCT04667286,FALSE,2021-11-01T21:55:06Z,NA,NA,NA,NA
tri07228,ISRCTN19845486,FALSE,2021-09-30T16:25:58Z,NA,NA,NA,NA
tri07229,ISRCTN77689525,FALSE,2021-09-28T11:10:05Z,NA,NA,NA,NA
tri07231,ISRCTN77941736,FALSE,2021-09-30T16:26:31Z,NA,NA,NA,NA
tri07252,NL8477,FALSE,2021-10-06T08:00:53Z,NA,NA,NA,Primary outcome is number of days absence from work
tri07256,NL8842,FALSE,2021-09-23T10:04:15Z,NA,NA,NA,NA
tri07265,NL9007,FALSE,2021-09-23T05:57:31Z,NA,NA,NA,NA
tri07270,NL8954,FALSE,2021-10-31T08:23:21Z,NA,NA,NA,"Monitoring, not treatment"
tri07274,NL9081,FALSE,2021-09-23T10:03:13Z,NA,NA,NA,"I think this counts as rehab? Even if not, it's seeing whether people can go home with support. Not really treatment or prevention directly."
tri07288,NCT04417335,FALSE,2021-10-18T04:29:53Z,NA,NA,NA,NA
tri07294,IRCT20200621047859N2,FALSE,2021-09-23T07:33:59Z,NA,NA,NA,NA
tri07297,IRCT20170611034452N12,FALSE,2021-09-24T14:57:31Z,NA,NA,NA,NA
tri07300,IRCT20200927048849N1,FALSE,2021-09-21T01:46:14Z,NA,NA,NA,Study is on healthy volunteers but primary outcome is incidence of covid symptoms
tri07338,NCT04679415,FALSE,2021-10-22T10:25:17Z,NA,NA,NA,NA
tri07339,NCT04681001,FALSE,2021-10-17T08:31:48Z,NA,NA,NA,I think COVID-19 symptom score is a good enough outcome for inclusion on prevention basis.
tri07345,NCT04695821,FALSE,2021-09-23T08:44:05Z,NA,NA,NA,NA
tri07347,NCT04696601,FALSE,2021-10-14T07:32:05Z,NA,NA,NA,NA
tri07354,NCT04699227,FALSE,2021-10-22T10:22:13Z,NA,NA,NA,NA
tri07364,NCT04703478,FALSE,2021-11-08T08:58:03Z,NA,NA,NA,NA
tri07377,NCT04686773,FALSE,2021-10-22T10:20:29Z,NA,NA,NA,Safety outcomes
tri07380,NCT04705753,FALSE,2021-09-21T03:10:04Z,NA,NA,NA,NA
tri07381,NCT04706039,FALSE,2021-09-30T16:29:32Z,NA,NA,NA,NA
tri07387,NCT04707742,FALSE,2021-09-21T01:28:01Z,NA,NA,NA,NA
tri07388,NCT04707820,FALSE,2021-11-09T19:31:45Z,NA,NA,NA,NA
tri07390,NCT04708158,FALSE,2021-10-17T08:06:33Z,NA,NA,NA,NA
tri07395,NCT04709172,FALSE,2021-10-22T10:19:45Z,NA,NA,NA,NA
tri07402,NCT04712279,FALSE,2021-10-01T11:53:25Z,NA,NA,NA,NA
tri07408,NCT04713878,FALSE,2021-09-19T04:20:58Z,NA,NA,NA,NA
tri07414,ACTRN12621000034831,FALSE,2021-09-18T02:51:02Z,NA,NA,NA,NA
tri07415,ACTRN12621000048886,FALSE,2021-10-01T04:26:18Z,NA,NA,NA,Diagnostic feasibility
tri07416,ACTRN12621000031864,FALSE,2021-10-01T10:07:03Z,NA,NA,NA,NA
tri07417,ISRCTN18107122,FALSE,2021-09-21T03:05:03Z,NA,NA,NA,NA
tri07452,CTRI/2020/12/029735,FALSE,2021-10-01T12:12:54Z,NA,NA,NA,NA
tri07455,CTRI/2020/12/029745,FALSE,2021-10-14T07:21:18Z,NA,NA,NA,NA
tri07464,CTRI/2020/12/029814,FALSE,2021-10-01T12:23:50Z,NA,NA,NA,NA
tri07511,CTRI/2020/12/030165,FALSE,2021-10-14T06:59:51Z,NA,NA,NA,NA
tri07571,CTRI/2021/01/030729,FALSE,2021-10-01T12:32:25Z,NA,NA,NA,NA
tri07580,NCT04715295,FALSE,2021-10-28T09:43:16Z,NA,NA,NA,NA
tri07582,NCT04715997,FALSE,2021-10-28T09:40:53Z,NA,NA,NA,NA
tri07585,NCT04716179,FALSE,2021-10-18T14:06:20Z,NA,NA,NA,NA
tri07588,NCT04716647,FALSE,2021-10-15T23:06:51Z,NA,NA,NA,NA
tri07591,NCT04718285,FALSE,2021-10-22T10:03:33Z,NA,NA,NA,NA
tri07593,NCT04718506,FALSE,2021-10-18T14:05:53Z,NA,NA,NA,Rehab
tri07599,NCT04720794,FALSE,2021-09-19T23:44:41Z,NA,NA,NA,NA
tri07606,NCT04724538,FALSE,2021-10-14T06:24:58Z,NA,NA,NA,NA
tri07607,NCT04724616,FALSE,2021-10-18T14:05:32Z,NA,NA,NA,NA
tri07608,NCT04724629,FALSE,2021-10-01T12:37:58Z,NA,NA,NA,NA
tri07611,ACTRN12621000067875,FALSE,2021-10-01T10:06:28Z,NA,NA,NA,Primary outcomes are safety measures
tri07614,ChiCTR2000040146,FALSE,2021-10-01T17:49:33Z,NA,NA,NA,NA
tri07615,ChiCTR2000039369,FALSE,2021-09-19T04:25:54Z,NA,NA,NA,NA
tri07617,NCT04674644,FALSE,2021-09-21T02:18:05Z,NA,NA,NA,NA
tri07618,NCT04682041,FALSE,2021-11-06T11:05:30Z,NA,NA,NA,NA
tri07629,NCT04721535,FALSE,2021-10-22T09:57:56Z,NA,NA,NA,NA
tri07630,NCT04723524,FALSE,2021-11-06T11:01:21Z,NA,NA,NA,other registration: https://www.wuxuwang.com/linchuangus/5a46b828-6044-11eb-8ee7-b8599fb47a0c
tri07637,NCT04725110,FALSE,2021-10-01T12:47:00Z,NA,NA,NA,NA
tri07638,NCT04726098,FALSE,2021-11-06T10:58:21Z,NA,NA,NA,NA
tri07642,NCT04726163,FALSE,2021-10-14T05:32:46Z,NA,NA,NA,NA
tri07654,NCT04729491,FALSE,2021-09-21T03:49:52Z,NA,NA,NA,NA
tri07656,NCT04730323,FALSE,2021-09-19T04:25:23Z,NA,NA,NA,NA
tri07662,NCT04733625,FALSE,2021-10-26T02:24:00Z,NA,NA,NA,NA
tri07665,NCT04734912,FALSE,2021-10-12T03:22:51Z,NA,NA,NA,NA
tri07673,NCT04678687,FALSE,2021-09-21T05:52:07Z,NA,NA,NA,NA
tri07674,NCT04678700,FALSE,2021-10-18T14:04:45Z,NA,NA,NA,Rehab
tri07686,NCT04733651,FALSE,2021-10-28T09:30:27Z,NA,NA,NA,NA
tri07689,NCT04734171,FALSE,2021-09-18T02:40:43Z,NA,NA,NA,NA
tri07692,NCT04734717,FALSE,2021-11-08T08:50:16Z,NA,NA,NA,NA
tri07703,NCT04739410,FALSE,2021-09-23T07:10:10Z,NA,NA,NA,NA
tri07708,NCT04742049,FALSE,2021-09-30T16:30:22Z,NA,NA,NA,NA
tri07712,NCT04742738,FALSE,2021-11-04T04:10:37Z,NA,NA,NA,NA
tri07714,NCT04742946,FALSE,2021-10-18T14:04:24Z,NA,NA,NA,rehab
tri07725,ACTRN12621000131853,FALSE,2021-10-26T13:43:34Z,NA,NA,NA,Safety and tolerability outcomes in healthy volunteers
tri07742,NCT04739020,FALSE,2021-10-12T03:19:59Z,NA,NA,NA,NA
tri07748,NCT04745442,FALSE,2021-10-29T00:34:03Z,NA,NA,NA,NA
tri07753,NCT04746365,FALSE,2021-09-29T04:23:00Z,NA,NA,NA,NA
tri07756,NCT04747132,FALSE,2021-09-21T01:57:05Z,NA,NA,NA,NA
tri07764,NCT04748120,FALSE,2021-10-18T14:04:02Z,NA,NA,NA,This is saying whether surgery for other stuff is OK during COVID which is not treatment or preventions of covid
tri07767,NCT04749121,FALSE,2021-10-14T05:31:35Z,NA,NA,NA,NA
tri07768,NCT04750317,FALSE,2021-09-21T04:21:52Z,NA,NA,NA,NA
tri07769,NCT04750343,FALSE,2021-10-31T08:00:11Z,NA,NA,NA,NA
tri07774,NCT04751617,FALSE,2021-09-22T03:49:18Z,NA,NA,NA,Rehab
tri07782,NCT04754113,FALSE,2021-10-14T05:22:19Z,NA,NA,NA,NA
tri07790,IRCT20200424047184N1,FALSE,2021-10-29T04:35:12Z,NA,NA,NA,NA
tri07793,IRCT20200928048865N1,FALSE,2021-10-01T04:22:50Z,NA,NA,NA,NA
tri07794,IRCT20191125045496N3,FALSE,2021-09-21T02:15:04Z,NA,NA,NA,"Trial is evaluating the effect of Pulmonary Rehabilitation on Depression, Anxiety, Fatigue and Quality of Life"
tri07809,IRCT20180316039112N3,FALSE,2021-10-29T05:40:53Z,NA,NA,NA,NA
tri07846,CTRI/2021/01/030829,FALSE,2021-10-22T05:14:27Z,NA,NA,NA,NA
tri07858,CTRI/2021/02/030957,FALSE,2021-10-07T02:58:50Z,NA,NA,NA,"While the study says they are looking at COVID symptoms, the primary outcome is only on influenze-like illness. That is not the same thing as covid.\n\nThere is a paper and this too also only reports not getting ILI symptoms. Not the same thing as COVID.\nhttps://myselfhealthcheck.co.uk/wp-content/uploads/2021/09/ASMI-04-0925.pdf"
tri07877,CTRI/2021/02/031256,FALSE,2021-10-01T13:38:15Z,NA,NA,NA,NA
tri07884,CTRI/2021/02/031375,FALSE,2021-10-28T09:22:27Z,NA,NA,NA,NA
tri07895,NCT04749173,FALSE,2021-10-01T10:05:09Z,NA,NA,NA,Primary outcome is incidence of adverse events
tri07896,NCT04750759,FALSE,2021-10-12T03:17:05Z,NA,NA,NA,No primary efficacy endpoint
tri07902,NCT04756609,FALSE,2021-11-06T10:22:17Z,NA,NA,NA,NA
tri07910,NCT04757818,FALSE,2021-10-06T04:52:25Z,NA,NA,NA,NA
tri07915,NCT04758286,FALSE,2021-10-14T05:10:22Z,NA,NA,NA,NA
tri07917,NCT04760561,FALSE,2021-10-06T04:56:49Z,NA,NA,NA,NA
tri07920,NCT04760743,FALSE,2021-10-18T11:44:04Z,NA,NA,NA,Phase 1 safety outcomes
tri07943,NCT04678843,FALSE,2021-10-18T14:02:24Z,NA,NA,NA,NA
tri07946,NCT04681053,FALSE,2021-10-20T08:04:02Z,NA,NA,NA,NA
tri07949,NCT04701502,FALSE,2021-10-14T04:05:09Z,NA,NA,NA,No completion date and no enrollment date reported
tri07950,NCT04701710,FALSE,2021-09-23T06:25:34Z,NA,NA,NA,NA
tri07952,NCT04713176,FALSE,2021-10-19T10:21:00Z,NA,NA,NA,NA
tri07953,NCT04723563,FALSE,2021-10-28T09:15:16Z,NA,NA,NA,https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bcp.14714 - I thought this may be the study protocol but had different NCT.
tri07959,NCT04747158,FALSE,2021-10-24T07:26:42Z,NA,NA,NA,NA
tri07960,NCT04757857,FALSE,2021-10-14T03:59:32Z,NA,NA,NA,NA
tri07965,NCT04768179,FALSE,2021-10-30T07:46:13Z,NA,NA,NA,NA
tri07973,NCT04769297,FALSE,2021-10-18T11:43:30Z,NA,NA,NA,NA
tri07976,NCT04769999,FALSE,2021-09-20T02:46:32Z,NA,NA,NA,NA
tri07982,NCT04771598,FALSE,2021-10-18T14:02:01Z,NA,NA,NA,Rehab
tri07987,NCT04773756,FALSE,2021-09-21T01:15:41Z,NA,NA,NA,NA
tri07997,ChiCTR2000041375,FALSE,2021-10-18T14:01:38Z,NA,NA,NA,NA
tri08004,NCT04690413,FALSE,2021-09-23T05:59:20Z,NA,NA,NA,NA
tri08006,NCT04706403,FALSE,2021-10-18T14:01:01Z,NA,NA,NA,Intention to vaccinate is one step removed from the outcomes we actually care about.
tri08007,NCT04716556,FALSE,2021-10-22T10:55:10Z,NA,NA,NA,NA
tri08010,NCT04747574,FALSE,2021-10-05T04:04:58Z,NA,NA,NA,- Phase 1 study with no primary efficacy outcome
tri08012,NCT04756466,FALSE,2021-10-20T07:53:19Z,NA,NA,NA,NA
tri08015,NCT04771559,FALSE,2021-11-05T10:03:38Z,NA,NA,NA,NA
tri08019,NCT04777981,FALSE,2021-10-28T09:06:16Z,NA,NA,NA,NA
tri08043,NCT04785781,FALSE,2021-09-30T16:33:06Z,NA,NA,NA,NA
tri08045,NCT04785898,FALSE,2021-09-19T14:11:34Z,NA,NA,NA,NA
tri08047,NCT04786080,FALSE,2021-10-18T14:00:22Z,NA,NA,NA,NA
tri08049,NCT04786483,FALSE,2021-09-22T02:57:50Z,NA,NA,NA,NA
tri08058,ISRCTN47591507,FALSE,2021-10-24T07:19:18Z,NA,NA,NA,NA
tri08073,NCT04713111,FALSE,2021-09-19T23:37:56Z,NA,NA,NA,NA
tri08074,NCT04715607,FALSE,2021-10-28T08:57:11Z,NA,NA,NA,NA
tri08082,NCT04780425,FALSE,2021-11-08T08:11:09Z,NA,NA,NA,NA
tri08092,NCT04789525,FALSE,2021-09-19T23:39:33Z,NA,NA,NA,NA
tri08094,NCT04791072,FALSE,2021-10-01T10:03:06Z,NA,NA,NA,NA
tri08096,NCT04791241,FALSE,2021-11-08T08:10:23Z,NA,NA,NA,NA
tri08101,NCT04793243,FALSE,2021-09-21T02:13:28Z,NA,NA,NA,NA
tri08103,NCT04793984,FALSE,2021-11-05T09:58:37Z,NA,NA,NA,NA
tri08107,NCT04794803,FALSE,2021-09-21T00:59:57Z,NA,NA,NA,NA
tri08111,NCT04796064,FALSE,2021-09-21T00:53:48Z,NA,NA,NA,NA
tri08114,NCT04797936,FALSE,2021-09-21T05:06:40Z,NA,NA,NA,NA
tri08115,NCT04798599,FALSE,2021-10-18T14:00:02Z,NA,NA,NA,NA
tri08127,ISRCTN85787008,FALSE,2021-09-19T23:40:06Z,NA,NA,NA,NA
tri08140,ChiCTR2100041704,FALSE,2021-10-06T05:23:24Z,NA,NA,NA,NA
tri08147,NCT04716569,FALSE,2021-10-15T23:18:11Z,NA,NA,NA,Results Submitted - Not Posted on ClinicalTrials.gov (2021-10-16)
tri08152,NCT04738045,FALSE,2021-10-06T05:29:12Z,NA,NA,NA,NA
tri08159,NCT04779047,FALSE,2021-10-06T05:35:49Z,NA,NA,NA,NA
tri08164,NCT04789356,FALSE,2021-11-05T09:37:40Z,NA,NA,NA,NA
tri08182,NCT04801134,FALSE,2021-11-01T06:40:51Z,NA,NA,NA,NA
tri08191,NCT04803227,FALSE,2021-10-20T07:31:53Z,NA,NA,NA,Safety outcomes
tri08193,NCT04803812,FALSE,2021-09-28T11:10:57Z,NA,NA,NA,NA
tri08197,NCT04805684,FALSE,2021-10-01T09:55:40Z,NA,NA,NA,NA
tri08200,NCT04806074,FALSE,2021-09-19T14:11:54Z,NA,NA,NA,NA
tri08217,ACTRN12621000344897,FALSE,2021-10-18T13:59:42Z,NA,NA,NA,NA
tri08218,ACTRN12621000309886,FALSE,2021-11-08T08:45:56Z,NA,NA,NA,NA
tri08221,ISRCTN16806663,FALSE,2021-10-15T17:38:11Z,NA,NA,NA,NA
tri08274,NCT04678739,FALSE,2021-09-28T08:56:43Z,NA,NA,NA,NA
tri08275,NCT04679493,FALSE,2021-10-22T05:02:11Z,NA,NA,NA,Phase 1 safety outcomes
tri08276,NCT04680949,FALSE,2021-10-06T05:44:13Z,NA,NA,NA,NA
tri08277,NCT04689399,FALSE,2021-10-01T09:54:25Z,NA,NA,NA,NA
tri08278,NCT04690387,FALSE,2021-09-28T08:43:21Z,NA,NA,NA,Phase 1 safety
tri08280,NCT04700163,FALSE,2021-11-01T07:56:26Z,NA,NA,NA,Only efficacy and pharmacokinetic outcomes for early stage treatment trial in healthy volunteers.
tri08289,NCT04723290,FALSE,2021-09-21T02:05:19Z,NA,NA,NA,NA
tri08294,NCT04737486,FALSE,2021-10-01T09:54:59Z,NA,NA,NA,Phase 1 vaccine safety
tri08311,NCT04798677,FALSE,2021-10-22T05:02:35Z,NA,NA,NA,NA
tri08314,NCT04802018,FALSE,2021-11-08T07:58:58Z,NA,NA,NA,device to monitor covid symptoms
tri08327,NCT04812184,FALSE,2021-09-21T01:56:19Z,NA,NA,NA,NA
tri08330,NCT04813471,FALSE,2021-10-06T05:58:41Z,NA,NA,NA,NA
tri08331,NCT04813497,FALSE,2021-10-18T14:44:59Z,NA,NA,NA,NA
tri08332,NCT04813575,FALSE,2021-10-18T14:45:58Z,NA,NA,NA,NA
tri08344,NCT04816084,FALSE,2021-09-19T14:11:00Z,NA,NA,NA,NA
tri08347,NCT04816682,FALSE,2021-11-05T07:16:29Z,NA,NA,NA,non-english registration? https://ichgcp.net/ru/clinical-trials-registry/NCT04816682
tri08351,NCT04817332,FALSE,2021-10-15T17:21:30Z,NA,NA,NA,NA
tri08363,NCT04820803,FALSE,2021-10-22T05:02:00Z,NA,NA,NA,NA
tri08367,NCT04821934,FALSE,2021-10-18T14:47:10Z,NA,NA,NA,NA
tri08368,NCT04821973,FALSE,2021-10-18T14:46:54Z,NA,NA,NA,Monitoring not treatment
tri08370,NCT04822285,FALSE,2021-09-16T07:35:19Z,NA,NA,NA,Primary Outcome Measures :\n\n    severity of psychological distress
tri08378,NCT04824391,FALSE,2021-10-20T07:16:17Z,NA,NA,NA,NA
tri08396,NCT04828668,FALSE,2021-11-01T06:41:39Z,NA,NA,NA,Post-acute covid
tri08411,NCT04834115,FALSE,2021-10-20T07:15:21Z,NA,NA,NA,NA
tri08415,ACTRN12621000347864,FALSE,2021-10-14T05:35:29Z,NA,NA,NA,NA
tri08418,ISRCTN21085622,FALSE,2021-10-01T13:44:35Z,NA,NA,NA,NA
tri08428,ISRCTN14966097,FALSE,2021-11-08T08:41:04Z,NA,NA,NA,NA
tri08434,ChiCTR2100042069,FALSE,2021-10-06T06:02:02Z,NA,NA,NA,NA
tri08435,ChiCTR2100042068,FALSE,2021-10-06T06:03:43Z,NA,NA,NA,NA
tri08436,ChiCTR2100042066,FALSE,2021-10-06T06:05:38Z,NA,NA,NA,NA
tri08437,ChiCTR2100042004,FALSE,2021-09-21T03:47:11Z,NA,NA,NA,NA
tri08438,ChiCTR2100042003,FALSE,2021-09-17T08:22:11Z,NA,NA,NA,NA
tri08453,NCT04685447,FALSE,2021-09-17T09:21:27Z,NA,NA,NA,NA
tri08457,NCT04716426,FALSE,2021-10-06T06:50:01Z,NA,NA,NA,NA
tri08459,NCT04720235,FALSE,2021-10-01T13:45:12Z,NA,NA,NA,NA
tri08464,NCT04747821,FALSE,2021-10-28T03:57:51Z,NA,NA,NA,NA
tri08465,NCT04748783,FALSE,2021-10-20T02:56:37Z,NA,NA,NA,NA
tri08468,NCT04762173,FALSE,2021-10-14T05:33:50Z,NA,NA,NA,NA
tri08469,NCT04762771,FALSE,2021-10-06T06:55:49Z,NA,NA,NA,NA
tri08473,NCT04791423,FALSE,2021-10-28T03:50:54Z,NA,NA,NA,NA
tri08474,NCT04794036,FALSE,2021-10-18T14:47:30Z,NA,NA,NA,rehab
tri08475,NCT04796402,FALSE,2021-10-14T05:57:18Z,NA,NA,NA,NA
tri08478,NCT04800939,FALSE,2021-10-29T00:35:23Z,NA,NA,NA,NA
tri08479,NCT04808921,FALSE,2021-09-22T02:56:40Z,NA,NA,NA,NA
tri08481,NCT04815057,FALSE,2021-09-19T23:37:30Z,NA,NA,NA,NA
tri08492,NCT04834739,FALSE,2021-10-01T13:46:01Z,NA,NA,NA,NA
tri08505,NCT04836780,FALSE,2021-11-01T21:59:20Z,NA,NA,NA,NA
tri08507,NCT04838080,FALSE,2021-10-30T14:40:55Z,NA,NA,NA,Phase 1 safety outcomes
tri08516,NCT04840082,FALSE,2021-10-01T13:55:14Z,NA,NA,NA,NA
tri08520,NCT04841681,FALSE,2021-09-19T23:45:24Z,NA,NA,NA,NA
tri08522,NCT04842734,FALSE,2021-10-18T14:48:21Z,NA,NA,NA,NA
tri08526,ISRCTN72605600,FALSE,2021-10-18T14:48:49Z,NA,NA,NA,NA
tri08531,ChiCTR2100042356,FALSE,2021-09-15T13:53:24Z,NA,NA,NA,NA
tri08537,NCT04711863,FALSE,2021-10-28T03:33:13Z,NA,NA,NA,NA
tri08541,NCT04751474,FALSE,2021-10-01T13:55:33Z,NA,NA,NA,NA
tri08544,NCT04800224,FALSE,2021-11-01T21:51:50Z,NA,NA,NA,Protocol is a preprint
tri08568,NCT04844710,FALSE,2021-09-21T00:35:25Z,NA,NA,NA,NA
tri08570,NCT04845880,FALSE,2021-10-06T06:56:34Z,NA,NA,NA,NA
tri08571,NCT04845971,FALSE,2021-10-19T10:31:06Z,NA,NA,NA,NA
tri08577,NCT04847362,FALSE,2021-10-18T14:49:09Z,NA,NA,NA,NA
tri08578,NCT04847375,FALSE,2021-11-01T06:57:41Z,NA,NA,NA,There was a very similar preprint: https://www.researchsquare.com/article/rs-136365/v1\n\nThat is on treatment of ventilated pts while while this is pre-ventilation treatment with same drug.\n\nThe preprint was removed but is available through ResearchGate: https://www.researchgate.net/publication/348149020_Exogenous_Surfactant_Versus_Placebo_in_the_Treatment_of_Moderate_and_Severe_ARDS_in_COVID-19_The_Pilot_Study_of_a_Clinical_Trial
tri08594,NCT04849637,FALSE,2021-11-01T21:44:24Z,NA,NA,NA,NA
tri08595,NCT04849793,FALSE,2021-09-28T11:09:04Z,NA,NA,NA,NA
tri08600,NCT04853901,FALSE,2021-09-28T08:40:13Z,NA,NA,NA,NA
tri08632,IRCT20150815023620N9,FALSE,2021-09-20T03:08:55Z,NA,NA,NA,NA
tri08635,IRCT20200823048495N1,FALSE,2021-09-17T08:17:27Z,NA,NA,NA,NA
tri08638,IRCT20160516027929N8,FALSE,2021-09-21T00:31:41Z,NA,NA,NA,NA
tri08641,IRCT20201212049681N1,FALSE,2021-10-19T10:04:56Z,NA,NA,NA,NA
tri08683,CTRI/2021/02/031430,FALSE,2021-10-06T06:59:39Z,NA,NA,NA,NA
tri08684,CTRI/2021/02/031479,FALSE,2021-10-19T05:14:05Z,NA,NA,NA,NA
tri08690,CTRI/2021/02/031570,FALSE,2021-10-18T14:49:50Z,NA,NA,NA,NA
tri08733,CTRI/2021/03/032072,FALSE,2021-10-28T03:29:20Z,NA,NA,NA,NA
tri08753,NCT04748536,FALSE,2021-10-18T11:47:02Z,NA,NA,NA,Safety outcomes on healthy volunteers
tri08757,NCT04761874,FALSE,2021-09-15T13:52:50Z,NA,NA,NA,NA
tri08762,NCT04784481,FALSE,2021-09-19T14:54:55Z,NA,NA,NA,NA
tri08766,NCT04833101,FALSE,2021-11-01T21:41:03Z,NA,NA,NA,NA
tri08774,NCT04852770,FALSE,2021-11-04T04:54:05Z,NA,NA,NA,NA
tri08780,NCT04853134,FALSE,2021-10-27T07:50:49Z,NA,NA,NA,NA
tri08787,NCT04854941,FALSE,2021-10-06T07:07:37Z,NA,NA,NA,NA
tri08792,NCT04858542,FALSE,2021-10-18T14:50:08Z,NA,NA,NA,NA
tri08800,NCT04860219,FALSE,2021-09-21T03:43:16Z,NA,NA,NA,NA
tri08803,NCT04860271,FALSE,2021-09-28T11:08:49Z,NA,NA,NA,NA
tri08804,NCT04860284,FALSE,2021-09-30T07:45:16Z,NA,NA,NA,NA
tri08828,NCT04678778,FALSE,2021-09-30T06:18:58Z,NA,NA,NA,NA
tri08829,NCT04685681,FALSE,2021-11-08T08:37:04Z,NA,NA,NA,NA
tri08841,NCT04732819,FALSE,2021-10-01T13:50:45Z,NA,NA,NA,NA
tri08845,NCT04767477,FALSE,2021-10-18T14:50:20Z,NA,NA,NA,Rehab
tri08849,NCT04790786,FALSE,2021-10-31T08:43:55Z,NA,NA,NA,NA
tri08864,NCT04854486,FALSE,2021-10-27T07:35:54Z,NA,NA,NA,NA
tri08866,NCT04854928,FALSE,2021-10-27T07:29:30Z,NA,NA,NA,NA
tri08870,NCT04859244,FALSE,2021-10-26T13:42:18Z,NA,NA,NA,Safety outcomes in healthy volunteers
tri08873,NCT04860895,FALSE,2021-10-27T07:20:58Z,NA,NA,NA,NA
tri08882,NCT04864015,FALSE,2021-10-27T07:20:26Z,NA,NA,NA,NA
tri08884,NCT04864925,FALSE,2021-10-27T07:19:53Z,NA,NA,NA,NA
tri08900,NCT04869072,FALSE,2021-09-21T00:25:29Z,NA,NA,NA,NA
tri08909,NCT04871633,FALSE,2021-09-21T00:18:03Z,NA,NA,NA,NA
tri08935,ChiCTR2100042726,FALSE,2021-09-24T14:56:55Z,NA,NA,NA,NA
tri08953,NCT04681430,FALSE,2021-10-12T02:42:32Z,NA,NA,NA,NA
tri08954,NCT04715932,FALSE,2021-10-27T07:18:05Z,NA,NA,NA,NA
tri08958,NCT04753645,FALSE,2021-10-19T05:14:11Z,NA,NA,NA,not covid specific
tri08972,NCT04834726,FALSE,2021-10-18T14:53:36Z,NA,NA,NA,One step removed from treatment and prevention.
tri08979,NCT04859023,FALSE,2021-09-27T14:03:29Z,NA,NA,NA,NA
tri08983,NCT04866589,FALSE,2021-10-27T07:12:53Z,NA,NA,NA,NA
tri09004,NCT04876560,FALSE,2021-09-19T23:38:57Z,NA,NA,NA,NA
tri09007,NCT04876885,FALSE,2021-10-18T14:54:06Z,NA,NA,NA,Intention to vaccinate
tri09009,NCT04877002,FALSE,2021-10-18T14:54:33Z,NA,NA,NA,diagnostic
tri09014,NCT04878042,FALSE,2021-11-01T21:28:15Z,NA,NA,NA,NA
tri09019,NCT04880122,FALSE,2021-09-19T23:43:06Z,NA,NA,NA,NA
tri09020,NCT04880135,FALSE,2021-10-18T14:54:59Z,NA,NA,NA,NA
tri09035,ISRCTN18100261,FALSE,2021-10-30T14:40:00Z,NA,NA,NA,NA
tri09039,ISRCTN22331899,FALSE,2021-09-19T23:42:02Z,NA,NA,NA,NA
tri09058,ChiCTR2100045845,FALSE,2021-10-27T07:11:55Z,NA,NA,NA,NA
tri09073,ChiCTR2100044026,FALSE,2021-09-22T02:55:28Z,NA,NA,NA,NA
tri09121,NCT04674566,FALSE,2021-10-12T02:42:02Z,NA,NA,NA,NA
tri09127,NCT04771013,FALSE,2021-10-26T13:41:28Z,NA,NA,NA,NA
tri09130,NCT04789603,FALSE,2021-10-18T14:56:02Z,NA,NA,NA,NA
tri09131,NCT04799392,FALSE,2021-10-18T14:55:46Z,NA,NA,NA,diagnostics
tri09132,NCT04801836,FALSE,2021-11-01T21:17:46Z,NA,NA,NA,NA
tri09148,NCT04872686,FALSE,2021-10-27T06:50:35Z,NA,NA,NA,NA
tri09159,NCT04883203,FALSE,2021-09-21T03:33:04Z,NA,NA,NA,NA
tri09183,NCT04889274,FALSE,2021-10-31T08:45:16Z,NA,NA,NA,Reducing vaccine side-effects so not acute treatment.
tri09190,NCT04894721,FALSE,2021-10-27T06:54:40Z,NA,NA,NA,NA
tri09198,ChiCTR2100043210,FALSE,2021-10-19T05:57:41Z,NA,NA,NA,NA
tri09301,CTRI/2021/05/033339,FALSE,2021-11-01T21:15:03Z,NA,NA,NA,Primary outcomes are about treatment satisfaction and quality of life
tri09336,IRCT20201127049504N1,FALSE,2021-10-06T07:37:57Z,NA,NA,NA,NA
tri09385,NCT04706299,FALSE,2021-10-18T14:56:20Z,NA,NA,NA,NA
tri09397,NCT04753476,FALSE,2021-10-31T08:14:21Z,NA,NA,NA,NA
tri09398,NCT04758299,FALSE,2021-10-07T04:11:48Z,NA,NA,NA,NA
tri09402,NCT04765839,FALSE,2021-10-07T04:11:30Z,NA,NA,NA,NA
tri09434,NCT04870385,FALSE,2021-09-23T09:28:23Z,NA,NA,NA,NA
tri09447,NCT04890483,FALSE,2021-10-07T04:11:12Z,NA,NA,NA,NA
tri09448,NCT04890509,FALSE,2021-10-30T14:23:37Z,NA,NA,NA,NA
tri09451,NCT04890665,FALSE,2021-09-23T09:28:02Z,NA,NA,NA,NA
tri09466,NCT04894409,FALSE,2021-09-17T08:59:30Z,NA,NA,NA,NA
tri09471,NCT04895267,FALSE,2021-10-30T14:17:47Z,NA,NA,NA,NA
tri09480,NCT04896840,FALSE,2021-09-23T09:35:44Z,NA,NA,NA,NA
tri09491,NCT04898088,FALSE,2021-09-21T04:42:12Z,NA,NA,NA,NA
tri09502,NCT04900129,FALSE,2021-09-24T14:54:01Z,NA,NA,NA,NA
tri09510,NCT04900415,FALSE,2021-09-23T09:27:14Z,NA,NA,NA,Rehab and just symptomatic
tri09521,NCT04902976,FALSE,2021-10-26T13:20:40Z,NA,NA,NA,NA
tri09530,NCT04904510,FALSE,2021-09-23T09:26:44Z,NA,NA,NA,NA
tri09542,NCT04907877,FALSE,2021-11-02T05:05:04Z,NA,NA,NA,NA
tri09546,NCT04907942,FALSE,2021-09-24T14:52:17Z,NA,NA,NA,NA
tri09566,ISRCTN37254291,FALSE,2021-09-27T13:57:45Z,NA,NA,NA,NA
tri09580,NCT04676867,FALSE,2021-10-26T13:04:53Z,NA,NA,NA,NA
tri09582,NCT04701489,FALSE,2021-10-06T07:59:17Z,NA,NA,NA,NA
tri09589,NCT04730856,FALSE,2021-10-30T14:06:39Z,NA,NA,NA,NA
tri09597,NCT04780152,FALSE,2021-10-07T03:45:11Z,NA,NA,NA,NA
tri09610,NCT04851821,FALSE,2021-10-26T13:01:00Z,NA,NA,NA,NA
tri09615,NCT04867265,FALSE,2021-10-30T14:02:32Z,NA,NA,NA,NA
tri09626,NCT04893512,FALSE,2021-10-30T14:01:44Z,NA,NA,NA,Phase 1 safety outcomes
tri09629,NCT04895371,FALSE,2021-10-07T03:45:24Z,NA,NA,NA,NA
tri09634,NCT04910230,FALSE,2021-09-17T09:20:52Z,NA,NA,NA,NA
tri09638,NCT04910516,FALSE,2021-09-23T09:40:38Z,NA,NA,NA,NA
tri09642,NCT04911790,FALSE,2021-10-30T14:01:17Z,NA,NA,NA,NA
tri09664,NCT04914832,FALSE,2021-10-22T11:12:48Z,NA,NA,NA,NA
tri09681,ISRCTN13848929,FALSE,2021-09-15T13:54:24Z,NA,NA,NA,NA
tri09720,NCT04672291,FALSE,2021-10-31T08:15:45Z,NA,NA,NA,Safety only outcomes
tri09726,NCT04724720,FALSE,2021-10-26T12:51:43Z,NA,NA,NA,NA
tri09739,NCT04806113,FALSE,2021-10-31T07:16:04Z,NA,NA,NA,Vaccine study with safety as primary endpoint.
tri09750,NCT04858633,FALSE,2021-10-30T13:46:58Z,NA,NA,NA,NA
tri09777,NCT04916574,FALSE,2021-10-06T07:56:58Z,NA,NA,NA,NA
tri09792,NCT04920773,FALSE,2021-10-26T12:46:50Z,NA,NA,NA,NA
tri09801,NCT04922814,FALSE,2021-11-01T08:00:46Z,NA,NA,NA,NA
tri09803,NCT04922905,FALSE,2021-09-17T09:20:09Z,NA,NA,NA,NA
tri09804,NCT04922918,FALSE,2021-10-30T13:42:24Z,NA,NA,NA,NA
tri09807,NCT04923061,FALSE,2021-09-23T09:43:21Z,NA,NA,NA,NA
tri09819,NCT04925258,FALSE,2021-09-23T09:41:47Z,NA,NA,NA,NA
tri09856,DRKS00023911,FALSE,2021-09-30T16:35:05Z,NA,NA,NA,NA
tri09914,DRKS00024454,FALSE,2021-09-27T13:44:27Z,NA,NA,NA,NA
tri09926,DRKS00023271,FALSE,2021-09-24T14:51:16Z,NA,NA,NA,NA
tri09955,DRKS00025199,FALSE,2021-09-19T23:36:54Z,NA,NA,NA,NA
tri09969,SLCTR/2021/008,FALSE,2021-10-30T13:41:28Z,NA,NA,NA,NA
tri09971,SLCTR/2021/002,FALSE,2021-10-07T04:25:19Z,NA,NA,NA,NA
tri09972,SLCTR/2021/001,FALSE,2021-11-05T07:50:36Z,NA,NA,NA,NA
tri09973,SLCTR/2020/026,FALSE,2021-10-07T07:50:46Z,NA,NA,NA,NA
tri09999,LBCTR2021014651,FALSE,2021-09-24T14:47:54Z,NA,NA,NA,NA
tri10004,PACTR202012892855610,FALSE,2021-10-30T13:34:44Z,NA,NA,NA,NA
tri10007,PACTR202101875903773,FALSE,2021-10-26T01:53:20Z,NA,NA,NA,NA
tri10014,PACTR202103574924457,FALSE,2021-10-07T03:44:27Z,NA,NA,NA,NA
tri10016,PACTR202103601407640,FALSE,2021-10-30T13:20:03Z,NA,NA,NA,NA
tri10017,PACTR202104601572565,FALSE,2021-10-26T01:34:09Z,NA,NA,NA,NA
tri10022,RPCEC00000349,FALSE,2021-10-08T12:14:59Z,NA,NA,NA,phase 1 vaccine safety
tri10029,RPCEC00000357,FALSE,2021-09-21T00:42:45Z,NA,NA,NA,NA
tri10032,RPCEC00000361,FALSE,2021-10-30T08:26:33Z,NA,NA,NA,NA
tri10034,RPCEC00000366,FALSE,2021-10-30T13:16:13Z,NA,NA,NA,Safety outcomes
tri10049,TCTR20210602002,FALSE,2021-09-19T23:36:11Z,NA,NA,NA,NA
tri10062,TCTR20210412005,FALSE,2021-10-01T04:38:35Z,NA,NA,NA,NA
tri10070,TCTR20210308003,FALSE,2021-10-26T12:41:08Z,NA,NA,NA,NA
tri10117,NCT04546581,FALSE,2021-10-22T11:18:29Z,NA,NA,NA,NA
tri10119,NCT04667780,FALSE,2021-10-30T13:06:57Z,NA,NA,NA,NA
tri10121,NCT04674189,FALSE,2021-10-08T13:58:11Z,NA,NA,NA,NA
tri10123,NCT04698993,FALSE,2021-10-01T13:56:06Z,NA,NA,NA,NA
tri10125,NCT04701658,FALSE,2021-10-07T04:50:44Z,NA,NA,NA,NA
tri10134,NCT04751682,FALSE,2021-10-30T13:04:50Z,NA,NA,NA,Phase 1 safety outcomes
tri10137,NCT04754698,FALSE,2021-10-30T13:04:22Z,NA,NA,NA,NA
tri10138,NCT04758962,FALSE,2021-10-19T10:17:13Z,NA,NA,NA,Phase 1 safety outcomes
tri10140,NCT04765540,FALSE,2021-11-08T08:06:15Z,NA,NA,NA,NA
tri10144,NCT04782700,FALSE,2021-10-30T13:03:50Z,NA,NA,NA,NA
tri10157,NCT04822701,FALSE,2023-01-05T06:11:09Z,NA,NA,NA,NA
tri10174,NCT04867226,FALSE,2021-10-30T13:01:10Z,NA,NA,NA,NA
tri10176,NCT04872075,FALSE,2021-10-30T12:58:35Z,NA,NA,NA,NA
tri10177,NCT04878055,FALSE,2021-10-30T12:56:23Z,NA,NA,NA,NA
tri10222,NCT04931238,FALSE,2021-10-31T08:16:47Z,NA,NA,NA,NA
tri10236,NCT04933864,FALSE,2021-09-17T09:19:18Z,NA,NA,NA,NA
tri10250,NCT04935502,FALSE,2021-09-23T09:48:58Z,NA,NA,NA,NA
tri10253,NCT04936503,FALSE,2021-09-23T09:58:30Z,NA,NA,NA,NA
tri10254,NCT04936893,FALSE,2021-09-23T10:04:35Z,NA,NA,NA,NA
tri10279,ISRCTN16993428,FALSE,2021-09-23T10:00:49Z,NA,NA,NA,Just sampling blood. No actual treatments given.
tri10286,ISRCTN15162325,FALSE,2021-09-23T10:01:55Z,NA,NA,NA,An intervention to increase testing does not directly meet our inclusion criteria.
tri10295,ISRCTN69254139,FALSE,2021-11-01T07:41:11Z,NA,NA,NA,Full results journal article is Full b/c it is the primary outcome (immunogenicity at 28 days for 28 day boost cohort) but trial still ongoing for secondary outcomes (including f/u of longer boost schedule which is a secondary outcome)
tri10313,NL9365,FALSE,2021-09-23T10:03:51Z,NA,NA,NA,Testing uptake. Doesn't really meet our criteria.
